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The methylotrophic yeast Pichia pastoris is a popular expression platform for the production of 
heterologous proteins, has been implemented in over 1500 laboratories and used to produce over 70 
marketed proteins.  However, despite high volumetric productivities achievable in fermentor culture, 
and the methanol inducible AOX1 promoter, which can be manipulated to drive high levels of gene 
expression, P. pastoris suffers from low levels of cell specific productivity for secreted recombinant 
proteins. This has been attributed to bottlenecks in the secretory pathway, leading to product loss 
through the activation of ER stress responses, as well detrimental effects caused during cell growth 
on methanol.  In addition a large disparity in protein production is observable within supposedly 
homogenous clonal populations raised from single cell lines, known as clonal variation, requiring 
extensive screening of transformants to find adequate producers. 
The widespread use of zeocin, a known mutagen, as a selective agent was initially evaluated as a 
potential contributing factor to clonal variation.  A study comprising data for the production of 4 
different recombinant proteins from clonal samples raised in the presence of selection revealed that 
growth on zeocin does not exacerbate clonal variation and that selection itself appears to have a 
stabilising effect on the distribution of productivity phenotypes within certain populations.  Variation 
in a range of native factors was also explored for a recombinant strain secreting Penicillium 
funiculosum glucose oxidase, including transgene transcription, transcription of the UPR marker HAC1 
and growth rate in culture.  Whilst considerable variation was observed within samples for each of 
the factors tested, only a weak correlation between growth and productivity could be found, 
suggesting the involvement of other, currently unknown, factors that contribute to clonal variation. 
The homologue of the yeast transcription factor – OPI1 was deleted in P. pastoris as a strategy to 
increase productivity, as its removal in S. cerevisiae yields mutants with expanded ERs and improved 
secretion of recombinant proteins.  However the loss of OPI1 was shown to be detrimental to protein 
secretion, resulting in reduced productivities and an increased activation of  the UPR.  In a final study, 
3 strains centered on the concept of uncoupling the activity of the Mut pathway transcription f actor 
Mit1 from its transcriptional regulation were developed as a strategy to reduce glucose repression of 
the AOX1 promoter.  Each strain displayed alleviation of glucose repression to different degrees, with 
the least repressed strain - NGmit1; producing 20% more secreted recombinant protein than the 
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ampr  Ampicillin resistance 
BMG  Buffered minimal glycerol medium 
BMGY  Buffered glycerol-complex medium 
BMM  Buffered minimal methanol medium 
BMMY  Buffered methanol-complex medium 
bp  Base pair 
CCR  Carbon catabolite repression 
CHO  Chinese hamster ovary 
CRISPR  Clustered regularly interspersed short palindromic repeats 
CV  Coefficient of variation 
DNA  Deoxyribonucleic acid 
DTT  Dithiothreitol 
EDTA  Ethylenediaminetetraacetic acid 
ER  Endoplasmic reticulum 
ERAD  Endoplasmic reticulum associated degradation  
g  Gram 
GAP  Glyceraldehyde 3-phosphatase 
GOx  Glucose oxidase 
HIS4  Multifunctional protein involved in histidine biosynthesis in yeast 
HSA  Human serum albumin 
HuL T70A Synthetic human lysozymecontaining the T70A amino acid change 
Ire1p  Inositol requiring enzyme 1 
h  Hour 
KAR2  A karyogamy gene in yeast 
kb  Kilobase 
l  Litre 
LB  Lysogeny broth medium 
M  Molar 
MD  Minimal dextrose medium 
mg  Milligram 
mol  Moles 
mRNA  Messenger ribonucleic acid 
Mxr1t  Functional, truncated form of Mxr1p consisting of its N-terminal 400aa sequence 
nm  nanometres 
OD  Optical density 
PAOX1  AOX1 promoter 
PGAP  GAP promoter 
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PBS  Phosphate buffered saline 
PCR  Polymerase chain reaction 
Pdi  Protein disulphide isomerase 
pH  Measure of acidity or basicity in aqueous solution 
rpm  Revolutions per minute 
RT-PCR  Reverse transcription polymerase chain reaction 
RT-qPCR Reverse transcription quantitative polymerase chain reaction 
rDNA  Ribosomal DNA 
SDS PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SOC  Super optimal broth with catabolite repression 
TAE  Tris-acetate-EDTA buffer 
U  Unit 
UPR  Unfolded protein response 
UPRE  Unfolded protein response element 
UV  Ultra violet 
V  Volt 
v/v  Volume/ volume 
w/v  Weight/ volume 
YPD  Yeast extract, peptone, dextrose medium 
zeo  Zeocin 






1.1 The industrial impact of recombinant protein production 
 
Since human insulin was successfully expressed in Escherichia coli and subsequently manufactured as 
the first commercial recombinant product in 1982 (Ladisch and Kohlmann, 1992), recombinant 
protein production has formed the foundation of a global, multibillion-dollar enterprise.  The advent 
of genetic engineering has allowed the manipulation of organisms into cell factories capable of 
producing high quantities of foreign proteins, through the insertion of heterologous genes into the 
genome of the host, and has revolutionised the manufacture of proteins in industry and academia.  
Until the latter part of the 20th century their molecular and structural complexity limited protein 
production to purification from cells of the native host, and the transition to the use of 
microorganisms as in vivo expression systems in large scale fermentations has now provided a more 
viable and cost effective alternative for the mass production of specific proteins (Hayworth, 2013).  
Moreover, through the cloning of sequence-modified target genes, expression systems have provided 
a platform for the genetic engineering of recombinant proteins diverging from their native 
homologues.  This practice has not only proved essential in the discovery of novel, improved protein-
based therapeutics, such as the generation of monoclonal antibody libraries, but also has been a key 
tool in researching the structure and function of important proteins (Chen, 2012).   The global market 
for products made by recombinant expression technologies continues to show rapid growth, and is 
divided in the major part into two large niches: the manufacture of industrial enzymes and 
biopharmaceuticals. 
 
1.1.1 The industrial enzymes market 
 
As biological catalysts by nature, recombinantly produced enzymes across the tree of life have been 
successfully applied to a variety of chemical processes within vastly different industries to increase 
efficiency, product yields or refine final products.  The sale of degradative enzymes such as lipases, 
carbohydrases and proteases dominate the market, with proteases alone being estimated to account 
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for ~60% of the total market share (Adrio and Demain, 2014).  These are included in laundry 
detergents as well as being used in leather production, brewing and to improve the nutritional value 
of animal feed.  Amylases make up the second most significant product by demand and are used in 
the degradation or modification of starch oligosaccharides within the paper,  textiles, food and 
beverage industries (de Souza and de Oliveira Magalhães, 2010).  Whilst its intrinsic links to such 
large, established global industries explain the continuing success of the  industrial enzymes markets 
the advances and broadening scope within the field of biotechnology has also contributed to its 
steady growth (Adrio and Demain, 2014).  The emergence of newer ventures, such as the production 
of 2nd generation biofuels and the biorefining of waste materials into value added chemicals has 
placed a greater demand for specialised enzymes capable of degrading more complex feedstocks at 
high temperatures to be able to operate within current industrial processes (Adrio and Demain, 
2014).  The global industrial enzymes market was valued at 4.62 billion USD as of 2015 with a 
projected annual growth of ~7.0% until 2024; predicted to be driven by the expansion of the leather, 
bioethanol and nutraceutical industries (Grand View Research, 2016). 
 
1.1.2 The biopharmaceutical market 
 
Biopharmaceuticals, often shortened to biologics, encompass all drugs used to treat human disease 
of which either all or a component is made up of a biological macromolecule.  Biologics represent by 
far the largest market for recombinant products, being valued at 162 billion USD in 2014 and 
expected to rise to 278 billion USD by the year 2020 (Persistence Market Research, 2015).  This 
reflects the impressive pipeline of novel biologics currently in development by pharmaceutical 
companies responsible for a record of 20 new, FDA-approved drugs being released in 2015 alone (U.S. 
Food and Drug Administration, 2015).  The rapid adoption of biologics is evident by the growth in 
their share of the global pharmaceutical market from just 10% in 2000 to 29% in 2014, and 
accounting for over 50% of the pharmaceutical revenue streams of top companies: Sanofi -Aventis, 
Roche and AbbVie in 2012 (Otto, Santagostino and Schrader, 2014).  Within the biologics market itself 
therapeutic monoclonal antibodies make up the dominant class of product and represented almost 
half of total, global sales, netting close to 75 billion USD in 2013 (Ecker, Jones and Levine, 2015; Kinch, 
2015).  A greater understanding of the molecular interactions governing antibody binding and antigen 
recognition has led to the engineering of monoclonal antibodies with high specificity and drug 
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delivery properties to a wide range of disease targets, or otherwise, that are often greatly improved 
over their small molecule drug counterparts (Ecker, Jones and Levine, 2015).  As such monoclonal 
antibody products have been implemented in a variety of medical applications from pregnancy tests 
to diagnostics to the treatment of cancers and autoimmune diseases. 
For their many advantages, a major drawback to recombinant proteins lies in the cost of their 
production, especially for biologics which are more heavily regulated due to the inherent nature of 
their end-use (Bren, 2006).  These costs are passed on from companies to the consumer, raising 
serious implications for the access of affordable services and products, particularly in the case of 
healthcare in a time where an increasing number of drugs used to treat disease are based on 
recombinant proteins.  For example in the United Kingdom the therapeutic monoclonal antibody 
Kadcyla®, made by Roche, was rejected by the National healthcare system as a routine prescription 
for breast cancer, citing its list price of 90,000 GBP per patient as the main reason (National Institute 
for Health and Care Excellence, 2015).  Hence investments have been made in advancing upstream 
and downstream technologies to maximise the efficiency of production in an effort to drive down 
final product costs while maintaining the profit margins of the companies involved. 
 
1.2 Microbial expression systems 
 
From a similar bioprocessing perspective it would also be pertinent to increase the efficiency and 
productivity of expression systems in order to reduce manufacturing costs and increase the yield of 
high value recombinant proteins.  Furthermore proteins developed for clinical use often require more 
complex cellular machinery typical to eukaryotes to be correctly folded and processed,  such as the 
formation and breakage of disulphide bonds between cysteine residues, as well as a pattern of post-
translational modifications that will render the protein stable and functional without eliciting an 
immune response when administered to humans (Schmidt, 2004).  The choice of microorganisms as 
hosts for recombinant protein production benefits from a number of advantages such as robust 
growth on inexpensive media and a high turnover of product (Meyer and Schmidhalter, 2012).  The 
ability to conduct protein production from microbial hosts in large scale fermentations within 
bioreactors also minimises space requirements and the equipment footprint for the process over 
more complex hosts such as plants or transgenic animals.  Extensive research into genetic tools, strain 
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development, media composition and fermentation strategies has resulted in the availability of a 
wide range of well characterised expression platforms from a variety of microbial hosts that have 
been optimised for the production of different target proteins.  Perfect, universal production of all 
commercial recombinant proteins meeting the correct specification of the final product is impossible 
in any one expression system, and has led to the propagation of multiple systems that occupy 
different niches of product requirements – as exemplified by the range of hosts used by the 




1.2.1 Bacterial expression systems 
 
Prokaryotic expression hosts currently remain the most popular systems for heterologous protein 
production as their ease of genetic manipulation, simple growth requirements and high levels of 
Figure 1: Data adapted from Walsh (2014) to display the distribution of expression hosts used in the production 
of all  approved biopharmaceutical recombinant proteins between 2010 and 2014.  Mammalian cell  and E. coli 
expression systems continue to produce the clear majority of biologics  although other notable hosts  include the 
yeasts S. cerevisiae and P. pastoris that have been used in the successful production of new biological entities 
that have passed clinical trials.  
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protein expression have made them widely accessible (Chen, 2012).  A workhorse for heterologous 
protein production in research and many industrial sectors is the model organism E. coli, which has 
fast established itself as arguably the most popular expression system (Rosano and Ceccarelli, 2014).  
E. coli is capable of growing to high cell densities of up to 200g dry cell weight per ml of culture  (Lee, 
1996) and, under optimal conditions, can grow at doubling times of up to 20 minutes in glucose salts 
medium (Sezonov, Joseleau-Petit and D’Ari, 2007), often meaning that batch cultures can grow to 
stationary phase within less than a day after inoculation.  In addition to its superior growth 
characteristics simple and efficient cloning techniques have been well established for the E. coli 
system (Pope and Kent, 1996; Froger and Hall, 2007) and a wealth of advanced molecular tools and 
engineered strains are available to optimise the expression of specific proteins (Chen, 2012). 
An alternative host commonly used in the production of recombinant proteins is the Gram positive 
bacterium Bacillus subtilis which, unlike E. coli, lacks any cell surface endotoxic lipopolysaccharides 
(LPS), granting it full GRAS status (Terpe, 2006).  Furthermore B. subtilis contains a high-capacity 
secretory pathway that can be manipulated to export recombinant proteins into the culture medium, 
aiding in product recovery (Simonen and Palva, 1993).  The higher guarantee that purified, secreted 
recombinant proteins from B. subtilis will be endotoxin-free has made it the more favoured bacterial 
expression system within the food industry (Westers, Westers, and Quax, 2004). 
 
1.2.2 Mammalian cell lines 
 
Bacterial expression systems are limited in the size and complexity of the recombinant proteins that 
can be expressed (Braun, 2002; Khow and Suntrarachun, 2012), as they do not possess the cellular 
machinery for post-translational modifications that are present in higher eukaryotes.  Mammalian 
cells are used extensively in the biopharmaceutical industry as their form of post-translational 
modification is highly similar to that of human cells, minimising the risk of an immune response or 
loss of functionality of complex therapeutic proteins (Vink et al, 2013).  Currently the most used and 
well studied mammalian expression systems are derived from immortalized Chinese hamster ovary 
(CHO) epithelial cell lines.  The first approved mammalian cell-expressed therapeutic protein, tissue 
plasminogen activator, was produced in CHO cells in 1987 (Gaffney and Curtis, 1987) and since then 
favourable growth characteristics and successive strain and process improvements have established 
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CHO cells as the primary expression system within the biopharmaceutical industry (Walsh, 2014).  
Other notable expression systems include the murine NS50 and the human embryonic kidney (HEK) 
cell lines, which have seen an increase in usage in the production of biologics (Gaughan, 2016). 
Nevertheless the costly media components required for growth, more complicated handling over 
bacterial systems and the higher risk of viral contamination arguably constrain the usage of 
mammalian expression systems to the production of very high value products within large industries, 
which fits in the case of biologics (Boehm, 2007; Yin et al, 2007).  The time required to transfect and 
grow a stable recombinant cell line is also far longer in comparison to bacterial systems, further 
increasing the cost of production (Hacker, 2009). 
 
1.2.3 Yeast expression systems 
 
Yeast cells offer a number of advantages over both bacterial and mammalian expression hosts: 
prolific growth and expression can be achieved with simpler growth requirements and, as eukaryotes; 
they are capable of post-translational modifications (Nasser et al, 2003).  Saccharomyces cerevisiae 
and, more recently, Pichia pastoris are the most commonly used yeast expression systems, with an 
extensive knowledge base and genetic toolbox developed from years of studying S. cerevisiae as a 
model organism (Nasser et al, 2003).  The major disadvantage of S. cerevisiae as a yeast system is that 
the glycosylation profile it modifies proteins with differs significantly from mammalian cells, limiting 
their use for the production of human therapeutic proteins.  N-linked glycosylation in human cells 
entails the removal of mannose from attached glycans and the addition of N-Acetylglucosamine 
(GlcNAc), galactose, fucose and sialic acid subunits, whereas S. cerevisiae is limited to the addition of 
further mannose and mannosylphosphate sugars (De Pourcq, De Schutter and Callewaert, 2010).  The 
extensive addition of mannose residues, known as hyper mannosylation, results in the attachment of 
numerous large, complicated, glycan structures to secreted proteins and has been observed in many 
yeast systems (De Pourcq, De Schutter and Callewaert, 2010).  Hyper-mannosylated glycoforms of 
recombinant proteins often exhibit reduced bioactivities and also hamper the scope for yeast 
production of biologics as they are rapidly cleared in the human bloodstream and can be 




1.3 Pichia pastoris (Komagataella phaffi); a history 
 
Pichia pastoris represents one of a number of genera of methylotrophic yeasts; the only eukaryotic 
organisms capable of utilising methanol as a sole carbon source (Yurimoto, Oku and Sakai, 2011).  
Owing to the high levels of biomass that could be achieved through growing on methanol, the 
organism was initially adopted for the production of single cell protein (SCP) during the 1970’s by 
Phillips Petroleum.  The low cost of methane, a major component for the industrial manufacture of 
methanol, made P. pastoris an attractive candidate for SCP production and so the first P. pastoris-
defined media and fermentation protocols were designed (Cregg et al, 2000).  However the rise in 
methane prices during the 1973 oil crisis led to the project becoming economically impractical until 
the development of yeast molecular techniques in the 1980’s gave rise to the possibility for the use of 
P. pastoris as an expression system (Cregg et al, 2000; Macauley-Patrick et al, 2005).  With the 
intention of creating high value SCP containing recombinant growth factors Philips Petroleum funded 
research at Salk Institute BioTechnology/Industrial Associates to create the first molecular tools for 
the genetic manipulation of P. pastoris, and to identify suitable promoters for the expression of 
heterologous proteins (Cregg et al, 1985; Biogrammatics, 2013).  The combination of strong native 
promoters to drive expression with the scale-up production processes already developed during its 
SCP years finally realised the potential of P. pastoris as an effective expression system during early 
trials in the 1990’s.  A notable example includes the large-scale production of hydroxynitrile lysase, 
derived originally from tropical rubber trees, from which final titres exceeding 20g/l were achieved 
(Hasslacher et al, 1997).  The first commercially available Pichia expression toolkits were released by 
Research Corporation Technologies (RCT), who have held the patent to the system since 1993 and 
have granted licenses to other companies, including Life Technologies, now part of Thermo Fisher 
Scientific, to increase its accessibility.  Publications relating to the use of P. pastoris as an expression 
system rose exponentially throughout the 1990’s following the system’s commercialization to the 
point where over 200 heterologous proteins had been reported to have been expressed successfully 
by the year 2000 (Cregg, Cereghino and Higgins, 2000).  The publication of the first full P. pastoris 
genome sequence in 2009 (De Schutter, 2009), the formation of new strains, tools and the 
transferability of many previously recognized yeast protocols have helped to establish Pichia as a 
mainstream, well-defined yeast expression system (Ahmad et al, 2014).  Despite this S. cerevisiae 
clearly remains the primary yeast expression system within the biopharmaceutical industry (Figure 1) 
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and, as of 2014, only two currently approved commercialised biologics have been produced in P. 
pastoris: Jetrea – a truncated form of human plasmin by Thrombogenics (Belgium) and Kalbitor – a 
plasma kallikrein inhibitor produced by Dyax (USA).  However the Pichia expression system has gained 
significant traction in other sectors and has been used to make over 70 commercial products 
(Research Corporation Technologies, 2013) and has even succeeded S. cerevisiae as the most cited 
yeast expression system for certain applications, such as the production of lipases (Valero, 2012). 
Despite the phenotypic similarities originally observed across the methylotrophic yeasts in the Pichia 
genera that led to their initial grouping, sequencing studies of the 18S and 26S ribosomal RNAs 
revealed that the genus was not monophyletic; instead containing a number of distantly related 
species (Yamada, Maeda, and Mikata, 1994).  The results substantiated the reclassification of a 
number of species including P. pastoris, which was assigned to the newly described genus 
Komagataella (Yamada et al, 1995).  The result of a multigene sequence analysis between members 
of the Komagataella genus in 2009 revealed that K. pastoris was in fact synonymous with the species 
K. phaffi, described in 2005 (Kurtzman, 2005), and should therefore be reclassified as such (Kurtzman, 
2009).  Whilst the phylogenetic classification is formally recognised, it has not completely replaced P. 
pastoris as the associated name for the organism within the community with many academic articles 
published since the finding and throughout the period of this project continuing to reference P. 
pastoris.  Even though seven years have passed since its reclassification the reluctance to fully replace 
all reference to P. pastoris with K. phaffi is most likely due to the fact that the fundamental research 
establishing the Pichia system and its commercialisation was all conducted under the name P. 
pastoris, proposing that a certain degree of brand recognition exists in the name.  For the sake of 





1.4 Key features of the Pichia system 
 
1.4.1 Growth on methanol 
 
The key feature that first garnered interest in P. pastoris as a candidate for use in biotechnology 
processes was its ability to reach high cell densities in minimal media containing methanol as a sole 
carbon source for respiration.  Methanol is sequentially converted into glyceraldehyde 3-phosphate 
and assimilated into the tricarboxylic acid cycle (TCA) through a tightly regulated, unique pathway 
conserved among methylotrophic yeasts, named the methanol utilisation (Mut) pathway (Hartner 
and Glieder, 2006) (Figure 2). 
The initial steps of the Mut pathway produce the highly oxidative species hydrogen peroxide and 
formaldehyde.  To prevent oxidative damage to the cell interior these steps are housed in specialised 
peroxisomes, containing enzymes catalyzing the first three reactions of methanol assimilation, which 
proliferate from the endoplasmic reticulum (ER) upon growth on methanol and occupy large 
cytoplasmic spaces in the cell.  Of the peroxisomal Mut pathway enzymes alcohol oxidase (AOX) 
catalyses the oxidation of methanol into formaldehyde and hydrogen peroxide, and is essential for 
methanol metabolism in P. pastoris.  In what is possibly an evolutionary adaptation to compensate 
for the suboptimal kinetics of AOX caused by its low affinity for oxygen, P. pastoris produces large 
quantities of its primary alcohol oxidase (AOX1) during growth on methanol.  Production of AOX1 is so 
high that it accumulates to form up to 30% of the total, soluble, intracellular protein content in 







The deletion of the AOX1 gene results in mutants with reduced growth on methanol (MutS) while the 
double deletion of AOX1 and the secondary, lesser expressed P. pastoris alcohol oxidase – AOX2 
(Koutz et al, 1989) causes the complete impairment of methanol metabolism (Mut-) (Chiruvolu, 
Cregg, and Meagher, 1997).  Whilst the wild type phenotype (Mut+) for the Mut pathway is generally 
favoured as standard for expression in P. pastoris, the MutS phenotype holds bioprocess value as it 
Figure 2: Schematic displaying the methanol utilisation pathway in P. pastoris from Hartner and Glieder (2006).  
Abbreviated enzymes/pathways/molecules are AOX: alcohol oxidase, CAT: catalase, FLD: formaldehyde 
dehydrogenase, FGH: S-formylglutathione hydrolase, FDH: formate dehydrogenase, DAS: dihydroxyacetone 
synthase, TPI: triosephosphate isomerase, DAK: dihydroxy-acetone kinase, FBA: fructose 1,6-bisphosphate 
aldolase, FBP: fructose 1,6-bisphosphatase, MFS: methylformate synthase; DHA: dihydroxyacetone, 
GAP:glyceraldehyde 3-phosphate, DHAP: dihydroxyacetone phosphate, F1,6BP: fructose 1,6-bisphosphate, F6P: 
fructose 6-phosphate, Pi: phosphate, Xu5P: xylulose 5-phosphate, GSH: glutathione, PYR: pyruvate; PPP: 




has been used in conjunction with modified fermentation strategies to increase production of certain 
recombinant proteins (Pla et al, 2006) (Krainer et al, 2012). 
 
1.4.2 Inducible and constitutive promoters 
 
Growing P. pastoris on methanol also serves a dual purpose as the Mut pathway plays host to a 
number of methanol-inducible promoters that regulate the expression of genes within it, and are 
therefore suitable for controlling transgene expression.  Of these the AOX1 promoter (PAOX1), which is 
responsible for directing high levels of transcription of AOX1 to meet its high production demand, is 
the most commonly used due to its characteristically high strength.  PAOX1 is also strictly regulated by a 
number of trans-acting mechanisms in response to growth in different sources; expression is fully 
activated only with the presence of methanol in the culture medium and tight repression occurs 
during cell growth on glucose or glycerol.  Its switchable nature has led to PAOX1 becoming a classic 
genetic tool for tuning transgene expression in P. pastoris and has allowed the development of 
fermentation strategies with discrete stages that prioritise cell growth, followed by protein 
production, proving particularly useful for the production of recombinant proteins with cytotoxic 
effects (Jahic et al, 2006).  The strength of PAOX1 can be detrimental to the production of certain 
heterologous proteins if other downstream factors such as translation, folding or post-translational 
processing become limiting factors.  Therefore weaker promoters of other methanol inducible genes 
comprising the Mut pathway have also been tested successfully, including the AOX2, FLD1 and DAS 
and PEX8 promoters.  Methanol induction in itself is not always viable for certain processes due to 
the inherent safety concerns associated with working with large volumes of methanol.  This has 
spurred the search for alternative inducible promoters and, in 2013, the glucose-regulated promoters 
PG1 and PG6 were identified through microarray analysis (Prielhofer et al, 2013).  Both promoters are 
strongly repressed in cultures containing excess glucose, and are subsequently activated to induce 
high levels of transcription upon glucose depletion in culture (Prielhofer et al, 2013). 
A number of promoters for constitutive transgene expression are also available in the P. pastoris 
genetic toolkit of which the PGAP promoter, controlling the expression of the glyceraldehydes 3-
phosphate dehydrogenase gene natively in P. pastoris, has emerged as the most popular alternative 
to PAOX1.  Advantages of PGAP include strong expression when cells are grown in glucose or glycerol-
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based media, resulting in high protein production which can compare favourably to PAOX1 under 
certain situations.  As in the case of methanol induction, weaker constitutive promoters have also 
been validated and include the promoters for translation elongation factor 1 alpha (PTEF), enolase 
(PENO1) and a GTPase (PYTP1). 
 
1.4.3 Common expression vector design 
 
A regular challenge that presents itself in a number of expression systems is in the replication and 
maintenance of vectors containing the target transgene throughout the entire process of culture 
growth and expression.  The recombinogenic nature of P. pastoris has allowed the design of vectors 
that are maintained stably in cells by integrating into specific locations in the host genome (Mokdad-
Gargouri et al, 2012).  Expression vectors containing regions sharing homology to the target locus in 
the genome are restricted to form a linear construct with homologous ends.  Upon successful 
transformation into cells homologous recombination (HR) directs the insertion of the vector into the 
target locus through a single or double crossover event.  Common sites of integration include the 
regions containing the native P. pastoris promoter included in the vector to direct transgene 
expression, such as the AOX1 or GAP loci (Sears et al, 1998).  Since relatively large quantities of vector 
are recommended for the efficient transformation of integrating vectors, with approximately 5-10μg 
total DNA content used as standard for a single transformation of P. pastoris by electroporation, 
bacterial origins of replication and selectable markers are included in Pichia system vectors to enable 
their storage and biosynthesis in E. coli hosts (Higgins and Cregg, 1998).  A host of products employing 
this benchmark design are available commercially and include the pPICZα range of plasmids; a 
popular set of vectors for AOX1-based expression marketed by Thermo Fisher Scientific and used as 





Whilst the genomic integration of vectors into the genome persists as the most common method for 
maintaining stable expression, increasing interest in the value of high-throughput cloning techniques 
and transient expression for synthetic biology projects has spurred the further development of 
episomal vectors for use in P. pastoris (Camattari et al, 2016).  An episomal plasmid containing a 
452bp autonomous replicating sequence originating from Kluyveromyces lactis (panARS) was 
successfully assembled in vivo, cloned and retained in P. pastoris and even outperformed equivalent 
integrated vectors in the expression of blue fluorescent protein (Camattari et al, 2016).   Whilst the 
use of ARS’s in P. pastoris has been historically validated (Cregg, 1986) the field appears to be 
experiencing a resurgence, with exploratory studies of the P. pastoris genome in 2014 identifying a 
number of native ARS sequences from which to develop new episomal vectors (Liachko et al, 2014).  
Most recently a novel plasmid utilising native centromeric DNA to autonomously replicate in P. 
pastoris has also been described (Nakamura et al, 2016). 
Figure 3: Vector map of pPICZα.  Notable features include the AOX1 promoter region for methanol inducible 
expression and integration into the AOX1 locus, the S. cerevisiae α-mf for heterologous protein secretion, 




1.4.4 Post translational modifications 
 
Whilst other standard yeast expression systems such as S. cerevisiae have been reported to hyper-
mannosylate heterologous proteins during post-translational modification, a key feature that 
distinguishes P. pastoris from S. cerevisiae is that it is less prone to hyper-mannosylation, and so is 
more suited to the expression of secreted proteins (De Pourcq, De Schutter  and Callewaert, 2010; 
Jahic, 2013).  Furthermore the arrival of a glycoengineered, “humanized” strain of P. pastoris in 2006, 
capable of performing human type N-linked glycosylation, has potentially overcome the issues of the 
immunogenicity of therapeutic proteins expressed in yeasts (Hamilton, 2006).  The scale -up 
production of a fully functional monoclonal antibody with a high uniformity of N-linked glycans, at a 
productivity of over 1g/l by a glycoengineered P. pastoris strain in 2009 (Potgeiter, 2009) has 
demonstrated that P. pastoris could also rival mammalian expression systems for the production of 
therapeutic proteins.  However, in spite of the commercial availability of glycoengineered strains, the 
most notable being the Pichia Glycoswitch® system from RCT, the usage of P. pastoris within the 
biopharmaceutical industry has not increased in response.  A potential reason is that the principles 
originally applied in the glycoengineering of P. pastoris were replicated in S. cerevisiae more recently 
to develop strains also capable of performing humanized N-linked glycosylation (Arico, Bonnet, and 
Javaud, 2013).  The availability of two different yeast expression systems capable of uniform, human-
like glycosylation and the longer history of S. cerevisiae in the biopharmaceutical industry could 
provide an explanation for its low adoption of glycoengineered P. pastoris. 
 
1.4.5 Recombinant protein secretion 
 
Heterologous proteins can be targeted for secretion in the Pichia system through addition of a 
number of yeast signal sequences, and benefit from a low background of endogenous proteins 
secreted by P. pastoris into the media (Cregg et al, 2000; Lin-Cereghino et al, 2002).  Therefore, if cells 
are grown in minimal media containing no added protein, the secreted recombinant protein often 
constitutes the vast majority of the total protein in the medium after expression, reducing the cost 
and resources required in downstream processing.  The most common signal sequence used to target 
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proteins to the secretory pathway in P. pastoris encodes the alpha mating factor (α-mf) from S. 
cerevisiae, and is typically cloned to be expressed at the N-terminus of the target protein (Kurjan, and 
Herskowitz, 1982).  Other secretion signals have also been used in the past and include the signals for 
the S. cerevisiae invertase (SUC2) and the P. pastoris acid phosphatase (PHO1) (Daly and Hearn, 
2005). 
 
1.5 Advanced tools and techniques 
 
1.5.1 Genome sequence 
 
The first publication of a P. pastoris genome in 2009, specifically from the strain GS115, has provided 
information that greatly enabled strain improvement strategies and contributed to the associated 
knowledge base (De Schutter et al, 2009).  Accessibility to the genome for users was improved 
significantly through its integration with a web-based Genome browser made publicly available; with 
a Wiki based platform to allow users to add new annotations for currently identified genes 
(Mattanovich et al, 2009).  In 2011 a high quality genome sequence for the parental P. pastoris strain 
– CBS7435 was published and included, for the first time, sequence for the P. pastoris mitochondrial 
genome (Kuberl et al, 2011).  The most ambitious sequencing project to date assembled genomes 
from seven different strains and developed an updated reference genome sequence , correcting over 
500 positions from previous sequences and including sequences of putative chromosomal 
centromeres as well as two cytoplasmic plasmids found in certain strains (Sturmberger et al, 2016).  
The successive revisions and additions to the P. pastoris genome sequence has provided a high 
quality resource for the user community from which to mine for elements or genes that could 





1.5.2 Promoter libraries 
 
The industrial and commercial relevance of the AOX1 promoter for methanol inducible protein 
production has led to studies attempting to elucidate its transcriptional regulation (Vogl and Glieder 
2013).  Truncation studies as well as the investigation of predicted transcription factor binding sites 
resulted in the mapping of multiple cis-acting regulatory sequences (Inan, 2000; Hartner et al, 2008; 
Xuan et al, 2009).  The sequential deletion or repetition of these elements by Hartner et al (2008) 
resulted in the development of a PAOX1 variant library ranging from ~6% to ~160% of the original 
promoter strength of PAOX1, based on the expression of recombinant GFP.  Considering that the 
strength of the native PAOX1 can somewhat tuned by controlling the concentration of methanol in 
culture (Jahic et al, 2006), the availability of a PAOX1 promoter library provides the user with more 
control over transgene expression levels to optimise the productivity of specific proteins, and has 
increased the versatility of methanol induction in P. pastoris. 
Constitutive expression has been similarly innovated and, in 2011, a GAP promoter library was 
generated by error prone PCR and quantified for activity by measuring the associated expression of a 
yeast-enhanced GFP (Qin et al, 2011).  A wide range of promoter activities were encompassed in the 
library with the strongest variant, named PG1, increasing expression by 19.6 fold over the native PGAP. 
 
1.5.3 Post transformational vector amplification (PTVA) 
 
As discussed previously, the recombinogenic nature of P. pastoris permits the design of vectors that 
target genes to integrate into a specific locus within the host genome by homologous recombination.  
Through this process multicopy clones can spontaneously arise through the integration of more than 
one copy of the vector into the genome, and in many cases has been shown to increase specific 
productivity through an increase in gene dosage (Clare et al, 1991).  The importance of gene dosage 
in increasing productivity was discovered for a number of different proteins, leading to the 
development of techniques to enrich transformant populations for high copy number variants, or to 
stimulate copy number increase in vivo (Cos et al, 2005).  In 2008 Sunga et al described a protocol to 
select for multicopy integrants through the re-plating of transformant colonies containing vectors 
bearing the zeocin resistance marker on agar media containing successively higher concentrations of 
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zeocin.  The study reported that the use of PTVA was able to increase the probability of obtaining a 
“jackpot” colony containing 10 or more vector copies from ~1% to 5-6%, and has been generally 
adopted as a process for selecting multicopy integrants of P. pastoris (Sunga et al, 2008).  Since its 
conception PTVA has also been validated for selection with G418 and hygromycin, the latter being 
significantly less expensive than zeocin (Cole, 2009; Yang et al, 2014).  Recently the protocol was 
adapted for the selection of strains in liquid media, significantly reducing antibiotic usage and clone 
growth times for the zeocin and G418 PTVA protocols (Aw and Polizzi, 2016). 
 
1.5.4 Improved platform strains for genetic engineering and productivity 
 
In conjunction to the those previously discussed, considerable research into strain development has 
given rise to a range of engineered platforms, many of which have been made available commercially, 
that improve on the usability or efficacy of the Pichia system.  A compilation of some of the more 
notable strain modifications made in P. pastoris, and their outputs are summarised in Table 1. 
The initial development of genetic tools to engineer P. pastoris resulted in the creation of auxotrophic 
mutant strains incapable of synthesising different organic compounds, allowing for the selection of 
positive transformants with vectors containing the required gene to rescue the biosynthetic pathway 
(Cregg et al, 1985; Lin Cereghino et al., 2001).  Many of these are still used as popular expression 
platforms, including P. pastoris GS115, currently marketed by Thermo Fisher Scientific and Ade- 
strains, which are included within the PichiaPink™ commercial expression kit.  Also included within 
PichiaPink™ are strains lacking the major proteases Pep4 and proteinase B, which have been 
demonstrated to improve the production of certain recombinant proteins that are particularly 
sensitive to protease-mediated degradation (Gleeson et al, 1998; Ahmad et al, 2014).  The further 
improvement of production of different recombinant proteins has been achieved in engineered 
strains achieving higher rates of secretion, with common strategies for strain improvement centring 






Modification Description Output Reference 
Methanol utilisation mutants 
aox1 Disruption of the gene 
encoding alcohol oxidase 1 
(AOX1), generating the MutS 
phenotype. 
Slow growth on methanol.  
Increased production of A33 




Pla et al (2006) 
aox1, aox2 Disruption of both alcohol 
oxidase genes, generating the 
Mut- phenotype. 




his4 Disruption of HIS4, encoding a 
multifunctional enzyme 
essential for histidine 
biosynthesis. 
Histidine auxotrophic strain 
GS115 (Thermo Fisher 
Scientific).  Selectable by HIS4 
complementation. 
Cregg et al 
(1985)  
ade2 Disruption of ADE2, encoding a 
Phosphoribosylaminoimidazole 
carboxylase - essential for 
adenine biosynthesis. 
Adenine auxotrophic strain 
JC220.  Selectable by ADE2 
complementation. 
Lin Cereghino 
et al., 2001 
arg4 Disruption of ARG4, encoding 
Argininosuccinate lyase – 
essential for arginine 
biosynthesis. 
Arginine auxotrophic strain 
GS190.  Selectable by ARG4 
complementation. 
Lin Cereghino 
et al., 2001 
ura3 Disruption of URA3, encoding 
Orotidine 5'-phosphate 
decarboxylase – essential for 
uracil biosynthesis. 
Uracil auxotrophic mutant 
JC254.  Selectable by URA3 
complementation. 
Lin Cereghino 
et al., 2001 
Glycoengineered strains 
och1 Disruption of the α-1,6-
mannosyltransferase gene in P. 
pastoris to reduce hyper-
mannosylation. 
Incorporated into the Pichia 
Glycoswitch® expression 
platform.  Contains a range of 
strains and plasmids expressing 
different combinations of the 
stated glycosyltransferases to 
perform more uniform, as well 
as mammalian type N-
glycosylation of recombinant 
proteins. 
Vervecken et al 
(2007); Laukens 
et al (2015) 
H. sapiens 
GNT-I 

















Expression of Trichoderma 
mannosidase. 




Modification Description Output Reference 
Increased productivity 
KAR2 Overexpression of the ER-
resident chaperone KAR2 by 
PAOX1 
High secreting strain producing 
3-fold more A33 single- chain 
antibody over the parent strain  
Damasceno et 
al (2007) 
PDI Overexpression of S. cerevisiae 
protein disulphide isomerase 
by PGAP. 
High secreting strain producing 
1.9 fold more 2F5 ant- HIV Fab 
fragment over the parent 
strain. 
Gasser et al 
(2005)  
AFT1 Overexpression of the P. 
pastoris transcription factor 
Aft1 involved in the regulation 
of carbohydrate metabolism 
and protein secretion. 
High secreting strain producing 
2.5 fold more Sphingopyxis 
carboxylesterase than the 
parent strain. 
Ruth et al 
(2014)  
bgs13 Disruption of the P. pastoris 
homologue to S. cerevisiae 
protein kinase C 
Mutant strain with a high 
secretion phenotype – capable 
of producing ~3 fold more HSA 
than the parental strain. 
Larsen et al 
(2013)  
Protease deficient strains 
Δpep4 Deletion of the gene encoding 
a major vacuolar aspartyl 
protease 
Protease deficient strains 
designated SMD1163 (Δhis4, 
Δpep4. Δprb1) and SMD1168 
(Δhis4, Δpep4).  Incorporated 
into the PichiaPink™ expression 
platform (Thermo Fisher 
Scientific) 
Gleeson et al 
(1998)  
prb1 Disruption of the gene 
encoding proteinase B 
Genetic stability of recombinant clones 
Δku70 Deletion of the P. pastoris 
KU70 homologue, forming part 
of the heterodimer initiating 
non homologous end joining 
(NHEJ). 
NHEJ deficient strain targeted 
more efficiently by genomic 
integration vectors.  High 
genetic stability of clones 
containing 4-7 transgene 
copies 






1.6 Factors affecting the process efficiency of P. pastoris 
 
1.6.1 Bottlenecks in secretion 
 
Despite exhibiting high volumetric productivities, due in part to the high cell densities that can be 
achieved in fermentor culture, the specific productivity of individual P. pastoris cells, relative to other 
expression systems, has been historically reported as low for secreted heterologous proteins (Krainer 
et al, 2012).  This intrinsic flaw in the Pichia system was recently supported in a study comparing 
recombinant protein secretion between P. pastoris and CHO cells, finding that the latter secreted 
1011-fold more 3D6 single chain Fv-Fc anti-HIV-1 antibody and 26-fold more human serum albumin 
(HSA) per unit biomass (Maccani et al, 2014).  Different independent studies have shown that a 
significant proportion of highly expressed heterologous proteins targeted to the secretory pathway 
accumulate within the endoplasmic reticulum (ER) and Golgi body in an insoluble form, indicating 
that a limiting factor to the specific productivity of P. pastoris is the capacity of its secretory pathway 
(Inan et al, 2006; Love et al, 2012).  Furthermore the activation of cellular processes acting to clear 
excess protein from the bottlenecked regions of the secretory pathway introduce a number of 
product loss points throughout the route of protein export (Puxbaum, Mattanovich and Gasser, 





YPS1, encoding yapsin 1 – a cell wall associated protease involved in cell wall assembly, was found to 
be involved in the proteolysis of heterologous proteins during exocytosis at the cell periphery  (Silva et 
al, 2011).  Deletion of YPS1 resulted in the increased secretion of collagen inspired proteins as well as  
an HSA and human parathyroid hormone fusion protein for a double deletion of YPS1 and PEP4 (Silva 
et al, 2011; Wu et al, 2013).  Another known bottleneck of heterologous protein secretion is caused 
by the mistargeting of proteins from the Golgi body to the vacuole through the carboxypeptidase Y 
(CPY) pathway, where they are subsequently degraded by vacuolar proteases; a process which has 
been studied more comprehensively for other yeast expression systems (Idiris et al, 2006).  Recently 
though a novel mutant strain of P. pastoris with a disrupted vesicular transport pathway between the 
Golgi and vacuole, coupled with the deletion of a vacuole-resident protease was presented and 
reported to exhibit increased production of secreted HSA (Gasser, 2016). 
Figure 4: Location of bottlenecks and processes causing loss  (red) in the overall  titre of heterologous proteins  
(green) during transport through the secretory pathway in P. pastoris. 
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However a major bottleneck in secretion that has yet to be addressed fully occurs in the ER and 
relates to the activation of the ER associated stress pathways: the unfolded protein response (UPR) 
and endoplasmic reticulum associated degradation (ERAD) in response to its saturation with 
misfolded heterologous protein (Puxbaum, Mattanovich and Gasser, 2015).  This has led to the 
establishment of the ER in P. pastoris and other expression systems as an engineering “hotspot” for 
research, for which numerous strategies have been developed to artificially increase its capacity for 
protein processing (Delic et al, 2014). 
 
1.6.1.1  The unfolded protein response (UPR) 
 
The overexpression of recombinant proteins that are foreign to the folding and transport 
environment of the ER can burden the secretory system by exceeding the ER’s folding capacity, 
leading to the accumulation of insoluble aggregates by the interaction of misfolded proteins (Patil  and 
Walter, 2001).  Prolonged ER stress leads to the activation of the unfolded protein response (UPR); a 
stress response conserved in all eukaryotes that serves to temporarily increase the folding capacity of 
the ER (Patil and Walter, 2001).  The model for the activation of the UPR in yeast has been well 
studied and, although certain elements of the pathway are still disputed (Pincus et al, 2010), an 






In yeast, including P. pastoris, the detection of misfolded proteins, and therefore the primary step in 
the activation of the UPR, is facilitated by the interaction between the chaperone Kar2p and the ER 
membrane-bound protein kinase - Ire1p (Cox, Shamu and Walter, 1993).  Under non-stressed 
conditions Kar2p is associated with Ire1p on the ER lumenal side of the transmembrane protein.  The 
dissociation of Kar2 from Ire1p in response to an increase in misfolded proteins within the ER, as well 
as the direct binding of misfolded proteins to Ire1p leads to the dimerization of Ire1p and the 
activation of its cytosolic, endonuclease domain (Shamu and Walter, 1996; Credle et al, 2005).  The 
gene encoding the transcription factor for UPR-regulated genes, named HAC1, is expressed 
constitutively (Patil and Walter, 2001).  However, under unstressed conditions The HAC1 gene 
Figure 5: Schematic of the model for the activation of the UPR in yeast.  The dimerization of the transmembrane 
ER protein Ire1p occurs due to the dissociation of Kar2p in response to the build-up of incorrectly folded 
proteins in the ER.  Subsequent autophosphorylation of the cytosolic kinase domains (K) in the Ire1p dimer 
results in the activation of its endonuclease domain (E), responsible for the alternative splicing of the HAC1 to 
yield the functional form of the Hac1p transcription factor.  Hac1p binds to UPREs within the promoters of UPR 
associated genes to upregulate their transcription. 
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product is present in an inactive form due to the presence of an intron in the HAC1 mRNA transcript 
(Cox and Walter, 1996).  The endonuclease activity of the activated Ire1p serves to splice the intron 
from the HAC1 mRNA to produce the active form of HAC1p (Cox and Walter, 1996; Mattanovich et al, 
2004).  HAC1p in turn binds to the UPR element (UPRE), a 22bp element found upstream of all UPR 
regulated genes, and activates the expression of genes involved in the UPR response, including ER 
resident chaperones, foldases and membrane biogenesis factors (Mattanovich 2004).  
Research into the HAC1 homologue in P. pastoris revealed some diversification in its regulation from 
the canonical yeast model of UPR (Guerfal et al, 2010).  The spliced form of HAC1 encoding the active 
factor was detected under standard growth conditions, suggesting that a basal level of UPR is 
constitutively active.  Whilst HAC1 is expressed at consistent levels in yeast, the transcription of both 
variants of P. pastoris HAC1 was increased during UPR, indicating that Hac1p upregulates its own 
transcription in a positive feedback loop fashion (Guerfal et al, 2010). 
 
1.6.1.2  Endoplasmic reticulum associated degradation (ERAD) 
 
While the activation of the UPR may at first seem beneficial to the production of heterologous 
proteins as it aids in the correct processing of proteins and in returning the ER to homeostasis, its 
prolonged upregulation eventually leads to the increased activation of the endoplasmic reticulum 
associated degradation pathway (ERAD) (Travers et al, 2000).  The accumulation of misfolded proteins 
in the ER lumen in yeast triggers the activation of a specific arm of the ERAD pathway, named ERAD-L, 
through the assembly of complex containing the UPR factor Kar2p and Yos9p that specifically bind 
misfolded proteins (Ismail and Ng, 2006).  The elements comprising ERAD-L function to clear the ER 
lumen of any terminally misfolded protein aggregates by their translocation into the cytosol.  Once in 
the cytosol the misfolded proteins are subsequently tagged for degradation by proteasomal 
complexes by ubiquitination (Hampton, 2002).  Ultimately the prolonged upregulation of the UPR is 
detrimental to the production of heterologous proteins, not only through the loss of product caused 
by the ERAD pathway, but also because a number of apoptotic factors have been identified further 




Genes involved in the UPR and ERAD pathways have been found to be upregulated during the 
production of secreted recombinant proteins in P. pastoris in multiple studies, implicating ER 
associated stress as a limiting factor for productivity (Inan et al, 2006; Gasser et al, 2007A; Love et al, 
2010; Whyteside et al, 2011).  An analysis of productivity and ER stress activation for P. pastoris 
secreting a library of human lysozyme variants differing in their native state stabilities found an 
inverse relationship between secreted titre of recombinant protein and increasing instability (Kumita 
et al, 2006).  The secretion of more unstable variants also resulted in higher upregulation of UPR and 
ERAD factors, leading the authors to conclude that proteins with weaker stabilities saturate the 
folding capacity of the ER in smaller doses due to a higher propensity to misfold, resulting in higher 
levels of product loss from a more active ERAD (Whyteside et al, 2011).  The relationship between 
protein stability, the induction of ER stress and the rate of intracellular degradation of recombinant 
proteins provides some insight as to why maximum titres can often vary greatly between different 
recombinant proteins produced in P. pastoris.  Some example comparisons include HSA and E. coli 
phytase which can both be secreted to reported titres of over 10 and 6.4g/l respectively whereas the 
expression Anti-IL6 receptor antibody fragment, used to treat rheumatoid arthritis, yielded only 
30mg/l of final product (Bushell et al, 2003; Chen et al, 2004; Zhiyi et al, 2007). 
 
1.6.2 Clonal variation 
 
Clonal variation, within the context of expression systems, describes a phenomenon in which clones 
derived from daughter cells raised from homogenous cell lines or following transformation display a 
wide distribution in recombinant protein productivities beyond the expected levels of biological 
variation.  Clonal variation is a widely reported factor of P. pastoris expression and necessitates the 
excessive screening of several colonies post-transformation to eliminate clones that secrete well 
below average titres of recombinant proteins, and to identify high secretors (Brankamp et al, 1995; 
Love et al, 2010; Baumann et al, 2011).  A known source of interclonal variation, occurring between 
transformants cloned with an integrated expression vector, is a variation in transgene copy numbers, 
as it is predicted that multicopy clones arise at a frequency of 1% within a transformed population 
(Romanos et al, 1998).  However an intrinsic level of unaccounted variation is still observable 
between P. pastoris clones secreting identical proteins at equivalent copy numbers (Love et al, 2010; 
Aw, 2012).  A few studies have attempted to analyse clonal variation at the genetic and 
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transcriptional level.  Genetic fingerprinting of 17 different single copy clones transformed with an 
expression vector for an unspecified protein revealed the presence of random mutations throughout 
the genome in comparison to control strains; indicated to have occurred during the transformation 
process (Viader-Salvadó et al, 2006).  The highest producers within the tested sample correlated with 
having the fewest genetic differences from the host strain, implicating the random genetic mutations 
observed as contributors to clonal variation, although the source of the mutagenesis was not 
identified (Viader-Salvadó et al, 2006).  A microarray analysis was conducted on a subset of high, 
medium and low secreting single copy clones of recombinant HSA by Aw (2012) to determine any 
differences in global gene transcription underlying clonal variation.  Significant variation was found 
not only between but within samples of clones with different secretion phenotypes, although genes 
comprising the ERAD pathway were uniformly upregulated in high secreting samples, suggesting the  
variation in the degree of its activation as a contributing factor (Aw, 2012). 
There is also evidence to suggest that variation is apparent at the intraclonal level and affects the 
stability of the productivity phenotype of isolated “high secreting” homogenous cell lines through 
subsequent generations.  A study by Love et al (2010) examined the productivity of different cell lines 
characterised by their rate of secretion of a human Fc fragment after growth to late exponential 
phase in liquid culture.  The results showed that cultures derived from high secreting cells did not 
retain the parental phenotype and rather displayed a range of secreted productivities similar to the 
daughter cells of “low secretors” (Love, 2010).  The results highlight a potential transient nature of 
high secreting phenotypes found through recombinant clone screening, and raise concerns for the 
maintenance of high productivities for recombinant proteins during expression trials requiring longer 
incubation times. 
Other than the studies discussed, little research has been undertaken to define the extent of clonal 
variation or search for causative factors within the biology of P. pastoris and within the techniques 




1.7 Aims and objectives 
 
One of the objectives of this project was to engineer new platform strains displaying an increased 
specific productivity for a host of diverse and industrially relevant recombinant proteins.  The project 
initially focused on attempting to improve productivity by engineering the ER to increase its 
processing capacity for heterologous proteins while minimising the activation of ER-stress responses, 
with scope for exploring other process limiting factors identified within the Pichia system. 
Secondly, this project attempted to build on the limited research into clonal variation by examining 
underlying factors within the fundamentals of the Pichia expression system that could give rise to 
variation in specific productivity.  Studies were divided into searching for inherent, natural variability 
within the native P. pastoris cell population that could predispose cells to secrete heterologous 
proteins as well as investigating external sources of variation that could be artificially introduced in 
well established protocols used in the engineering, growth and expression of the P. pastoris.  The 
implications of locating factors responsible for clonal variation range from the design of a more 
robust expression system with a consistent level of productivity, to the potential of def ining a set of 
characteristics in a clonal population that skew variation towards the pre-selection of highly 
productive strains.   
From these broad aims, a set of objectives encompassed by the project were designed as follows: 
 The effect on clonal variation from the use of zeocin, a known mutagen, as a selectable 
marker was examined. 
 Variation in native factors between members of set clonal populations such as AOX1-based 
transcription, UPR activation, and growth characteristics were compared and correlated with 
productivity to assess their contribution to clonal variation. 
 The gene putatively belonging to the Opi1p yeast transcription factor family was knocked out 
in P. pastoris and the resulting mutant strains were tested for specific productivity and ER 
stress activation for the production of a range of recombinant proteins. 
 Strains exhibiting reduced levels of glucose repression of the AOX1 promoter were 
engineered, and were tested for recombinant protein productivity through screens and 
expression trials with glucose/methanol mixed feeds. 
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2. Materials and Methods 
 
2.1 Strains and plasmids 
 
2.1.1 E. coli strains 
 
Strain Description Source Reference 
BioBlue recA1 ,em>endA1 gyrA96 thi-1 hsdR17(rk-
, mk+) supE44 relA1 lac [F’ proAB 
lacIqZΔM15 Tn10(Tetr)]  
Bioline Bioline 
catalogue 
DH5 alpha F– endA1 glnV44 thi-










JM109 endA1 glnV44 thi-1 relA1 gyrA96 recA1 
mcrB+ Δ(lac-proAB) e14- [F' traD36 

















BioBlue (pAVE522) Fujifilm Diosynth 
Biotechnologies 
Unpublished 
E. coli pIB2 DH5 alpha (pIB2) Gift from Benjamin 
Glick (Addgene 
plasmid #25451)  










BioBlue (pGrzαHSA, Zeor, hsa) Rochelle Aw, 
Imperial College 
Aw (2012) 
E. coli pAG32 DH5 alpha (pAG32) Gift from John 
McCusker (Addgene 







DH5 alpha (p414-TEF1p-Cas9-CYC1t) Gift from George 
Church (Addgene 
plasmid #43802)  
Dicarlo et al 
(2013)  
Table 2: E. coli strains used in this study 
45 
 
2.1.2 P. pastoris strains 
 
Strain Description Source Reference 














CLD804 NRRL11430 (pAVE522; BPTI), subjected to 





CLD819 NRRL11430 (pAVE522; PI3), subjected to PTVA 





CLD883 NRRL11430 (pAVE522; PRSS1), subjected to 





GpαGOxZ GS115 (pPICZαB; GOX) This study Unpublished 
GpαGOxH GS115 (pPICZαB; sh bleΔ::HIS4; GOX) This study Unpublished 
NRRL 11430 
Δopi1 
NRRL 11430 (opi1Δ::Tn903kanr) This study Unpublished 
CLD804 
Δopi1 
CLD804 (opi1Δ::Tn903kanr) This study Unpublished 
NpαGOxZ NRRL 11430 (pPICZαB; GOX) This study Unpublished 
NpαGOxZ 
Δopi1 
NRRL 11430 (opi1Δ::Tn903kanr; pPICZαB; GOX) This study Unpublished 
NAαT70A NRRL 11430 (pPICZαA; HUL-T70A)-single copy This study Unpublished 
NAαT70A 
Δopi1 
NRRL 11430 (opi1Δ::Tn903kanr; pPICZαA; HUL-
T70A) – single copy  
This study Unpublished 
P. pastoris + 
PAVECRS 
NRRL 11430 (pAVE522; sh bleΔ::Tn903kanr; sh 
ble (under control of the AOX1 promoter)) 
This study Unpublished 
P. pastoris + 
PpCas9 
NRRL 11430 (pGrzαHSA; sh bleΔ::hph; 
αmf::HSAΔ::CAS9-sv40) 
This study Unpublished 
NGmit1 NRRL 11430 (pGrzαHSA; sh bleΔ::hph, 
αmf::HSAΔ::MIT1) – single copy 
This study Unpublished 






2.2.1 Lysogeny broth (LB) medium 
 
LB medium was composed of 0.5% (w/v) yeast extract (Melford, UK), 1.0% (w/v) peptone from casein 
(Merck, UK), 1.0% (w/v) NaCl (Sigma-Aldrich, UK).  For LB agar plates agar (Melford, UK) was added to 
a final concentration of 1.6% (w/v).  For ampicillin resistance selection ampicillin (Sigma-Aldrich, UK) 
was added to a final concentration of 100µg/ml.  For selection by zeocin resistance zeocin (Thermo 
Fisher, UK) was added to a final concentration of 25µg/ml.  For selection by kanamycin resistance 
kanamycin (Thermo Fisher, UK) was added to a final concentration of 30µg/ml.  For selection by 
hygromycin resistance hygromycin b (Roche, UK) was added to a final concentration of 100µg/ml. 
Strain Description Source Reference 
NGmit1 
+pAVECRS 
NRRL 11430 (pGrzαHSA; sh ble::hph; αmf-
HSAΔ::MIT1; pAVE522; sh bleΔ::Tn903kanr; sh 
ble (under control of the AOX1 promoter)) – 
single copy 
This study Unpublished 
NGmit1-
AαT70A 
NRRL 11430 (pGrzαHSA; sh ble::hph; αmf-
HSAΔ::MIT1; pPICZαA; HUL-T70A) – single copy  




NRRL 11430 (pGrzαHSA; sh ble::hph; 
αmf::HSAΔ::MIT1; pAVE522; sh 
bleΔ::Tn903kanr; MXR1(1-1200)-sv40; sh ble 
(under control of the AOX1 promoter))) – 
single copy 
This study Unpublished 
NGmm1 NRRL 11430 (pGrzαHSA; sh ble::hph, 
αmf::HSAΔ::MIT1-T2A-MXR1(1-1200)) – single 
copy 
This study Unpublished 
NGmm1-
AαT70A 
NRRL 11430 (pGrzαHSA; sh ble::hph, 
αmf::HSAΔ::MIT1-T2A-MXR1(1-1200);  
pPICZαA; HUL-T70A) – single copy 
This study Unpublished 
NGmm1 
+pAVECRS 
NRRL 11430 (pGrzαHSA; sh ble::hph; 
αmf::HSAΔ::MIT1-T2A-MXR1(1-1200); 
pAVE522; sh bleΔ::Tn903kanr; sh ble (under 
control of the AOX1 promoter)) – single copy 
integrant 
This study Unpublished 
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2.2.2 Super optimal broth with catabolite repression (SOC) medium 
 
SOC medium was composed of 0.5% (w/v) yeast extract (Melford, UK), 2.0% (w/v) peptone from 
casein (Merck, UK), 10 mM NaCl (Sigma-Aldrich, UK), 2.5 mM KCl (Sigma-Aldrich, UK), 10 mM MgCl2 
(Acros, UK), 10 mM MgSO4 (Fisher, UK) and 20 mM dextrose (glucose) (Merck, UK). 
 
2.2.3 Yeast extract peptone dextrose (YPD) medium 
 
YPD medium was composed of 1% (w/v) yeast extract (Melford, UK), 2% (w/v) peptone from casein 
(Merck, UK), 2% (w/v) dextrose (glucose) (Merck, UK).  For YPD agar plates, agar (Melford, UK) was 
added to a final concentration of 1.6% (w/v).  For selection by zeocin resistance zeocin (Thermo Fisher 
Scientific, UK) was added to a final concentration of 100µg/ml from a 100mg/ml stock solution.  For 
selection by G418 resistance G418 sulphate (Sigma-Aldrich, UK) was added to a final concentration of 
500µg/ml from a 50mg/ml stock solution.  For selection by hygromycin b resistance, hygromycin b 
(Sigma-Aldrich, UK) was added to a final concentration of 200µg/ml from a 50mg/ml stock solution. 
 
2.2.4 Minimal dextrose (MD) medium 
 
MD medium was composed of 1.34% (w/v) yeast nitrogen base (YNB) (Sigma-Aldrich, UK), 4 x 10-5% 
(w/v) biotin (Sigma-Aldrich, UK), 2% (w/v) dextrose (glucose) (Merck, UK).  For MD agar plates, agar 
(Melford, UK) was added to a final concentration of 1.6% (w/v). 
 
2.2.5 Minimal methanol (MM) medium 
 
MM medium was composed of 1.34% yeast nitrogen base (YNB) (w/v) (Sigma-Aldrich, UK), 4 x 10-5% 
(w/v) biotin (Sigma-Aldrich, UK), 0.5% (v/v) methanol (Sigma-Aldrich, UK).  For MM agar plates, agar 
(Melford, UK) was added to a final concentration of 1.6% (w/v). 
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2.2.6 Minimal dextrose and methanol (MDM) medium 
 
MDM medium was composed of 1.34% yeast nitrogen base (YNB) (w/v) (Sigma-Aldrich, UK), 4 x 10-5% 
(w/v) biotin (Sigma-Aldrich, UK), 0.5% (v/v) dextrose (glucose) (Merck, UK), 0.5% (v/v) methanol 
(Sigma-Aldrich, UK).  For MDM agar plates, agar (Melford, UK) was added to a final concentration of 
1.6% (w/v). 
 
2.2.7 Buffered minimal glycerol medium (BMG) and buffered minimal methanol medium 
(BMM) 
 
BMG/BMM medium was composed of 1.34% (w/v) yeast nitrogen base (YNB) (w/v) (Sigma-Aldrich, 
UK), 4 x 10-5% (w/v) biotin (Sigma-Aldrich, UK), 100mM potassium phosphate pH 6.0 (Fisher, UK), 1% 
(v/v) glycerol (BDH Prolabo, UK) or 0.5% (v/v) methanol (Sigma-Aldrich). 
 
2.2.8 Buffered glycerol-complex medium (BMGY) and buffered methanol-complex 
medium (BMMY) 
 
BMGY/BMMY medium was composed of 1% (w/v) yeast extract (Melford, UK), 2% (w/v) peptone 
from casein (Merck, UK), 1.34% (w/v) yeast nitrogen base (YNB) (w/v) (Sigma-Aldrich, UK), 4 x 10-5% 
(w/v) biotin (Sigma-Aldrich, UK), 100mM potassium phosphate pH 6.0 (Fisher, UK), 1% (v/v) glycerol 




2.3 Molecular biology methods 
 
2.3.1 End point Polymerase chain reaction (PCR) 
 
PCR reactions were carried out in 0.25ml PCR tubes (Fisher, UK) using the Bioer Genepro thermal 
cycler (Alpha Laboratories, UK).  50µl reactions were composed of: 1µl DNA template, 5µl 2.5mM 
dNTPs, 5µl 5µM each primer, 10µl 5X Phusion HF buffer or 5X Q5 buffer, 1 unit Phusion Hot Start II 
polymerase (Thermo Fisher, UK) or Q5® High-Fidelity DNA Polymerase (New England Biolabs, UK) and 
Milli-Q water (18.2 mΩ).  PCR reactions were carried out using the conditions specified in the 
instructions for the appropriate polymerase for 35 cycles, although the annealing temperature was 
varied depending on the Tm of the primers used within the reaction. 
 
2.3.2 Diagnostic/ colony PCR 
 
20µl reactions using KAPATaq Ready Mix DNA Polymerase (Anachem, UK) were composed of: 10µl 2x 
KAPATaq ReadyMix with Mg+, 1.6µl each primer (5µM), 1µl genomic DNA template for P. pastoris or 
bacterial colony added directly in the case of E. coli, and Milli-Q water (18.2 mΩ).  PCR reactions were 
carried out under the conditions stated in the user manual for 35 cycles, although the annealing 
temperature was varied depending on the Tm of the primers used within the reaction.  The time of 
initial denaturation was set to 5 minutes for colony PCRs. 
 
2.3.3 Quantitative Polymerase chain reaction (qPCR) 
 
qPCR was implemented in this project to primarily determine recombinant gene copy numbers in P. 
pastoris.  Templates of genomic DNA were prepared using the YeaStarTM Genomic DNA kit 
(Cambridge Bioscience, UK), quantified and diluted to a working stock concentration of 10ng/μl. 
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qPCR primers for target genes were designed using the online tool Primer3 
(http://bioinfo.ut.ee/primer3/) with the following constraints: 
 The amplified region of DNA does not exceed 200bp. 
 Primer size ranges from 18-24bp. 
 GC content of 50-60%. 
 Tm range between 60-63°C. 
 Maximum Tm difference of 5°C (although 1°C was optimal) 
 Maximum 3’ self complementary score (achieved by global alignment of 3’ regions of primer 
pairs to predict the likelihood of primer dimer formation) of 1. 
 Maximum size of mononucleotide repeats restricted to 3. 
3μl of working stock DNA template was loaded onto 96 – well PCR plates (Thermo Fisher Scientific, 
UK).  Forward/reverse qPCR primers and 2X LuminoCt® SYBR® Green qPCR ReadyMix™ (Sigma-
Aldrich, UK) were added to final concentrations of 0.25μM each and 1X respectively within a final 
reaction volume of 20μl after which the samples were centrifuged at 2000rpm for 1 minute before 
running.  qPCR reactions were run in triplicate for each sample, using the DNAEngine® Peltier thermal 
cycler coupled with the Chromo4™ Real-Time PCR Detector (BioRad, Hemel Hempstead, UK) and data 
was outputted through the Opticon 3 thermal cycler software program (BioRad, Hemel Hempstead, 
UK).  qPCR conditions were set as specified by the manufacturer’s instructions for the qPCR of 
genomic templates with SYBR® Green qPCR ReadyMix™, specifically an initial denaturation step of 
95°C for 2 minutes, followed by 40 cycles consisting of a denaturation step of 95°C for 3 seconds and 
an annealing/extension step of 60°C for 30 seconds.  A melt curve to confirm the formation of single 
products during qPCR was performed for each sample, in which the temperature was raised from 
55°C to 95°C and fluorescence readings were taken at 0.2°C increments. 
Cycle threshold (Ct) values obtained for each sample were interpreted using the method first 
described by Pfaffl (Pfaffl, 2001) and applied by Abad et al (2010) to determine gene copy numbers in 
P. pastoris.  The formula is given as: 
 
  
             
                           
                
                               
51 
 
In which “R” represents the relative abundance of the target gene to the reference gene, “E” is the 
efficiency of amplification achieved through 1 cycle by the specific primer pair amplifying the 
detected region of either the target or reference gene and ΔCt is calculated as the difference in Ct 
values between the no template control/ negative control and the sample.  The gene encoding beta-
actin (ACT1) in P. pastoris was selected as a reference gene for copy number determination due to its 
presence in the genome as a single copy. 
 
2.3.4 Storage of P. pastoris cell samples for RNA isolation 
 
For cell samples that were not processed immediately for RNA purification after growth, 600μl of 
culture was diluted in 3ml Ambion RNAlater® solution (Thermo Fisher Scientific) and incubated at 
room temperature for 1 hour.  Cell suspensions were then centrifuged at 4000 rpm for 5 minutes and 
resuspended in 1ml RNAlater®.  Samples were stored at -80°C prior to RNA purification. 
 
2.3.5  Isolation of RNA from P. pastoris cells 
 
RNA was isolated from cell samples of P. pastoris using the GenElute™ Total RNA Purification Kit 
(Sigma Aldrich, UK) according to the manufacturer’s instructions for the preparation of RNA from 
yeast samples, with some modifications to improve cell lysis and the removal of genomic DNA.  
During the cell wall digestion step lysozyme concentration was increased from 1U/μl to 2U/μl and the 
digest incubation step was extended to 1.5 hours.  During cell lysis the vortexing of samples 
containing lysis buffer RL was extended to 1 minute and the incubation period during the removal of 
genomic DNA with the On-Column DNase I Digestion Set (Sigma Aldrich, UK) was extended from 15 
minutes to 45 minutes.  Prior to elution the eluting solution was warmed to 60°C to increase the final 





2.3.6 Reverse transcription of RNA samples 
 
The Applied Biosystems High Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific, UK) 
was used for the preparation of cDNA from purified RNA samples according to the manufacturer’s 
instructions.  1μg of RNA sample diluted in 10μl nuclease – free water (Thermo Fisher Scientific) was 
used in a single reaction.  cDNA samples were subsequently stored at -20°C. 
 
2.3.7 Reverse Transcription Quantitative Polymerase chain reaction (RT-qPCR) 
 
The protocol and data analysis for RT-qPCR, to identify changes in gene transcription as part of this 
project, is similar to the methods previously described for qPCR with the exception of the preparation 
of template for samples and the conditions of the PCR reaction.  Following reverse transcription of 
isolated RNA samples, a 1 in 10 dilution of the resulting cDNA in Milli -Q water (18.2 mΩ) was 
prepared to give a working stock solution at a concentration of 5ng/μl based on the concentration of 
the original RNA sample.  5μl of diluted template was used per 20μl reaction and the initial 
denaturation step of the PCR was shortened from 2 minutes to 20 seconds. 
 
2.3.7.1 Determination of amplification efficiency for qPCR primer sets 
 
To improve the validity of results obtained from qPCR and RT-qPCR experiments, 3-5 qPCR primer 
sets for a single target gene were tested for amplification efficiency prior to their use, unless 
previously validated.  A 10 – fold serial dilution of pure genomic DNA or cDNA was carried out to 
provide a range of 5 template quantities of 0.001ng, 0.1ng, 1ng, 10ng and 100ng per 20μl qPCR 
reaction.  qPCR with the tested primer pairs was conducted in triplicate for each condition and the 
final Ct values were plotted against the logarithm of the original template quantity.  The gradient of 
the linear plot produced could be used to calculate the efficiency for the primer set using the formula: 
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Where “E” is the amplification efficiency (%) and “g” is the gradient.  Primer sets that displayed the 
highest efficiencies and only formed single products during PCR, as determined by melt curve analysis 
or gel electrophoresis samples if necessary, were used in qPCR experiments.  qPCR primer sets used 
in this project are displayed in Table 4, and full sequences can be found in 9.1. 
 





























2.3.8 Gel electrophoresis of DNA 
 
For the separation of DNA fragments within a sample by size, 0.8% agarose (Sigma-Aldrich, UK) gels 
were used.  Agarose gels were set in 1X TAE buffer, diluted from a 50X stock solution containing 
Table 4: List of primers used in qPCR and RT-qPCR experiments with their associated efficiencies . 
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24.2% (w/v) Tris base, 5.71% (v/v) acetic acid, 10% (v/v)  0.5 M EDTA, pH 8.0.  10,000X SYBR® Safe 
(Thermo Fisher, UK) was added to the agarose gel after heating and before setting, to a final relative 
concentration of 0.5X.  The DNA molecular weight marker used in this study was the GeneRuler™ 1kb 
DNA Ladder (Figure 6) (Thermo Fisher Scientific, UK), of which 5µl aliquots were loaded in a well for 
each DNA gel.  5X DNA loading buffer (30% [v/v] glycerol, 0.25% [w/v] bromophenol blue) was added 
to samples to a 1X final relative concentration.  Agarose gels were normally run in Bio-Rad Wide Mini-
Sub Cell GT Tanks (Bio-Rad, UK) containing 1X TAE buffer at 100V for approximately 40 minutes.  The 
Bio-Rad Power Pac Basic (Bio-Rad, UK) was used as a power source.  A Syngene G:Box ChemiHR 





2.3.9 Purification of DNA from agarose gels 
 
DNA in agarose gels was visualised by exposure to UV light from a UV box (Fotodyne, USA), and bands 
were cut out with a scalpel.  The ZymocleanTM Gel DNA Recovery Kit (Cambridge Bioscience, UK) was 
used to purify DNA from the gel blocks, cut out from the agarose gels, according to the 
manufacturer’s instructions. 
Figure 6: Estimation of DNA fragment sizes from the GeneRuler™ 1kb DNA Ladder used in this project. 
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2.3.10  Purification and concentration of DNA in solution. 
 
2 different methods were used to purify and concentrate DNA.  The DNA Clean & Concentrator -5 kit 
from Zymo research (Cambridge Bioscience, UK) was typically used to concentrate plasmid DNA from 
miniprepped samples into a volume of 10µl in Milli-Q water (18.2 mΩ). 
Ethanol precipitation was used when a more efficient method for concentrating higher quantities of 
DNA was required, such as for the preparation of linearized plasmid for transformation into P. 
pastoris.  For every 10µl of DNA sample 1µl 3M sodium acetate buffer pH 5.2 (Thermo Fisher 
Scientific, UK), 20µl 100% ethanol (Sigma Aldrich, UK) and 0.5µl 0.6% (w/v) blue dextran solution 
(Sigma Aldrich, UK) were added. Samples were then incubated at -20°C for 1 hour to overnight 
depending on the total DNA quantity within the sample, and were then centrifuged at 14000rpm, at 
4°C for 1 hour.  The resulting DNA pellets were washed twice by adding 150µl 70% ethanol without 
resuspending the pellet, centrifuging at 4°C for 15 minutes and air drying at 37°C.  The pellets were 
then typically resuspended in 10µl Milli-Q water (18.2 mΩ). 
 
2.3.11  DNA/ RNA quantification 
 
DNA and RNA concentration was measured using the NanoVue Plus spectrophotometer (GE 
Healthcare, UK).  3µl of DNA sample was loaded and quantified by measuring the absorbance of light 
at 260nm.  Purity of the sample and the presence of protein contaminants in the sample were 
quantified by calculating the ratio of absorbance at 260nm to 280nm. 
 
2.3.12  Plasmid purification from E. coli cultures 
 
Plasmid DNA was purified from E. coli cultures, grown overnight in 5ml LB media, using the Qiaprep® 




2.3.13  DNA restriction 
 
Restriction enzymes were purchased from Thermo Fisher Scientific (UK) or New England Biolabs (UK), 
and restriction digests were carried out according to the manufacturer’s instructions.  Most regular 
DNA restriction reactions were carried out in 20µl volumes at 37°C for 3-4 hours, or 1 – 2.5 hours for 
fast digest enzymes.  Double digests were performed using a compatible buffer for both enzymes 
and, if the specific buffer was not available, sequential digests were used.  Restriction products were 
run on DNA gels and subsequently gel purified. 
 
2.3.14  DNA ligation 
 
T4 DNA ligase (Thermo Fisher Scientific, UK) was used for DNA ligations in 10µl volumes according to 
the manufacturer’s instructions.  An insert to vector ratio of 3:1 was used and ligations were 
incubated at room temperature for 30 minutes before transformation into chemically competent E. 
coli. 
 
2.3.15  Gibson assembly 
 
An adaptation of the original Gibson assembly protocol (Gibson, 2009) was implemented for the 
assembly of novel vectors without the need to PCR amplify the vector backbone.  PCR primers for 
amplifying the insert were designed to include ~40bp linkers sharing identity with the regions flanking 
the site of insertion in the vector, at both the 5’ and 3’ ends of the final PCR product.  A master mix 
containing 320µl 5x isothermal reaction buffer (25% PEG-8000, 500 mM Tris-HCL pH7.5, 50 mM 
MgCl2, 50 mM DTT, 1mM full set of dNTPs and 5 mM NAD), 0.64 μl 10U μL-1 T5 exonuclease (New 
England Biolabs, UK),  20 μl 2U μL-1 Phusion DNA polymerase (New England Biolabs, UK), 160 μl 40U 
μL-1 Taq DNA Ligase (New England Biolabs, UK) and Milli-Q water (18.2 mΩ) to a final volume of 1.2ml.  
15µl aliquots of master mix were then prepared from the total volume and stored at -20°C.  5µl 
volumes containing 100ng vector, linearized at the site of insertion, and an equimolar quantity of 
insert were then added to a single aliquot of the master mix and incubated for 1 hour at 50°C in the 
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Bioer Gene Pro thermal cycler (Eppendorf, Stevenage, UK).  5μl of the assembled sample was then 
transformed into chemically competent E. coli or PCR amplified. 
For Gibson assembly reactions between PCR amplified parts ~20bp linker regions were added to the 
5’ and 3’ ends of each PCR product as standard. 
 
2.3.16  Transformation of chemically competent E.coli by heat shock 
 
A 20µl aliquot of chemically competent E. coli BioBlue cells was thawed on ice for approximately 5 
minutes.  5-10µl of the ligation or Gibson assembly mix was added to the cells, which were then 
incubated on ice for 20 minutes.  The cells were then heat shocked at 42°C for 45 seconds, and then 
held on ice for 2 minutes.  The cells were recovered in 1ml SOC medium at 37°C for 1 hour with 
shaking at 250rpm.  Following recovery 100µl of the transformed cell sample was plated onto a 
suitable LB + antibiotic plate and incubated at 37°C overnight. 
 
2.3.17  Transformation of P. pastoris by electroporation 
 
For the targeted integration of expression vectors into the P. pastoris genome 5-10μg of vector was 
linearized by a single digest within the vector’s region of homology to the relevant locus within the P. 
pastoris genome (e.g. the AOX1 promoter region in pPICZ based vectors) and ethanol precipitated 
into a 10µl final volume. 
The protocol for the preparation of competent P. pastoris cells was adapted from the EasySelect™ 
Pichia Expression Kit (Thermo Fisher, UK) instruction to be more suited to a smaller sample size.  10ml 
of YPD was inoculated with P. pastoris from a -80°C stock or colony and incubated at 30°C with 
shaking at 250rpm for ~16 hours.  The culture was then diluted into a final volume of 100ml YPD in a 
500ml flask to an OD600 of ~0.8.  The culture was grown aerobically at 30°C at 250rpm until an OD600 
of 1.3-1.5 had been reached, after which it was decanted into 2 sterile 50ml Centrifuge tubes, and 
transferred to ice.  During the wash stage the cells were centrifuged at 4000rpm for 5 minutes at 4°C, 
and resuspended in 50ml ice cold, sterile dH2O.  The centrifugation step was repeated 3 more times, 
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resuspending in 25ml ice cold dH2O, 2ml ice cold 1M sorbitol (Sigma-Aldrich, UK) and finally 400µl ice 
cold 1M sorbitol respectively.  Competent P. pastoris cells prepared with this method exhibit a 
decline in transformation efficiency once stored so fresh competent cells were used for every 
transformation. 
During the transformation step an 80µl aliquot of competent cells, prepared in the previous step, was 
added to each linearized vector sample, transferred to 2mm electroporation cuvettes (Bio-Rad, UK) 
and kept on ice for 5 minutes.  The GenePulser electroporater (Bio-Rad, UK) was used to pulse the 
cells at 2000V, 25 μF, 200 Ω, for approximately 5 milliseconds.  Immediately following electroporation 
1ml ice cold 1M sorbitol was added to each sample and the cells were recovered by incubating at 
30°C without shaking for 2 hours.  Once the recovery stage was complete 100µl of the transformed 
cell samples were spread onto the appropriate selective agar plate, and incubated at 30°C for 3 to 5 
days. 
For experiments requiring a higher efficiency of transformation an electroporation protocol involving 
the pretreatment of cells with lithium acetate and dithiothreitol (DTT), developed by Wu and 
Letchworth (2004) was used.  Initial growth of P. pastoris cells was conducted in the same manner as 
the in the standard electroporation protocol until, once cells had reached and OD600 of 1.3, 11ml 
samples of culture, equating to approximately 8.0x108 cells, were centrifuged at 4000 rpm for 5 
minutes, resuspended in 8ml of 100mM lithium acetate (Sigma Aldrich, UK), 10mM DTT (Thermo 
Fisher Scientific, UK), 0.6M sorbitol and 10mM Tris-HCl pH 7.5 (Thermo Fisher Scientific, UK) and 
incubated at room temperature for 30 minutes.  The cell suspensions were then pelleted by 
centrifugation at 4000rpm for 5 minutes and resuspended 1.5ml ice cold 1M sorbitol.  2 wash steps 
consisting of centrifuging and resuspending cells in 1.5ml ice cold 1M sorbitol were then carried out 
before resuspending cells in a final volume of 80μl ice cold 1M sorbitol as single aliquots for 
transformation.  Electroporation of cells was then conducted as standard immediately following the 




2.3.18  Isolation of P. pastoris genomic DNA 
 
A simple method for the extraction and purification of genomic DNA from yeast cells, developed by 
Lõoke, Kristjuhan and Kristjuhan (2011) was used to prepare genomic DNA from P. pastoris colonies 
for end-point PCR applications.  Single colonies of P. pastoris were suspended in 100μl of solution 
containing 200mM lithium acetate and 1% SDS (Thermo Fisher Scientific), mixed by vortexing and 
incubated at 70°C for 5 minutes on a heat block.  300μl ice cold 96%-100% ethanol was added after 
which the samples were vortexed and centrifuged at 15,000g for 3minutes to pellet precipitated DNA.  
The supernatant was removed by aspiration and samples were washed by resuspending in 500μl ice 
cold 70% ethanol and centrifuging 15,000g for 3minutes.  The supernatant was removed and samples 
resuspended in 100μl Milli-Q water (18.2 mΩ).  Cell debris was removed by centrifuging the sample at 
15,000g for 1 minute.  The resulting supernatant containing dissolved genomic DNA was removed and 
stored at -20°C. 
For applications requiring samples with higher purity, such as qPCR – experiments, genomic DNA was 
isolated from P. pastoris colonies using the YeaStar Genomic DNA kit from Zymo Research (Cambridge 
bioscience, UK) according to the manufacturer’s instructions. 
 
2.4 Cell biology methods 
 
2.4.1 Storage of E. coli and P. pastoris strains 
 
Single E.coli or P. pastoris colonies were inoculated in 3ml LB at 37°C or YPD at 30°C respectively, and 
incubated at 250rpm overnight.  Overnight E.coli cultures were stored in 20% glycerol (BDH Prolabo, 
UK) in sterile 2ml cryogenic vials (Thermo Fisher Scientific, UK) at -80°C whereas P. pastoris strains 




2.4.2 Raising clonal populations of P. pastoris  
 
5ml YPD was inoculated with a single colony of the desired P. pastoris strain, or a -80°C stock 
originating from a single colony, and grown overnight for ~16 hours at 30°C, 250rpm.  The culture was 
serially diluted 10 fold in phosphate - buffered saline solution (PBS), consisting of 137mM NaCl (Sigma 
Aldrich, UK), 2.7mM KCl (Thermo Fisher Scientific, UK), 10mM Na2HPO4 (Thermo Fisher Scientific, UK), 
1.8mM KH2PO4 (Thermo Fisher Scientific, UK), with pH adjusted to 7.4 with HCl, to give a range of 
diluted samples with dilution factors up to 106 of the original culture.  100μl of the dilutions were 
plated onto YPD plates to raise control populations exhibiting a native background of variation, and 
on the appropriate selective plates for the tested recombinant strain to raise populations exposed to 
a selective background during colony growth.  Plates containing adequately spaced, discrete colonies 
were kept and specified samples of colonies raised in each condition were selected at random as a 
representation of the overall clonal population to progress with expression experiments. 
 
2.4.3 Preparation and growth of P. pastoris strains on zeocin gradient agar plates  
 
In order to provide a semi quantitative measure for the activation state of the AOX1 promoter in 
response to growth on different carbon sources, strains expressing the zeocin resistance marker gene 
sh ble under PAOX1 were assayed for viability on plates containing a concentration gradient of zeocin. 
Gradient plates were set up by elevating 1 side of a Sterilin 100mm square Petri dish (Thermo Fisher 
Scientific, UK) by approximately 6mm, through resting on the end of a 20μl pipette tip (Anachem, UK).  
Molten 1.6% minimal medium agar containing the appropriate growth substrate was poured into 
each plate and allowed to set, forming a uniform agar slant across the plate.  Agar slants were 
overlayed with molten minimal medium agar matching the growth substrate composition of the slant, 
with the addition of 1000μg/ml zeocin (Thermo Fisher Scientific, UK).  Approximately 1cm  of the top 
portion of the slant was not overlayed to create a control area on the plate containing ~0μg/ml 
zeocin.  Zeocin gradient plates were stored overnight at 5°C to allow the downward diffusion of 
zeocin through the slant to create a gradient of zeocin concentration ranging from ~0μg/ml - 
1000μg/ml across the plate.  Prepared gradient plates were not stored for longer than 24 hours prior 
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to use to prevent further diffusion of zeocin through the agar, resulting in loss of the concentration 
gradient. 
P. pastoris strains were picked from single colonies on agar plates, inoculated into 5ml minimal media 
containing the desired carbon source and incubated at 30°C at 200rpm for a maximum of 16 hours.  
OD600 was measured and cultures were normalised to a final OD600 of 0.1 in PBS.  Using a grid as a 
template, normalised cell suspensions were applied to gradient plates matching the composition of 
the liquid media used for growth in 4μl droplets across the zeocin concentration gradient.  Droplets 
were allowed to dry and the plates were incubated at 30°C for 3-4 days depending on the relative 
growth rates of cells on the growth substrate.  Plates were imaged in white light from the Syngene 
G:Box ChemiHR system (Syngene, UK) and the paired GeneSNAP software (Syngene, UK). 
 
2.4.4 Secreted recombinant protein expression from P. pastoris 
 
Small scale expression studies in P. pastoris were conducted in 24 deep well micro titre plates 
(Whatman, UK), 50ml centrifuge tubes (Thermo Fisher Scientific), or in 250ml baffled cell culture 
flasks (Thermo Fisher Scientific, UK) using protocols adapted from the EasySelect™ Pichia Expression 
Kit instruction manual (Thermo Fisher Scientific, UK)  
Single colonies or -80°C stocks of P. pastoris were inoculated into 5ml BMGY or BMG in 50ml 
centrifuge tubes for aerobic growth and incubated at 30°C at 250rpm for ~16 hours.  The OD600 of 
each cell culture was measured, and used to calculate the volume of starter culture required to give a 
final OD600 of 1-5 in 3ml of media, depending on the recombinant protein being expressed.  The 
required volume for each cell culture was then centrifuged at 4000rpm for 5 minutes, and the cell 
pellets were resuspended in 3ml of BMMY or BMM unless stated otherwise.  The cells were 
incubated in 24 deep well plates (Whatman, UK) with gas permeable seals (Thermo Fisher Scientific) 
at 28°C, 200rpm for 48 hours to 5 days depending on the recombinant protein expressed, and 
expression was maintained by adding 100% (v/v) methanol to a final concentration of 0.5% (v/v) 
every 24 hours. 
Expression in 50 ml Centrifuge tubes followed the same protocol as expression in 24 deep well plates, 
except that 5ml volumes were used throughout expression as opposed to 3ml.  To i mprove aerobic 
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conditions throughout growth and expression the lid of each Centrifuge tube was loosened and 
secured with autoclave tape. 
For expression in 250ml baffled flasks, cultures grown in 5-10ml BMGY/BMG for ~16 hours prior to 
expression were normalised to the appropriate OD600 in 25ml BMMY and incubated in flasks with gas 
permeable seals. 
 
2.4.5 DiOC6(3) staining and confocal microscopy 
 
DiOC6(3) was obtained as part of the Yeast Mitochondrial Stain Sampler Kit from Thermo Fisher 
Scientific (UK) and diluted to a working stock concentration of 1mg/ml in 100% (v/v) ethanol.  5ml of 
MD medium was inoculated with P. pastoris cells from colonies grown on agar plates and grown 
overnight at 30°C/ 250rpm.  Before staining, individual 22x22mm coverslips (Thermo Fisher Scientific, 
UK) were placed into 6-well tissue culture plates (Corning, UK) and coated in 500μl 0.01% Poly-L-
lysine (mol wt 70,000-150,000) (Sigma Aldrich, UK) for 10 minutes at room temperature.  Excess poly-
L-lysine was removed by washing the wells 3 times with 1ml PBS.  Cells were resuspended to a final 
OD600 of 2.0 in 10mM HEPES (Sigma Aldrich, UK) buffer pH 7.4 with 5% (w/v) glucose and 100μl of 
suspensions were plated onto poly-L-lysine coated coverslips, held for 5 minutes and washed 3 times 
with 1ml PBS.  Adhered cells were then fixed with 500μl/well 4% (w/v) paraformaldehyde (Sigma 
Aldrich, UK) for 30 minutes and washed 3 times with 1ml PBS.  The DiOC6(3) working stock solution 
was diluted to a final concentration of either 0.5, 0.75 or 1.0μg/ml in 10mM HEPES buffer pH 7.4 and 
used to stain adhered cells by adding 300μl/well to coverslips, incubating for 30 minutes at room 
temperature and washing 5 times with 1ml PBS.  Coverslips were then mounted onto microscope 
slides (VWR, UK) with VectaShield Antifade Mounting Medium (H-1000) (Vector Laboratories, UK) as 
the mounting media and samples were immediately imaged with the LSM Meta 510 confocal 




2.5 Protein methods 
 
2.5.1 SDS-PAGE of protein samples 
 
2.5.1.1  Preparing SDS-PAGE gels 
 
SDS-PAGE gels were assembled between glass plates in a casting frame (BioRad, UK) using dH2O, a 
30% (w/v) acrylamide mix from National Diagnostics (Thermo Fisher Scientific, UK), 1.5M Tris-Cl, pH 
8.8 for resolving gels, 1.0M Tris-Cl, pH 6.8 for stacking gels, SDS (Thermo Fisher Scientific, UK), 
ammonium persulphate (Thermo Fisher Scientific, UK) and Tetramethylethylenediamine (TEMED) 
from National Diagnostics (Thermo Fisher Scientific, UK).  Volumes of each component used to make 




Volume required for a 5ml total gel volume/ ml 
 
12% resolving gel 15% resolving gel Stacking gel 
dH2O 1.6 1.1 3.4 
30% (w/v) acrylamide mix 2.0 2.5 0.85 
1.5M Tris-Cl, pH 8.8 1.3 1.3 0.0 
1.0M Tris-Cl, pH 6.8 0.0 0.0 0.65 
10% (w/v) SDS 0.05 0.05 0.05 
10% (w/v) ammonium 
persulphate 
0.05 0.05 0.05 
TEMED 0.002 0.002 0.002 
 
2.5.1.2  Sample preparation and running conditions 
 
5X SDS-PAGE loading buffer, made up of 10% (w/v) SDS, 20% (v/v) glycerol, 10mM DTT, 0.2M Tris (pH 
6.8) and 0.05% Bromophenol blue (Sigma Aldrich, UK) was added to culture supernatant samples to a 
final concentration of 1X.  Samples were then incubated at 90°C for 5 minutes to denature proteins 
Table 5: List of components used to make the resolving and stacking constituents of SDS-PAGE gels. 
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before loading.  20μl of prepared samples were loaded onto SDS-PAGE gels with either 6μl Unstained 
Protein Molecular Weight Marker (Thermo Fisher Scientific, UK) or PageRu ler™ Unstained Low Range 
Protein Ladder (Thermo Fisher Scientific, UK), and a protein standard (Sigma Aldrich, UK) of a defined 
concentration prepared under the same conditions. 
SDS-PAGE gels were run in SDS-PAGE running buffer (25mM Tris base, 192mM glycine and 0.1% SDS) 
at 25mA per gel for 1 hour, or until the dye front had migrated to the bottom of the gel, using the 
Mini-PROTEAN® Tetra System (BioRad, UK) connected to the PowerPac™ Basic (BioRad, UK) 
 
2.5.1.3  Staining/ Destaining 
 
Following electrophoresis SDS-PAGE gels were washed in dH2O and stained with Coomassie Blue stain 
solution (0.2% (w/v) Coomassie blue (Thermo Fisher Scientific, UK), 10% (v/v) acetic acid (Thermo 
Fisher Scientific, UK), 50% (v/v) methanol) for 2 hours.  Gels were then washed in dH2O to remove 
excess stain and then de-stained in 10% (v/v) acetic acid, 30% (v/v) methanol until protein bands 
could be visualized clearly with minimal background. 
For SDS-PAGE experiments in chapter 3 SimplyBlue™ SafeStain (Thermo Fisher Scientific, UK) was 
used to stain gels.  Gels were stained in SimplyBlue™ SafeStain for 1 hour, washed in dH2O and 
destained overnight in dH2O. 
 
2.5.1.4  Visualisation and image analysis 
 
SDS-PAGE gels were visualised in white light from the Syngene G:Box ChemiHR system (Syngene, UK) 
and the paired GeneSNAP software (Syngene, UK) or the GS-800™ Calibrated Densitometer (BioRad, 
UK).  Relative quantification of protein quantities in each sample by densitometric analysis of gels 
imaged by the densitometer was carried out using the manufacturer’s proprietary software.  
Quantification was based on the band intensity obtained from a pure standard of the relevant protein 
run and imaged from each gel.  Densitometric analysis of gels visualised using the Syngene G:Box 
ChemiHR system was completed using the ImageJ image processing software (http://imagej.net). 
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2.5.2 Glucose oxidase activity assay 
 
The Amplex® Red Glucose/Glucose Oxidase Assay Kit (Thermo Fisher Scientific, UK) was used to assay 
for the titre of secreted recombinant glucose oxidase in culture medium, based on its enzymatic 
activity, according to the manufacturer’s instructions.  Cell cultures were centrifuged at 14,000 rpm 
for 2 minutes and 1 in 10 dilutions of culture supernatants in the assay buffer were prepared.  
Samples were assayed in triplicate in black opaque 96 well microtiter plates (Greiner Bio-One, UK) 
using the BioTek Synergy HT plate reader (BioTek, UK).  The fluorescence from the oxidised form of 
the Amplex red reagent, which is produced at a rate proportional the concentration of glucose 
oxidase in the sample, was measured at an excitation of 530nm and detection of emitted light at 
590nm.  The fluorescence readings were converted to units (U) (where 1U is defined as the amount of 
enzyme that will oxidise 1.0μmol β-D-glucose to D-gluconolactone and H2O2 per minute at pH 5.1 and 
30°C) using a standard curve that was derived from assaying GOx standards provided by the kit which 
can be found in 9.2 (Figure A1). 
 
2.5.3 Lysozyme activity assay 
 
The lysozyme activity assay formatted by Lee and Yang (2002) for use in microplates was used to 
determine the relative titre of secreted synthetic human lysozyme T70A in culture supernatants, 
based on its enzymatic activity.  Dried Micrococcus lysodeikticus cells (Sigma Aldrich, UK) were 
suspended in 100mM potassium phosphate buffer pH 7.0 at a concentration of 0.3mg/ml prior to 
each assay.  50μl of culture supernatant was combined with 200μl of the M. lysodeikticus cell 
suspension, gently shaken for 1 minute and assayed with the BioTek Synergy HT plate reader (BioTek, 
UK).  The decline in the OD450 of samples, caused by the degradation of peptidoglycan in M. 
lysodeikticus cell walls through lysozyme activity, was recorded over a 7 minute period, immediately 
following shaking, at 1 minute intervals.  The lysozyme activity, calculated using the gradient of the 
linear plot of OD450 against time was used to infer the relative lysozyme titre of the sample in U/ml, 




2.6 Statistical methods 
 
2.6.1 Modified Levene’s test for homogeneity of coefficients of variation 
 
The Modified Levene’s test for the comparison of differences between the coefficients of variations of 
2 independent groups was calculated using the SPSS statistical software package 
(http://www.ibm.com/analytics/us/en/technology/spss/). 
 
2.6.2 Regression analysis 
 
Regression analysis was performed using the Data Analysis ToolPak add-in for Microsoft Excel 2007 
(www.office.com). 
 
2.6.3 Mann-Whitney U test 
 
The Mann-Whitney U test to compare differences in the median values between 2 groups without 
assuming the normal distribution of data sets was calculated using the Minitab statistical software 
package (www.minitab.com) 
 
2.6.4 Student’s T test 
 
Unpaired Student’s T tests without the assumption of homogeneity of variance were performed using 





2.6.5 ANOVA with Games-Howell post hoc test 
 
Analysis of variance (ANOVA) coupled with the Games – Howell post hoc test for significance between 
multiple groups, designed for unequal/ small sample sizes that do not meet the assumption of 










3.1.1 Aims and objectives 
 
The aim of this experiment was to determine and quantify the effect, if any, that selection with zeocin 
has on clonal variation in recombinant protein production.  Initially, unexposed cell populations and 
populations grown on a selective concentration of zeocin were compared to identify any significant 
changes in clonal variation attributable to a zeocin background. 
Secondly, to determine whether high levels of clonal variation are unique to zeocin selected 
populations, this study directly compared zeocin selection to alternative P. pastoris selection methods 
that do not require the use of any mutagenic chemicals. 
 
3.1.2 Selectable markers for P. pastoris 
 
A fundamental requirement for the amenability of an expression system to genetic modification is an 
effective selectable marker to easily determine the successful insertion of target DNA into the 
organism, with the number of available markers for an expression organism directly reflecting its 
accessibility and versatility.  The selective markers that have been identified and implemented in P. 






Table 6: List of known marker genes used for direct selection in P. pastoris. 
Gene  Function Standard method of 
selection in P. pastoris 
 
Source 
ADE1/ADE2 Biosynthetic pathway genes 
from P. pastoris 
(phosphoribosylaminoimidazole 
carboxylase), required for the 
synthesis of adenine 
Auxotrophic 
complementation of ade1 or 
ade2 mutants – restores 
growth on minimal media 
lacking adenine 
Lin Cereghino et 
al., 2001 
ARG4 A biosynthetic pathway gene 
from P. pastoris, 
(argininosuccinate lyase) 
required for the synthesis of 
arginine 
Auxotrophic 
complementation of arg4 
mutants – restores growth 
on minimal media lacking 
arginine 
Lin Cereghino et 
al., 2001 
HIS4 A biosynthetic pathway gene 
from P. pastoris, (histidinol 
dehydrogenase) required for the 
synthesis of histidine 
Auxotrophic 
complementation of his4  
mutants – restores growth 
on minimal media lacking 
histidine 
Cregg et al., 
1985 
MET2 A biosynthetic pathway gene 
from S. cerevisiae (homoserine-
O-transacetylase) required for 
the synthesis of methionine 
Auxotrophic 
complementation of met2 
mutants – restores growth 
on minimal media lacking 
methionine 
Thor et al., 2005 
URA3 A biosynthetic pathway gene 
from P. pastoris, (orotidine 5 -
phosphate decarboxylase) 
required for the synthesis of 
uracil 
Auxotrophic 
complementation of ura3 
mutants – restores growth 
on minimal media lacking 
uracil 
Lin Cereghino et 
al., 2001 
bsd Gene from Aspergillus tererus 
(blasticidin S deaminase), 
conferring resistance to the 
antibiotic blasticidin 





hph Gene from Klebsiella pneumonia 
conferring resistance to the 
antibiotic hygromycin b 
Growth on 200μg/ml 
hygromycin b 
Yang et al., 2014 
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Gene Function Standard method of 
selection in P. pastoris 
 
Source 
nat Gene from Streptomyces 
noursei, conferring resistance to 
the antibiotic nourseothricin 
 
Growth on 100μg/ml 
nourseothricin 
Nett et al., 2013 
sh ble Gene from Streptoalloteichus 
hindustanus, conferring 
resistance to the antibiotic 
zeocin 
 
Growth on 100μg/ml zeocin Higgins et al. 
1998  
acc1 Gene from Sorangium 
cellulosum, conferring resistance 
to the macrocyclic polyketide 
soraphen A 
 
Growth on 0.02μg/ml 
soraphen a 
Wan et al., 2004 
tn903kanr Gene modified from E. coli, 
conferring resistance to the 
antibiotic G418 
Growth on 0.5mg/ml G418 Ma et al., 2009 
 
The first marker systems to be implemented in P. pastoris exploited auxotrophic complementation – 
in which mutant strains incapable of synthesising a particular organic compound required for growth 
are transformed with genes encoding the enzyme required to rescue the biosynthetic pathway.  The 
resulting transformants are able grow in media lacking the specific organic compound to be 
distinguishable from cells that have not incorporated the recombinant DNA.  The development of the 
original auxotrophic complementation selectable markers in P. pastoris, his4 and arg4, were not only 
inspired by molecular genetics tools in S. cerevisiae but enabled by them as a number of previously 
isolated biosynthetic gene homologues in S. cerevisiae retained their functionality when expressed in 
P. pastoris (Cregg et al, 1985).  Currently a wide range of auxotrophic markers have been tested in P. 
pastoris, many of which have been brought to market as commercial vectors and strains, including 
the pPIC9/pPIC3.5 series of vectors and the PichiaPink™ system from Thermofisher.  
However auxotrophic complementation presents certain drawbacks, as each selectable marker can 
only be used in conjunction with its respective auxotrophic mutant strain, limiting compatibility 
between strains and vectors as well as prohibiting the use of wild type strains.  As such, antibiotic 
resistance markers, often previously described in S. cerevisiae, have also been developed for P. 
pastoris.   Despite their value as molecular biology tools only two dominant antibiotic resistance 
markers, the zeocin and blasticidin resistance genes: sh ble and bsd, were widely available and 
71 
 
accepted until 2008 (Kimura, Takatsuki, and Yamaguchi, 1994; Higgins et al, 1998).  Previously the 
G418 resistance marker tn903kanr was included in commercial vectors such as pPIC9k and pPIC3.5k, 
but its use was limited to secondary selection for multi-copy variants due to its low expression levels 
in P. pastoris (Scorer et al, 1994).  This was remedied by Ma et al. (2009) through the creation of 
novel vectors containing tn903kanr downstream of the strong, constitutive P. pastoris GAP promoter, 
enabling direct selection on G418.  The recent addition of the  resistance genes for hygromycin b and 
nourseothricin to its molecular tool kit further increases P. pastoris’ utility for recombinant gene 
expression and opens the system up to more complex molecular biology projects requiring insertions 
of multiple expression cassettes (Nett et al., 2013; Yang et al., 2014). 
 
3.1.3 Zeocin selection and sh ble 
 
Zeocin is a copper-chelated, glycopeptide antibiotic belonging to the bleomycin family (Berdy, 1980), 
and has been successfully used as a dominant selective marker in bacteria, eukaryotic 
microorganisms, plants and animal cell lines.  Its broad spectrum of toxicity is due to its ability to bind 
and introduce double stranded breaks in DNA once inside the cell.  The gene product Sh ble, from 
Streptoalloteichus hindustanus, confers resistance by directly binding zeocin stoichiometrically to 
inhibit its function (Drocourt et al, 1990). 
As one of the earliest markers described in P. pastoris, zeocin resistance is well established and 
arguably the most popular selective marker for the system.  Among the reasons for its popularity is 
the fact that zeocin selection provides a number of advantages to expression vector design. The cross 
functionality of the sh ble gene in both eukaryotic and bacterial systems, as well as its small overall 
size, has permitted the development of much smaller E. coli-P. pastoris shuttle vectors in comparison 
to those utilising different selectable markers.   For example the zeocin selection vectors pPICZ and 
pPICZα (Thermo Fisher Scientific) are approximately 3.6kb in size, in comparison to the 
aforementioned pPIC9k and pPIC3.5, marketed by Thermo Fisher Scientific, which range from ~9.0-
9.3kb. 
The 1:1 ratio in binding of a single unit of Sh ble to zeocin for its inactivation means that zeocin 
resistance is titratable, in which there is a direct relationship between the expression level of sh ble in 
the cell and the overall concentration of zeocin that it is capable of tolerating (Gatignol, Durand and 
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Tiraby, 1988).  Post transformational vector amplification (PTVA) is a technique that exploits this 
relationship by sequentially subculturing transformants containing an integrated zeor expression 
vector into media containing increasing concentrations of zeocin, selecting clones which are more 
zeocin resistant, many of which have integrated multiple copies of the vector (Sunga, Tolstorukov, 
and Cregg, 2008).  PTVA using zeocin resistance has been demonstrated to increase the probability of 
obtaining strains containing 10 copies or more from less than 1% through standard transformation, to 
6%, with a 40% probability of obtaining 3 copy strains (Sunga, Tolstorukov, and Cregg, 2008).  Since 
the use of multicopy strains is now a staple for increasing recombinant gene expression and for the 
other factors mentioned previously, zeocin selection provides a unique combination of advantages 
that prove its usefulness beyond its primary function as a dominant selectable marker. 
Unfortunately the induction of random double stranded breaks into the host genome strongly 
increases the probability of introducing mutations through the non-homologous end joining pathway 
(NHEJ).  NHEJ is a highly conserved DNA repair mechanism across a number of bacterial and 
eukaryotic species, including P. pastoris, and is directly involved in the re-ligation of double stranded 
breaks (Critchlow and Jackson, 1998; Daley et al, 2005; Näätsaari et al, 2012).  However, since NHEJ-
mediated DNA repair occurs independently of sequence homology-based repair of DNA breakages, 
the pathway is often error prone and additions or deletion of bases to break sites repaired by NHEJ 
are common (Khanna and Jackson, 2001).  Whilst, in theory, the presence of Sh ble should prevent 
zeocin from damaging host DNA in the cell, a study by Oliva-Trastoy et. al (2005) established that an 
increased background of double stranded breaks continue to occur in resistant human cell lines 
exposed to zeocin.  The evidence suggesting that Sh ble is incapable of fully inactivating its activity 
implicates zeocin as a potential mutagen in zeocin resistant cell lines.  Should the standard zeocin 
selection process of Zeor transformants provide sufficient exposure to introduce random mutations in 
genes directly or indirectly involved in growth on methanol or protein production, the process would 
be directly responsible for artificially enhancing the divergence in the productivities between colonies 





3.2 Examining the effects of zeocin selection on clonal variation in 
industrial P. pastoris strains 
 
To begin evaluating the contribution of zeocin selection towards clonal variation in the Pichia system - 
irrespective of the nature of the particular recombinant protein or its overall titre , three industrial 
strains secreting different proteins with a range of  titres - summarised in Table 7, were donated by 
Fujifilm Diosynth (Billingham, UK) for this study. 
 
Strain name Parent strain  Mode of selection  Secreted protein  
CLD804  NRRL-11430  ZeoR  Aprotinin  
CLD819  NRRL-11430  ZeoR  Elafin  
CLD883  NRRL-11430  ZeoR  Trypsinogen  
 
Using the technique described in section 2.4.2 cell lines for each strain were grown in YPD overnight 
and plated onto either YPD or YPD + 100μg/ml zeocin agar plates following serial dilution. The 
resulting colonies generated varied only in their exposure to zeocin during their growth, having 
otherwise originated from a homogenous cell line.  A control and a zeocin exposed population of 47 
colonies were randomly selected for each strain to proceed to micro expression trials.  The colonies 
were initially inoculated and grown for ~16 hours at 30°C/ 200rpm in 5ml BMGH before resuspending 
in 2ml BMMH, transferring to 24 deep well plates and growing for 5 days at 28°C/ 200rpm.  The final 
OD600 was measured, cultures were harvested by centrifugation and recombinant protein content 
was quantified by densitometric analysis of the corresponding band produced by SDS-PAGE of the 
culture supernatant.  The ranges of specific productivities from each population are displayed as box 
plots (Figure 7A, 8A, 9A).  The coefficient of variation (CV), calculated by dividing the population 
standard deviation by its mean, for specific productivity in each population was taken as a 
representative variable for clonal variation, and compared between control and zeocin selected 
populations.  The coefficients of variation for each strain were plotted (Figure 7B, 8B, 9B) and the 




modified Levene’s test for CV was used to infer the statistical significance of any differences observed 





Figure 7: Graphs comparing the variation in specific productivity between clonal populations of P. pastoris 
CLD804 grown in the absence and the standard concentration of zeocin for selection, where “n” represents the 
number of clones in each population and “p” is the significance value generated by the modified Levene’s test 
for the homogeneity of coefficients of variation between groups.  A – Boxplot comparing range of aprotinin 
titres between CLD804 populations following expression over 5 days in BMM media.  B – The CV for unselected 
and selected populations of CLD804. 
Figure 8: Graphs comparing the variation in specific productivity between clonal populations of P. pastoris 
CLD819 grown in the absence and the standard concentration of zeocin for selection, where “n” represents the 
number of clones in each population and “p” is the significance value generated by the modified Levene’s test 
for the homogeneity of coefficients of variation between groups.  A – Boxplot comparing range of elafin titres 
between CLD819 populations following expression over 5 days in BMM media.  B – The CV for unselected and 






The CV observable appears to vary depending on the recombinant protein being secreted.  Whilst 
both CLD804 and CLD883 exhibit comparable levels of variation at 15.84% and 20.4% respectively for 
the control populations, whilst the CV for the CLD819 control population was measured at 32.11%.  
The disparity in clonal variation between recombinant strains could potentially be attributed to 
overall recombinant protein titres, as the median specific productivity of elafin for the control 
population of CLD819 is approximately 4 times higher than that of CLD804 for aprotinin, and 
approximately 8 times higher than CLD883 for trypsinogen.  Since the CV accounts for the increased 
degree of variation associated with larger sample averages, it therefore suggests that the higher 
productivity phenotype for CLD819 shows increased instability over CLD804 and CLD883.  Whilst 
unconfirmed, as each of the strains tested within this experiment were selected by PTVA, should the 
titre of CLD819 exceed the other 2 strains due to it containing more copies of the elafin transgene, its 
increased intraclonal variation in the absence of selection could be attributed to, in part, by copy 
number variation between its daughter cells – the probability of which is increased in high copy 
number strains (Aw and Polizzi, 2013). 
Contrary to the original hypothesis, for CLD804 and CLD819, less clonal variation in specific 
productivity was observed within the populations grown in the presence of zeocin prior to expression.  
Figure 9: Graphs comparing the variation in specific productivity between clonal populations of P. pastoris 
CLD883 grown in the absence and the standard concentration of zeocin for selection, where “n” represents the 
number of clones in each population and “p” is the significance value generated by the modified Levene’s test 
for the homogeneity of coefficients of variation between groups.  A – Boxplot comparing range of trypsinogen 
titres between CLD883 populations following expression over 5 days in BMM media.  B – The CV for unselected 
and selected populations of CLD883. 
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In the case of CLD804 a decreased CV for aprotinin production of 11.33% in the zeocin selected 
population compared to 15.84% in the control population was recorded.  The difference was more 
pronounced for CLD819, in which the control population displayed close to double the CV of the 
zeocin-exposed population - 32.11% in contrast to 17.03% respectively.  Both decreases were inferred 
to be statistically significant at the 95% confidence level.  However, as can be seen from the  range of 
titres for the populations of both species represented in the box plots (Figure 7A, 8A), the average 
recombinant protein titre was also lower in both of the zeocin-exposed populations.  The mean 
specific productivity for aprotinin in CLD804 drops from 0.32μg/ml/OD600 in the control population to 
0.29μg/ml/OD600 in the zeocin-exposed whereas the difference observed for mean specific 
productivity of elafin in CLD819 is greater – decreasing from 1.59μg/ml/OD600 to 1.02μg/ml/OD600. 
No obvious differences could be observed between the ranges of trypsinogen titres between the 2 
populations of CLD883 (Figure 9A), however the CV was found to be significantly lower in the control 
population at the 95% confidence level, contradicting the pattern observed for CLD804 and CLD819 
(Figure 9B).  However, a comparison of the overall volumetric productivities for trypsinogen showed 
no significant differences in clonal variation between the 2 populations (data not shown) suggesting 
that the differences observed for the specific productivity were introduced solely by variations in final 
cell density. 
 
3.3 Comparison of clonal variation between strains under zeocin and HIS4 
selection 
 
The distinct changes in variability in specific productivity observed for P. pastoris CLD804 and CLD819 
grown in the presence of zeocin raise the question as to whether the effect is unique to selection by 
zeocin resistance, or if it can also be observed with alternative modes of selection.  The HIS4 marker, 
complementating His- mutants with the native HIS gene to restore growth on media lacking histidine 
as a mode of selection, was chosen to compare against Sh ble.  Selection with HIS4 requires no 
further addition of compounds with the potential to compromise growth or productivity, or to exhibit 







The commercial P. pastoris vector pPICZαB was chosen as the backbone for the vector design.  
pPICZαB contains a number of features required for the experimental vectors, including the S. 
cerevisiae α-mating factor pre-pro signal sequence and sh ble.  The most notable feature of pPICZα is 
the presence of a number of single restriction sites flanking sh ble, the use of which would permit the 
exchange of genes into the selective marker locus, under the control of the constitutive yeast 
promoter - PTEF1 and the CYC1 transcription terminator. 
Glucose oxidase (GOx) was selected as a marker to measure specific, secreted productivity from P. 
pastoris.  The ~1.8kb gene has successfully been expressed in both S. cerevisiae and P. pastoris 
(Malherbe, 2003) (Guo, 2010) and liquid assays for its activity are commercially available, in 
comparison to the proteins produced by CLD804, CLD819 and CLD883 where productivity can only be 
quantified by densitometry of protein electrophoresis gels.  Specifically the GOx homologue produced 
by the filamentous fungus Penicillium funiculosum is reported to have a high activity and an identical 
optimal temperature to the growth temperature of P. pastoris - 30°C (Sukhacheva, 2004).  
The ampicillin resistance gene (ampR) was selected as a bacterial selectable marker as HIS4 will not 
be usable in E. coli.  A ~1.2kb region encoding the ampR promoter, ampR and a Rho-independent 
transcription terminator from the pUCG18 (based on pUC18) plasmid was predicted by the web-
based program ARNold (Institut de Génétique et Microbiologie, Université Paris Sud), and included in 
the design of the vectors.  
Following the above specifications 2 plasmids to compare zeocin resistance and HIS4 
complementation for their effects on clonal variation were designed and designated: pGOxZα and 





The assembly of pGOxZα was divided into the insertion of ampR into pPICZα to form the empty 
vector backbone – pAmpZα, followed by the cloning of gox into the multiple cloning site (MCS) to 
Figure 10: Vector maps of pGOxZα and pGOxHα.  Aside from the selectable marker genes both consist of an 
identical vector backbone and expression cassette for GOX. 
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assemble the final construct.  To insert the ampR expression cassette into an independent site, 
pPICZα was linearized by a single digest with the restriction enzyme PciI, cutting between the pUC 
origin and the CYC1 terminus.  The fragment encoding ampR, with its native promoter and 
terminator, was PCR amplified from pUCG18 using the Gibson primers 06-GibAmpRpαb-F and 07-
GibAmpRpαb-R (9.1).  The ampR expression cassette was inserted into pPICZα by Gibson assembly 
and cloned into E. coli BIOBlue.  The positive transformants were identified by selection on ampicillin, 
colony PCR and sequencing (Figure 11). 
 
 
GOX was PCR amplified from P. funiculosum genomic DNA ATCC® 11797-D2 (LGC Standards, UK), with 
08-GibGOx-F and 09-GibGOx-R (9.1).  Following its assembly, pAmpZα was linearised within the MCS 
with PstI.  Gibson assembly was once again used to insert gox into the linearized pAmpZα, in frame of 
the α mating factor, cloned into E. coli BIOBlue, and selected on 100μg/ml ampicillin.  The successful 
assembly of pGOxZα was confirmed by colony PCR and sequencing of the AOX1 locus (Figure 12). 
Figure 11: Colony PCR of 3 E. coli BioBlue colonies cloned with pAmpZα.  The presenc e of the ~1.2kb band 
corresponding to the gene conferring amp
r
 indicates the successful construction of pAmpZα.  Lane 1 – 1kb DNA 





The assembly of pGOxHα required the replacement of sh ble from pAmpZα with his4, without altering 
the corresponding promoter and transcription terminator flanking the gene within the vector.  To 
remove the ~400bp sh ble gene from pAmpZα, a double digest was carried out with NcoI and StuI.  
Whereas NcoI cuts between the 5’ end of sh ble and the TEF1 promoter, the StuI site is located 30bp 
downstream of the 3’ end of sh ble, resulting in the removal of 30bp of the CYC1 transcription 
termination region during the double digest.  To restore CYC1 TT upon the insertion of HIS4, a reverse 
PCR primer for HIS4 was designed to include the 30bp region that was excised from pAmpZα.  HIS4, 
the 5’ 30bp of CYC1tt and 5’/3’ linker regions was successfully PCR amplified from the P. pastoris 
vector – pIB2, and Gibson assembled into the double digest of pAmpZα.  The resulting E. coli 
transformants were screened by colony PCR, and sequenced with primers annealing 50 bp upstream 
and downstream of the predicted position of HIS4, to confirm its insertion as well as the restoration 
of the full CYC1 terminator (Figure 13). 
Figure 12: Colony PCR of E. coli BIOBlue cloned with pGOxZα. The 1.8kb band corresponding to GOX, found in 3 
of the tested colonies indicates the successful assembly of pGOxZα. Lanes 1: 1kb DNA size marker, 2 -9: PCR 





Following the replacement of sh ble in pAmpZα with HIS4, GOX was inserted into the vector MCS to 
complete the assembly of pGOxHα, by the same method used for the construction of pGOxZα. 
To clone pGOxZα and pGOxHα into P. pastoris the plasmids were linearised in the AOX1 promoter 
region with Sac1 and transformed into P. pastoris GS115 (His-) by electroporation.  The resulting 
transformants were selected either on 100μg/ml zeocin for pGOxZα, or on MD media for pGOxHα.  
The new recombinant strains were named P. pastoris GpαGOxZ (zeoR) and GpαGOxH (His+), and are 




Figure 13: Colony PCR of E. coli BioBlue cloned with pAmpZα + HIS4 . The presence of the ~2.5kb band 
(corresponding to the size of his4) indicates the successful replacement of sh ble with HIS4 within the vector.  
Lanes 1 - 1kb DNA size marker, 2-9 - PCR from 8 individual colonies for HIS4 
 
Table 8: Summary of strains used within this section.  A more comprehensive overview of strains can be found 
in section 2.1.2. 
Strain name Parent strain  Mode of selection  Secreted protein  
GpαGOxZ GS115 ZeoR  Glucose oxidase  
GpαGOxH GS115 His+ Glucose oxidase 
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3.3.2 Expression trials of control and selected clonal populations of P. pastoris GpαGOxZ 
and GpαGOxH 
 
Using the technique described in section 2.4.2 a single colony of GpαGOxZ was inoculated into YPD 
medium, grown overnight and plated onto either YPD or YPD + 100μg/ml zeocin agar plates following 
serial dilution.  The same process was repeated for GpαGOxH except that zeocin agar plates were 
substituted for MD agar plates.  After growth on plates a selected and control population of 24 
colonies were randomly selected for each strain to proceed to micro expression trials.  The colonies 
were initially inoculated and grown for ~16 hours at 30°C/ 200rpm in 5ml BMGY before resuspending 
cultures in 3ml BMMY at a normalised OD600 of 5.0, transferring to 24 deep well plates and growing 
for 48 hours at 28°C/ 200rpm.  The final OD600 was measured, cultures were harvested by 
centrifugation and recombinant protein content was quantified using the Amplex Red Glucose 
Oxidase Assay Kit (ThermoFisher Scientific, UK) of the culture supernatant.  Figure 14 displays the 





The zeocin-exposed and control populations of GpαGOxZ produced similar ranges of glucose oxidase 
titres, and no statistically significant differences in their coefficients of variation, suggesting that no 
detectable difference in clonal variation existed between them.  However, under selective conditions, 
the GpαGOxH population possessed a CV of approximately half of the respective control population, 
at 22.47% compared to 44.96% for the latter.  Whilst the magnitude of difference in CV is similar to 
Figure 14: Graphs comparing the variation in specific productivity between clonal populations of P. pastoris 
GpαGOxZ and GpαGOxH grown in the absence and presence of the relevant selective marker, where “n” 
represents the number of clones in each population.  A – Boxplot comparing range of glucose oxidase titres 
between GpαGOxZ and GpαGOxH populations following expression over 48 hours in BMMY media.  B – The CV 
for unselected and selected populations of GpαGOxZ and GpαGOxH.  The modified Levene’s test was used to 
test for significance between coefficients of variation between unselected and selected populations of each 
strain, yielding p values of 0.157 for GpαGOxZ and 0.001 for GpαGOxH. 
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the relationship between the selected and control populations of CLD819, the mean specific 
productivities of both populations of GpαGOxH were roughly equivalent, in contrast to the 
relationship observed between selected and exposed populations of CLD804 and CLD819.  This 
suggests that, in addition to the type of recombinant protein being produced, the effect on clonal 
variation could also be dependent on the mode of selection.  Based on these results no clear rationale 
can be provided to explain how a reduction in clonal variation can occur with HIS4 selection but not 
under zeocin selection, other than it could provide a stronger selective constraint on factors that 
contribute to the specific productivity phenotype, since its gene product is an essential component in 
a metabolic pathway that enables both protein synthesis and cell growth in a minimal medium.  
Regardless, it can be concluded that the partial relationship between selection and clonal variation 
observed is not unique to zeocin selection but appears to apply to alternative methods of selection. 
 
3.4 Maintenance of selection during expression does not have a 
significant effect on clonal variation 
 
Having observed a significant decrease in clonal variation in specific productivity of glucose oxidase 
within the selected population of GpαGOxH it would be pertinent to test whether the variability 
within the population can be sustained, or further reduced, by maintaining selection during a longer 
period of the strain’s use.  Clonal variation places constraints on expression conditions and 
fermentation strategies as copy number stability and consistency in protein production begin to 
deteriorate as the time period of expression is increased.  A possible explanation for how variability 
arises during extended periods of expression is that a drift in specific productivity caused by processes 
such as copy number loss by loop-out recombination, or clonal variation, results in a rise of new 
variants with productivities differing from the native strain, that continue to persist or even out-
compete the original high-producing strain in fermentor culture. 
Standard protocols for growth and expression of P. pastoris do not specify for selection to be 
maintained during expression trials.  Yet, based on the effect observed when the initial growth of 
certain populations was conducted in the presence of a selectable marker, it is possible that selection 
during recombinant protein expression could confer stability in specific productivity over an increased 
period of time.  If a consistent reduction in clonal variation can be achieved during expression by 
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maintaining a selective environment, this would implicate selectable markers as a means for 
improving consistency in productivity as well as increasing the stability of recombinant P. pastoris cell 
lines during fermentation.   
P. pastoris GpαGOxH was chosen for the purposes of this experiment as HIS4 selection was previously 
demonstrated to produce a clonal population with significantly reduced variability in productivity. 
Selection by HIS4 complementation would also be more viable and simpler to maintain as a selective 
condition over the course of an expression trial compared to zeocin resistance.  Specifically, the HIS4-
selected population from 3.3.2 was selected to test the hypothesis that applying marker selection 
during its expression trial would either maintain the population’s minimal degree of  variability or 
decrease it further. 
Each of the 24 cell stocks comprising the selected GpαGOxH population were inoculated in duplicate 
into both 5ml BMGY and BMG (- histidine) and grown for ~16 hours at 200rpm, 30°C.  Cultures 
growing in BMGY were then passaged into BMMY, and those grown in BMG were passaged into BMM 
to induce expression of glucose oxidase, all at a starting OD600 of 5.0.  Expression in 3ml culture 
volumes was continued for 48 hours at 28°C, shaken at 200rpm in 24 deep well plates and the 
variation in glucose oxidase titre was quantified as described in 3.3.2 (Figure 15). 
 
 
Figure 15: Graphs comparing the variation in specific productivity between a clonal population of P. pastoris 
GpαGOxH following a 48 hour expression trial in BMMY or BMM media, where “n” represents the number of 
clones in each population and “p” is the significance value generated by the modified Levene’s test for the 
homogeneity of coefficients of variation between groups.  A – Boxplot comparing range of glucose oxidase titres 
between expression on the standard expression media BMGY/BMMY and selective media BMG/BMM.  B – The 




Selective conditions were imposed on the cultures grown and expressed in the minimal versions of 
the media used, i.e. BMG and BMM, as both lack sources of histidine.  The results from Figure 15 
show that, when grown and expressed in minimal media lacking histidine, variability in glucose 
oxidase specific productivity is significantly lower compared to when the same population is grown in 
non-selective rich media.  The value obtained for the CV of GpαGOxH grown in BMGY/ BMMY is 
approximately equivalent to the previous CV obtained for GpαGOxH under identical conditions in 
3.3.2: 25.7% and 22.47% respectively.  However when expression was repeated in BMG/BMM the CV 
decreased significantly to 12.97%.  
However, the large disparity between the final cell density of cultures grown in rich media and 
minimal media, and its subsequent effect on the overall volumetric productivity introduces a number 
of additional variables that could affect the validity of comparing specific productivities in BMMY and 






Therefore the experiment was repeated but with BMGY and BMMY substituted by BMG and BMM 
supplemented with histidine (BMGH/BMMH) as the non-selective condition (Figure 17).   
 
Figure 16: Boxplots comparing the final cell  density (A) and volumetric productivity of glucose oxidase (B) 





Due to its similarity in composition the growth rate of P. pastoris in BMGH/BMMH was similar to its 
growth in BMG/BMM and so the final, average titres of glucose oxidase achieved in both media types 
are more comparable.  When BMGH/BMMH was used as a non-selective condition, there was no 
significant difference in CV to GpαGOxH expressed under selective conditions.  The significant 
reduction in CV observed for clonal populations of GpαGOxH grown in BMG/BMM compared to 
BMGY/BMMY therefore suggests that the causal factor for the difference observed is unrelated to 
marker selection.  Regardless, the increase in variability within the GpαGOxH population grown and 
expressed in rich media cannot be completely explained as an inherent increase due to the larger 
overall productivity, as the CV accounts for the sample mean, allowing for the standardisation of data 
sets with widely differing mean values.  This suggests that clonal variation increases in response to 
increases in cell growth and volumetric productivity in culture in a non-linear fashion, and is 
significantly minimised when growth is limited during expression. 
  
Figure 17: Graphs comparing the variation in specific productivity between a clonal population of P. pastoris 
GpαGOxH following a 48 hour expression trial in BMMH or BMM media, where “n” represents the number of 
clones in each population and “p” is the significance value generated by the modified Levene’s test for the 
homogeneity of coefficients of variation between groups.  A – Boxplot comparing range of glucose oxidase titres 
between expression on the standard minimal expression media BMGH/BMMH and selective media BMG/BMM.  
B – The corresponding CV for specific productivity under each condition. 
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3.5 Comparison of gene copy number variation between selected and 
unselected clonal populations 
 
One of the major contributors towards variation in recombinant protein productivity between the 
daughter cells of a recombinant strain is the deviation in the number of copies of the target gene in 
the host genome, brought about by homologous recombination events within the locus of 
integration.  To determine whether the differences in clonal variation between the clonal populations 
secreting glucose oxidase used in this study can be attributed to variation in GOX gene copy number, 
the relative copy number for each clone was measured. 
The clonal populations used in the study included both the selected and non-selected populations for 
GpαGOxZ and GpαGOxH, derived in 3.3.2.  The 24 clones comprising each population were first 
grown individually in YPD, YPD + 100μg/ml zeocin or MD, depending on the original growth conditions 
of the population.  Genomic DNA was then purified from each colony as described in section 2.3.15 
and copy number was measured by qPCR using primers specific to gox (40-qGOx2-F, 41-qGOx2-R) 
using beta-actin (act1) as a reference for a gene located in the genome as a single copy.  The range of 
GOX copy numbers for each population is illustrated in Figure 18. 
The distribution of GOX copy numbers in both the selected and control populations of GpαGOxH 
appears to be similar, with the majority of clones appearing to contain a single copy.  This eliminates 
copy number variation as a potential explanation for the reduction in clonal variation in GpαGOxH 
when grown under selective conditions, implicating a variation in the promoter strength of AOX1 






A considerable difference was observed between the zeocin-selected and control populations of 
GpαGOxZ, with a wider distribution, skewed further towards copy numbers higher than 1 in the 
control population.  Conversely the population raised under zeocin selection exhibited a similar range 
of copy numbers to the GpαGOxH, consisting predominantly of single copy clones and 4 clones 
potentially containing 2 copies of GOX.  The occurrence of higher numbers of multi-copy clones in a 
population raised in the absence of selection is unexpected, primarily because a selective background 
Figure 18: Boxplots showing the range of copy numbers of the GOX gene, measured by qPCR of previously 
tested clonal populations and normalised to the amplification of the act1 gene, with points representing the 
copy number of individual clones within each population overlaid. “n” is the number of clones plotted for each 
population.  A – Comparison in copy number range of gox between clonal populations of P. pastoris GpαGOxZ 
raised in the absence of selection or 100μg/ml zeocin. B – Comparison in copy number range of gox between 
clonal populations of P. pastoris GpαGOxH raised in the absence of selection or media lacking histidine. 
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favouring gene copy multimerisation is not being provided under any of the conditions tested.  
Despite the absence of a selective pressure favouring multiplication of the vector a clear drift in copy 
number has occurred in non-selected GpαGOxZ.  Secondly, in spite of the disparity in the range and 
average copy number of clones within the 2 GpαGOxZ populations, it does not appear to affect GOx 
productivity as no significant difference in clonal variation of GOx titre was observed between them.  
The degree by which increasing the target gene copy number in P. pastoris affects recombinant 
protein production is context dependent and hinges on properties specific to the recombinant 
protein in question (Zhu et al, 2009B; Zhu et al, 2011; Aw and Polizzi, 2013).  It is probable that an 
increase in copy number between the minimum of 1 and the maximum of 4, found in the control 
GpαGOxZ population, does not correlate with a strong increase in GOx production or that GOx 
production varies highly between clones with equivalent copy numbers such that a high producing 
single copy clone compares favourably with a 4 copy clone.  Whilst the observed difference in GOX 
copy numbers between the control and selected populations of GpαGOxZ does not appear to affect 
clonal variation in productivity it could potentially explain the differences in clonal variation found in 




Previous studies exploring clonal variation in P. pastoris have not established a standard method for 
quantifying and comparing variability in protein productivity, presenting an initial challenge to 
analysing clonal variation empirically.  The coefficient of variation, used commonly as a measure of 
variability of data within distributions, provides possibly the most representative measure for clonal 
variation.  Given a set of data points for any given sample the coefficient of variation is simple to 
calculate and, more importantly, it is possible to test for the homogeneity of coefficients of variation 
belonging to 2 or more groups through a modification of the Levene’s test: an inferential statistic 
originally designed to test the equality of variances.  The Levene’s test is particularly robust for 
inferring statistical significance over other more commonly used tests for variance, such as the F test, 
as it does not make the assumption that the data fits a normal distribution - which is relevant since 
the distribution of protein titres from P. pastoris is unknown (Levene, 1960).  However, unlike 
variance, the coefficient of variation is dimensionless and can therefore provide a standardised 
measure for dispersion for highly diverse data sets.  Valid comparisons between distributions varying 
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strongly in their means, measured variables and magnitude are possible with the coefficient of 
variation and so it is ideally suited for measuring variation between clonal populations with differing 
average titres or even the titres of different recombinant proteins if required. 
Initial research investigating the effect of zeocin selection on clonal variation in P. pastoris revealed 
that variation in specific productivity for 2 of 3 recombinant proteins tested was reduced when clonal 
populations were grown in the standard selective concentration of zeocin.   Whilst this directly 
contradicted the original hypothesis that the use of zeocin was contributing to clonal variation the 
fact that no significant difference in clonal variation could be observed for zeocin – selected clonal 
populations secreting trypsinogen or glucose oxidase suggests that the effect is not consistently 
replicable.  For the purpose of discovering if the reduction in clonal variation of populations grown 
under selection was a unique feature of zeocin selection the recombinant strains GpαGOxZ and 
GpαGOxH, sharing an identical parent strain and both secreting recombinant glucose oxidase but 
differing in their selectable markers, was created.  Whilst the mechanism of selection for HIS4 in 
GpαGOxH functions in an entirely separate fashion from zeocin resistance, a clonal population of 
GpαGOxH under selection exhibited a reduction in clonal variation of a similar scale to the previously 
tested strains.  Hence it is highly likely that raising a population with less clonal variation is achievable 
through multiple selectable markers, and is not limited to zeocin resistance.  Nevertheless, the 
application of HIS4 selection throughout expression is unsuccessful at maintaining a significantly 
lower variability in titre of GOx compared to using non-selective media for expression of the same 
clonal population.  This suggests that selection only exerts an effect on the diversity of protein 
secretion during the formative stages of the population.  For the purposes of this study cl onal 
populations were formed selecting individual colonies, forming allegedly from single cells, on agar 
plates.  One possible explanation is that selection promotes the proliferation of individual cells with 
certain phenotypes pertaining to growth or expression of the selectable marker, while cells that are 
compromised or grow poorly in response to selection do not form colonies.  Without any hypothetical 
penalties imposed by selection a greater extent of drift in growth and expression phenotypes could 
be able to occur, resulting in a population of colony forming units with a greater diversity in growth 
rate and gene expression.   
Surprisingly the range and average in copy number of GOX per clone was higher among a population 
of GpαGOxZ raised without zeocin selection, since there was no selective pressure present to 
stimulate an increase in copy number.  Conversely a larger proportion of clones from the population 
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grown with zeocin selection contained only a single copy of GOX.  Whilst PTVA utilises selectable 
markers to increase the probability of obtaining clones with high target gene copy numbers possibly 
only the more excessive concentrations of zeocin used in this practice, ranging up to a maximum of 
~3.0mg/ml (Sunga, Tolstorukov and Cregg, 2008) in comparison to the standard selective 
concentration of 100μg/ml applied in this study, provides a sufficient selective advantage for multi-
copy clones.  During exposure to low concentrations of antibiotic that do not require an increased 
gene dosage to confer resistance, the overexpression of the respective selectable marker could 
theoretically provide a selective disadvantage to high copy number strains in culture.  In this case, the 
over-production of redundant quantities of Sh ble in high copy strains would place a stronger burden 
on protein biosynthetic pathways and impeding the translation of other native proteins as the more 
abundant sh ble mRNA would increasingly occupy the limited number of ribosome binding sites 
within the cell.  This does not explain how the occurrence of multi-copy clones in an un-selected 
population is higher, although the phenomenon itself could provide an explanation as to how the  
average recombinant protein titres were higher in both non-selected populations of P. pastoris 
CLD804 and CLD819.   
Regardless of the unexpected, complex relationship observed between marker selection and clonal 
variation, the key conclusion that can be taken from the study is that there is no evidence to support 
that the use of zeocin as a selectable marker contributes significantly towards clonal variation.  
Selection by zeocin resistance can therefore be discounted as a candidate for inducing clonal variation 




4. Correlating variation in growth and the expression of native genes 




4.1.1 Aims and objectives 
 
This study quantified the recombinant protein titre from a large subset of clones taken from a single 
copy cell line in order to identify a basal, native degree of clonal variation representative of the P. 
pastoris system. 
Variation in cell growth and the transcription of candidate genes with hypothetical links to 
recombinant protein production were quantified, and regression analysis was used to determine their 
impact, if any, on clonal variation within the sample. 
 
4.1.2 Examining clonal variation in factors beyond protein production 
 
Clonal variation in P. pastoris is responsible for complications in upstream processing as well as drift 
in productivity during extended fermentation trials, at least in multicopy strains (Higgins and Cregg, 
1998; Zhu et al, 2009B; Love et al, 2010).  As such there is an interest in finding and removing any 
causal factors that exacerbate variability between clones.  However, with the exception of copy 
number, the absence of factors with obvious effects on clonal variation within standard P. pastoris 
expression protocols suggests that clonal variation could occur, at least in part, due to native sources 
of variability between cells. 
Compared to S. cerevisiae P. pastoris appears to be significantly recombinogenic (Cregg and Russell, 
2007) and it is this property which has been associated with the poor stability of multicopy clones 
(Mansur et al, 2005; Aw and Polizzi, 2013).  Since the majority of multicopy clones in P. pastoris are 
generated by integrating tandem repeats of an expression vector within a single locus, the probabili ty 
of recombination events occurring within the specified locus and disrupting the recombinant 
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sequence is increased.  However homologous recombination itself is an agent for inducing mutations 
and driving genetic variation within eukaryotes through a number of mechanisms - including cross-
over events during meiosis and genome rearrangements (Cooper, 2000).  Should the degree of 
variability observed within the locus of integration in P. pastoris be repeated in other loci within the 
genome it would be rational to predict a degree of natural diversity arising within a population for a 
number of traits that could affect individual protein productivity.  Whilst information on natural 
variation in P. pastoris is limited, a study from Love et al (2010) was not only capable of resolving 
significant variation in the rate and overall secretion of a human Fc antibody fragment between 
isolated, single cells, but that it could be correlated in part with more than a 2-fold range in cell 
doubling time between tested sub-populations.  The results indicate that a divergence in recombinant 
protein secretion and growth rate, a complex phenotype with ramifications for protein production, is 
occurring at the single cell level. 
Typically clonal variation in P. pastoris is only characterised by the range of final protein titres 
obtained from clones within a tested sample.  However, extending the scope of clonal variation to by 
examining variability in relevant native factors such as growth rate, gene transcription or ER stress 
response elements and correlating the results with protein productivity will provide further 
information on how variability in protein productivity arises in P. pastoris in addition to identifying 
phenotypes that predispose clones to produce optimal protein titres.  Furthermore if any strong 
correlations with protein titre can be identified, the tested native factors could inform the 
development of markers to screen for high producing clones without the need for expression trials. 
 
4.2 Establishing a distribution of recombinant protein titres from a single 
copy clonal population 
 
Having previously set up a simple and accurate protocol for measuring recombinant glucose oxidase 
secretion (chapter 3.3.2) P. pastoris GpαGOxZ was selected as the starting strain from which to 
conduct the study.  In order to minimise the risk of obtaining a clonal population with a significant 
divergence in gene copy numbers, distinguishing between native clonal variation and variation due to 
heterogeneity in copy numbers, a GpαGOxZ clone confirmed to contain a single copy of gox in 
chapter 3.5 was used as the parent strain.  A sample of 40 discrete colonies was randomly selected 
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from a series of clones grown on YPD + 100μ/ml zeocin plates following the procedure described in 
2.4.2 to proceed with micro expression trials. 
A 48 hour expression trial in 3ml BMMY in 24 deep well plates was conducted, after which the final 
titre of GOx was measured, and total RNA was isolated for each clone.  The distribution of specific 




The Anderson-Darling test for normality indicates that the range of specific productivities obtained 
for the sample of 40 clones does not belong to a normal distribution at a 99.5% confidence level.  The 
majority of clones exhibit a narrow range of productivities, with greater than 50% of the sample 
producing GOx titres between 9.5 and 11.5 mU/ml/OD600.  In spite of this, significant clonal variation 
within the sample group is apparent when examining the lowest and highest producers within the 
sample, in which a greater than a 2-fold difference in GOx titre even though both subsets of clones 
originated from a homogenous, single copy cell line.  As such, the nature in which the clonal 
population was raised, and the magnitude of the difference in productivity does suggest the 
Figure 19: Distribution of the specific productivities of GOx within a clonal population derived from a single copy 
variant of GpαGOxZ, following a 48 hour expression trial.  The mean specific productivity, standard deviation 
and sample size (N) are displayed. 
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occurrence of stochastic events influencing recombinant protein secretion in independent clones that 
cannot be accounted for by simple biological variation. 
 
4.3 Analysing the effect of total growth and growth rate on GOx 
productivity 
 
Contradictory evidence exists for the effect of growth rate in culture on overall recombinant protein 
titre in P. pastoris.  A transcriptomic analysis of P. pastoris identified the upregulation of numerous 
genes involved in ribosome biogenesis, protein synthesis and translocation when grown under 
conditions promoting higher specific growth rates, implicating a high growth rate as beneficial 
towards protein production (Rebnegger et al. 2014).  Conversely, in the aforementioned single cell 
analysis of P. pastoris secreting constitutively expressed Fc fragment, a direct trend between specific 
productivity and cell doubling time was observed, suggesting that overall productivity is, in fact, 
inversely proportional to the growth rate of independent cells in culture (Love, 2010).  However the 
same study also noted a subgroup, characterised by a rapid average growth rate, producing higher 
titres of Fc in comparison to other tested subgroups.  Whilst the suitability of faster growing clones to 
recombinant protein production remains unclear its association with specific productivity of cells in 
culture creates a case for growth rate during expression as a predictor variable for correlation studies. 
Both specific and volumetric productivities were initially correlated with the final OD600 recorded 





Figure 20: Linear regression between the volumetric productivity (A) or specific productivity (B) of GOx and the 
final cell  density of cultures  following a 48 hour expression trial.  The R
2
 value and significance value (p) from 
the regression analysis between the variables are displayed. 
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Simple linear regression was conducted in each case to determine the strength of the correlation, and 
coupled with regression analysis to evaluate their statistical significance.  The results of the regression 
analysis confirmed that the weak, negative correlation found between the final cell density of clones 
in culture and specific productivity was significant (p<0.05).  However caution should be taken when 
interpreting the relationship between final cell density and specific productivity, as the former is 
factored into the formula for calculating specific productivity, creating a potential bias in the strength 
of the correlation.  Therefore, in this case, examining the correlation with volumetric productivity 
would provide a more accurate representation of the effect of final cell density on clonal variation.  
As expected the strength of the correlation between final cell density and volumetric productivity is 
weaker and has a lower statistical power in comparison to the equivalent correlation for specific 
productivity.  However the reduced R2 value remained statistically significant within a 95% confidence 
limit (p<0.05). 
The OD600 recorded upon culture harvest however does not provide a wholly representative value to 
describe the growth phenotype as, after a 48 hour period, the measurement would have most likely 
been taken during the strain’s stationary phase of growth.  The growth  rate during exponential phase, 
usually calculated through growth curve analysis, is more commonly used to denote the growth 
phenotype and viability of a strain in culture, and is impossible to derive from the final OD600.  To 
identify any differences in growth rate between highest and lowest producing clones from the tested 
sample, and its connection to productivity, the sample was binned into quartiles based on the specific 
productivity for each clone, with the 1st (Q1) and 4th (Q4) quartiles, being selected for growth curve 






Growth curve analyses were conducted for Q1 and Q4, in which each clone was grown for ~16 hours 
in 5ml BMGY before resuspending to a final OD600 of 0.1 in 25ml BMMY in 250ml baffled flasks.  The 
cultures were grown at 30°C, and OD600 was measured at 2 hour intervals throughout exponential 
growth until the beginning of stationary phase.  The recorded OD600 was plotted for each clone, and 
the points encompassing the linear portion of exponential growth were used to calculate the 
doubling time – equivalent to the growth rate of each clone in culture during methanol-induced 
expression.  The doubling time was calculated using the formula: 
 
              
         
                                                  
 
 
In which the initial cell density represents the OD600 recorded at the start of linear growth, final cell 
density is the OD600 recorded upon the end of linear growth and t is the time period (in hours) 
between the 2 points. 
To account for any differences in conditions from the initial expression trial, the final OD600 and 
glucose oxidase titres for each culture were measured again once stationary phase had been entered.  
Figure 21: Average titre of GOx for sampled clones within the 1st and 4th quartiles for specific productivity.  
Error bars represent the standard deviation of 10 clones making up each quartile. 
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The new values for volumetric and specific productivity were then plotted against the doubling times 






Figure 22: Linear regression between the volumetric productivity (A) or specific productivity (B) of GOx and the 
doubling time of clones within Q1 and Q4 for specific productivity of the original test sample.  The R
2
 values and 




No significant relationship between either volumetric or specific productivity, and doubling time 
could be observed within the limits of the test.  However, due to the lower starting cell density and 
time period required for growth curve analysis in comparison to a 48 hour expression trial, the GOx 
titres recorded for clones within Q1 and Q4 were severely low to the point in which the activities 
recorded by the GOx liquid assay were measured at an extremely low point on the standard curve, 
indicating the possibility that insufficient expression to differentiate higher producers from lower 
producers based on the assay alone has occurred.  The enzyme activities recorded could therefore be 
unrepresentative of clone productivity under the conditions imposed during the original expression 
trial, with the added risk of the differences in titres being obscured by the background noise from the 
assay at such reduced activities.  Bearing this observation in mind the doubling times for each clone 






Due to the skewness in the distribution for the doubling times of both Q1 and Q4 the Mann-Whitney 
U test was deemed more appropriate to test the homogeneity between the 2 groups over the 
Student’s t-test, as it is non-parametric.  A significant difference between the median average 
doubling times within a 95% degree of confidence (p<0.05) was observed between clones in Q1 and 
Q4.  Whilst the difference itself appears to be small, with a decrease in 0.143 hours for the median 
average doubling time in high producing clones, its statistical significance indicates that Q1 and Q4 
belong to discrete subpopulations that have diverged in average doubling time from the original cell 
line.  If this is the case, the lower median doubling time suggests that the average growth rate 
appears to be marginally increased within the subpopulation containing clones with the highest 
productivities.  Whilst the data does not provide an understanding as to whether natural variation in 
growth provides a certain level of predisposition towards higher protein yields, or if it occurs as a 
result of clonal variation in productivity, it does suggest that the growth phenotype, comprised of 
overall growth and growth rate, is a minor predictor for productivity amongst a clonal population. 
Figure 23: Boxplots comparing the distributions of doubling times for GpaGOxZ clones belonging to Q1 and Q4 
for specific productivity from the original test sample.  The bottom and top of the boxes represent the 
interquartile range, and the line within the box represents the median value.  The “whiskers” illustrate the 1st 
and 4th quartiles for the data sets, excluding values outside of 2 standard deviations from the mean (starred).  
The sample size (N) is displayed and “p” represents the significance value from the Mann-Whitney U test for 




4.4 Correlating recombinant gene transcription with corresponding 
protein productivity for GOx 
 
The successful increase in titres of a number of recombinant proteins in response to increasing the 
number of copies of the corresponding gene within the cell confirms that a link exists between gene 
dosage and productivity (Cos et al, 2005) (Zhu et al, 2009A) (Norden et al, 2011).  However there is 
little insight as to whether significant variability in expression of recombinant genes at the 
transcriptional level exists between clones with uniform copy numbers, and if it affects clonal 
variation.  Hypothetically the rate of transcription from the AOX1 promoter should have a direct 
relationship with synthesis rates of the encoded, secreted protein if the quantity of transcript 
available for translation by ER-bound ribosomes is limiting.  To analyse the contribution of variation in 
recombinant gene transcription towards protein productivity within the GpαGOxZ clonal population, 
RNA was isolated from each clone upon harvest of expression cultures as described in 2.3.17.  The 
expression of GOX was quantified by RT-qPCR of the RNA samples using the primer set 40-qgox2-F 
and 41-qgox2-R and calculated as a fold change in expression relative to the expression of actin 






Figure 24: Linear regression between the volumetric productivity (A) or specific productivity (B) of GOx and the 
expression of recombinant GOX relative to the expression of native ACT1 following a 48 hour expression trial.  
The R
2
 value and significance value (p) from the regression analysis between the variables are displayed.  
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The range of expression for GOX among the sample was surprisingly large and significantly exceeded 
that of any other genes tested within this project, including those tested using identical cDNA 
samples.  This may however be characteristic of expression of genes from PAOX1, as comparable ranges 
have previously been derived during methanol-induced expression for alternative recombinant genes 
(Aw and Leak, 2012).  Even with the abnormally high variability in fold expression of GOX between 
clones, no correlation could be found between expression and volumetric/ specific productivity of 
GOx.  This is unexpected because, as surmised previously, a strong increase in transcription would be 
predicted to increase protein production.  A potential explanation could be that expression from PAOX1 
is prone to naturally high levels of fluctuation between higher and lower states depending on external 
factors, and that the values calculated for GOX expression for each clone may be inappropriate 
representations of an average rate of transcription.  Alternatively, under the set conditions, 
transcription may not be a limiting factor to productivity, supported by the fact that the minimal copy 
number drift identified in 3.5 also did not impact GOx production significantly. 
 
4.5 Correlating HAC1 expression, as a marker for UPR regulation, with 
GOx productivity 
 
The attribution of bottlenecks within the secretory pathway for P. pastoris to recombinant production 
has led to the examination of ER stress responses and total intracellular protein as indicators of the 
efficiency of secretion of recombinant proteins (Love et al, 2012).  Indeed, the study of the secretion 
of a library human lysozyme variants ranging in their native state stabilities found that de creasing 
stability resulted in both lower secreted productivities and an upregulation of UPR and ERAD pathway 
genes.  The implication of the limitations of P. pastoris’ secretory capacity for productivity has 
informed the development of high producing strains constitutively expressing certain UPR regulated 
genes that are beneficial to protein folding, for example the gene encoding protein disulphide 
isomerise (PDI) (Inan et al, 2006).  The rationale behind such strains is to artificially increase the 
folding capacity of the cell’s ER, along with the threshold for the activation of the aforementioned 
stress responses that eventually lead to product loss. 
Should natural variation in the ER folding capacity manifest within a clonal population due to 
unknown environmental or intrinsic factors, it could therefore confer a beneficial adaptation towards 
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protein secretion that would be partly responsible for the variability observed in the expression 
system.  As previously described (1.6.1.1) HAC1 encodes the transcriptional regulator for the UPR 
pathway in eukaryotes and is activated in yeast through the splicing of HAC1 mRNA to yield a 
transcript encoding its functional form of the protein.  However in P. pastoris a second regulatory 
feature for UPR activation is that the expression of its HAC1 homologue is also upregulated, indicating 
its usefulness as an indicator for relative ER stress (Guerfal et al, 2010).  Clones found to express 
lower levels of HAC1 than others could subsequently be interpreted as experiencing lower levels of ER 
associated stress in culture and vice versa. 
To test for variation in HAC1 regulation within clonal populations and its relation to productivity, RT-
qPCR with P. pastoris HAC1-specific primers (32-qHAC1-F, 33-qHAC1-R) was also carried out on the 
isolated RNA from the 40 GpαGOxZ clones following expression.  Again, the relationship between the 







Figure 25: Linear regression between the volumetric productivity (A) or specific productivity (B) of GOx and the 
expression of native HAC1 relative to the expression of native ACT1 following a 48 hour expression trial.  The R
2
 
value and significance value (p) from the regression analysis between the variables are displayed. 
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Compared to GOX, the range in expression for HAC1 within the sample is notably smaller and more 
typical, with the vast majority of clones clustering between a 0.1 and 1.5 fold change in expression 
related to ACT1.  Regression analysis failed to identify any significant correlation between HAC1 
expression and volumetric/ specific productivity of GOx, exemplified by clones expressing relatively 
high levels of HAC1 producing roughly equivalent titres to clones with significantly lower expression.  
The results indicate that impactful variations in ER stress thresholds either do not occur within the 
clonal population or that they have no effect on productivity for the tested scenario i.e. for the 
expression of a single copy of GOX under the parameters of the expression trial used for the study. It 
is not clear from this study whether the different levels of HAC1 expression reflect a natural variation 





This study examined the relationship between cell growth, recombinant gene transcription, the 
transcription of HAC1 and recombinant protein productivity within a defined sample of clones to 
evaluate their contribution towards clonal variation.  Both the volumetric and specific productivities 
of GOx were chosen to be investigated as response variables, on the basis that studying both would 
allow for the differentiation between higher productivities resulting from improved culture growth 
and higher cell-specific productivity.  However, for each of the variables tested, both measures for 
productivity corroborated each other, providing more valid confirmation for all of the conclusions 
made from the results. 
Of all of the variables tested, only the growth of clones in culture provided a statistically significant 
correlation with productivity of GOx.  However, in the case of the final cell densities recorded for each 
culture upon harvest, the weakness of the correlation suggests that variation in total cell growth is 
only a minor predictor of clonal variation amongst other, currently uncharacterised traits.  The trade-
off between biomass and yield of high value products is a commonly recognised phenomenon across 
a spectrum of microbial fermentations, in which microorganisms exhibit more inefficient metabolic 
activity and product formation during rapid growth, instead diverting more energy and resources 
available in culture towards the formation of cellular mass (Goel et al, 2012).  The issue is often 
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exacerbated for continuous fermentation strategies during which prolonged exposure to the culture 
environment places selective pressures that favour cells shifting energy towards growth rather than 
product formation.  This could provide an explanation for the negative relationship between final cell 
density and GOx productivity in the study.  Should the antagonistic relationship between total 
biomass and productivity form the underlying principle for the correlation observed, the strength of 
the correlation, and therefore the influence of varying total biomass formation on clonal variation, 
would hypothetically increase as expression is extended for longer periods of time.  The divergence 
towards slightly increased growth rates for the highest producers within the sample could be seen as 
somewhat contradictory to the inverse relationship between final cell density and productivity, as 
faster growing cells in culture would also be expected to yield higher cell concentrations in culture.  
However the difference is small, equating to an approximate difference of 8.4 minutes between the 
median doubling times of the high and low producers tested.  In this case the differentiation in 
growth rate could indicate minor differences in viability and the prolificacy of individual clones in the 
culture medium, in which case the findings made by Rebnegger et al (2014) apply.  As the study 
concluded that a higher rate of growth was synonymous with the increased expression of genes 
involved in protein synthesis and ribosome formation, minor divergences in these expression profiles 
within clonal populations could potentially be linked to the variable growth and specific productivity 
observed within this experiment.  The higher growth rate of certain clones within a controlled, 
relatively short expression trial could have benefitted from faster rates of protein synthesis and 
downregulated stress-related proteolytic responses, resulting in a high productivity phenotype.  In 
this situation protein production and growth rate would increase simultaneously, rather than trading 
off, utilising substrate from the media at a faster rate than low producers instead of biasing cell 
growth.  Unfortunately cell growth is a complex trait itself, comprised of a number of variables, while 
also alluding to other relevant phenotypes within cells such as viability and productivity.  Therefore it 
is difficult to ascertain from the data an ideal growth phenotype for recombinant protein production 
or indeed which aspect of growth is the most beneficial, especially since its variability between clones 
appears to only have a minor effect on their output.  An optimal balance must exist between growth 
and productivity beyond which one impedes the other and this is often managed in practice through 
carefully controlling the availability of metabolic substrate during expression as well as screening for 
suitable clones following the creation of new recombinant strains. 
The variation in transcription of GOX from PAOX1 between clones was unusually high compared to data 
for other genes, yet did not correlate with the overall productivity of GOx.  The AOX1 promoter has 
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been shown to be tightly controlled and sensitive towards methanol concentrations in culture as well 
other carbon catabolites (Kupcsulik and Sevella, 2004) (Hartner and Glieder, 2006).  For that reason it 
is likely that the high variability in GOX expression could reflect differences between methanol 
concentrations in each culture due to the variation in growth, and therefore methanol uptake, 
between clones at the point of harvest.  Alternatively, while the on/off states of PAOX1 are well 
regulated, the amplitude of transcription from it could be less so, putting the validity of conclusions 
made from data collected from PAOX1 controlled expression during later stages of methanol induction 
into question.  Nevertheless the results remain unexpected in the context of the strain used within 
the study, as using a single copy clone as a parent strain should minimise any background variation of 
recombinant gene copy numbers within the resulting clonal population.  It should be surmised that 
the wide range of GOx expression recorded is not caused by significant copy number variation 
between clones within the sample but is instead an inherent feature of the AOX1 system.  The lack of 
a positive correlation between GOX transcription and GOx titre cannot be fully explained either as a 
saturation point being reached for GOX expression, beyond which increasing transcription no longer 
has the effect of increasing protein synthesis, as higher producing variants than those observed in this 
study were found previously (Chapter 3).  Another possible justification could be that, considering the 
high standard rates of transcription achievable from PAOX1, more sizeable increases in transcript 
quantities are required to bring about notable changes in production of secreted proteins, particularly 
since previous studies have found its relationship with gene dosage/ copy number is non-linear (Liu et 
al, 2014) (Aw and Polizzi, 2013).  As mentioned previously though, a likely possibility is that the values 
recorded for GOX expression from PAOX1 could have fluctuated over the course of methanol induction 
and perhaps do not represent an average rate of transcription.  In order to test this prediction, and 
rectify it, a time course experiment for GOX transcription throughout various stages of growth, pre 
and post methanol supplementation would have to be considered in order to ascertain the 
consistency of PAOX1 expression within the parameters of micro expression trials. 
No correlation was also found between productivity and the expression of HAC1, providing evidence 
to suggest that variability in UPR induction is not responsible for the clonal variation observed for the 
expression of a single copy of GOX.  The average fold change in expression of HAC1 compared to ACT1 
in the tested clones was 1.17 which is on the lower end of the spectrum for HAC1 regulation following 
a 48 hour expression, based on the study of HuL variant secretion by Whyteside et al. (2011), in which 
all expression values were normalised using the same reference gene as this expe riment.  In addition 
to this, the fact that the clonal sample tested was raised from a single copy variant of GpαGOxZ 
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suggests that the properties and expression rates of GOx in this study do not exert exceptionally high 
levels of ER stress in cells.  Fluctuations in UPR upregulation within cells of GpαGOxZ, possibly in 
response to shifting rates in secretion throughout expression could not be extensive enough to 
trigger detrimental effects to productivity through the activation of protein degradation pathways 
such as ERAD.  Based on the links identified between ER stress and secretion rates of recombinant 
proteins variability in UPR regulation and its threshold for activation might become a contributing 
factor towards clonal variation for the production of proteins that elicit more critical levels of ER 
stress.  HAC1, however, only comprises 1 of many genes that are upregulated during periods of high 
protein burden on the ER, and so further tests could be conducted to establish the existence of 
natural variation in a clone’s adaptability to secretion bottlenecks and whether it has an effect on its 
productivity.  Factors such as total intracellular protein, expression data for more UPR regulated 
genes and the regulation of ERAD and other proteolytic pathways could be considered as valid 





5. Deletion of the OPI1 homologue in P. pastoris and its effect on 




5.1.1 Aims and objectives 
 
The objective of this experiment was to generate a knockout strains for the OPI1 homologue in P. 
pastoris and to assess the resulting mutant’s capability in secreting a range of recombinant proteins 
that have been shown to elicit different levels of ER stress.  The growth and UPR profiles of strains 
undergoing methanol-induced expression were also compared to the native P. pastoris expression 
system, and the study aimed to quantify changes in ER membrane size in Δopi1 strains to determine 
whether the function of Opi1p in P. pastoris is conserved from S. cerevisae.  The results of the study 
could be used to establish whether the loss of Opi1p confers an adaptation to the higher protein 
burden artificially introduced by recombinant protein overproduction and improves cell -specific 
productivity. 
 
5.1.2 Constitutive expression of UPR elements as a strategy to alleviate secretion 
bottlenecks 
 
The protein processing capacity of the ER has been identified as a limiting step impeding the secretion 
of recombinant proteins in P. pastoris, as large fractions of total protein targeted to the secretory 
pathway remain located intracellularly during AOX1 – based expression (Love et al, 2012).  The 
increase in unfolded protein concentration within the ER lumen induces upregulation of expression 
from promoters containing unfolded protein response elements (UPREs), signifying the activation of 
UPR to address the saturation of protein processing and folding machinery in the ER (Gasser et al, 
2007A).  Since continual upregulation of UPR is intrinsically linked to the triggering of ERAD 
(Friedlander et al, 2000; Travers et al, 2000) it is unsurprising that its excessive activation is correlated 
with declines in overall productivity; the phenomenon is exacerbated in strains secreting proteins 
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with lower native state stabilities (Kumita et al, 2006) or in certain multi-copy strains (Zhu et al, 
2009B).The processing limitations of the ER and the subsequent activation of stress responses 
therefore place constraints not only on the final protein titres achievable using the P. pastoris system, 
but also the organism’s amenability to producing adequate yields of complex proteins that require 
more post-translational modifications or are more prone to misfolding (Ahmad et al, 2014).  However 
the molecular processes within the ER governed by the UPR are in fact beneficial to protein 
processing and trafficking.  The transcription of genes encoding protein disulphide isomerase (Pdi), 
the molecular chaperone Kar2p and a facilitator of oxidative folding (Ero1) was increased significantly 
in P. pastoris mutants overexpressing the UPR regulator HAC1 (Gasser, 2007A).  Each of these 
proteins are classed as UPR-regulated factors in S. cerevisae and are known to facilitate protein 
folding and protein disulphide formation in the ER (Normington et al, 1989; Frand and Kaiser 1998; 
Xiao et al, 2004; Zito, 2015).  UPR factors that perform post-translational modifications and assist in 
protein folding have previously been identified as potential candidates for reducing secretion 
bottlenecks in P. pastoris with the hypothesis that uncoupling their expression from UPR regulation 
will have the effect of permanently increasing the protein folding capacity of the ER without 
activating ER stress responses.  This strategy has been successful in increasing productivity of certain 
proteins such as Necator americanus secretory protein (Na-ASP1) in a recombinant strain expressing 
PDI under the control of the AOX1 promoter (Inan et al, 2006).  It is possible that overexpression of 
PDI was especially advantageous to the production of Na-ASP1 as preliminary structural studies of the 
protein predicted it to contain 10 disulphide bonds, and could explain how strains containing 8 copies 
of the PDI overexpression cassette were able to increase final titres up to ~4.5 - fold in strains 
containing 2 copies of the Na-ASP1 gene (Inan et al, 2006).  Expression of the S. cerevisae PDI under 
the constitutive GAP promoter was also able to increase the production of the 2F5 anti-HIV Fab 
fragment by an average of 1.9 fold, which was otherwise accumulating at high levels intracellularly in 
the native host (Gasser et al, 2005).  The same study was even able to increase productivity through 
the GAP-regulated overexpression of HAC1, although not as well as for PDI overexpression.  Again 
examining the secretion of 2F5 Fab, strains overexpressing 15 different genes involved in ER stress or 
the secretory pathway, and found to be transcriptionally upregulated during recombinant protein 
production, were screened for their effect on volumetric productivity (Gasser et al, 2007B).  The 
screen was able to identify previously untested UPR factors and chaperones that were able to 
increase 2F5 Fab productivity when expressed under the GAP promoter, including Kar2p, Ero1, and 2 
other chaperones – Ssa4 and Sse1.  Overexpression of KAR2 under PAOX1 was also able to increase the 
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secreted productivity of a recombinant A33 single- chain antibody fragment by up to 3-fold of the 
control (Damasceno et al, 2007).  However no change in product yield was observed when PDI was 
overexpressed, suggesting that the efficacy of overexpression of different UPREs is dependent on the 
properties of the secreted product (Damasceno et al, 2007).  In spite of this, the uncoupling of UPR 
factors from their native regulation, through expression under high strength promoters, has emerged 
as a valid approach for increasing recombinant protein titres and warrants the consideration of other 
UPR-specific pathways that act to increase the processing capacity of the ER as potential candidates 
for strain improvement. 
 
5.1.3 The role of ER membrane expansion in UPR and protein trafficking 
 
While the precise mechanism of its action is yet to be completely understood, the activation of UPR 
alters the homeostasis of the ER in yeast and mammalian cells (Shaffer et al, 2004; Schuck et al, 
2009).  The result is an increase in ER – resident phospholipid biogenesis and an overall expansion in 
ER volume.  In S. cerevisae the ER membrane contains a high phosphatidylinositol content, the 
biosynthesis of which requires inositol as a precursor and is regulated by a heterodimeric 
transcription factor complex comprising the proteins Ino2p and Ino4p (Ambroziak and Henry, 1994) 
(Block – Alper et al, 2002).  The native function of these 2 proteins, as well as UPR regulation is 
essential for correct ER membrane expansion, as the deletion of INO2 or HAC1 results in cells that 
either form aberrant, considerably smaller ER structures (Block-Alper et al, 2002) or fail to increase ER 
size in response to exposure to ER stressors (Schuck et al, 2009) respectively.  Membrane expansion 
during UPR also appears to be conserved in P. pastoris, where cells constitutively expressing HAC1 
were found to form highly ordered, stacked intracellular membrane structures that are absent in un – 
stressed cells (Guerfal et al, 2010).  The actual physiological role of ER membrane expansion in 
response to excessive ER stress remains to be completely understood, although it is suggested that it 
acts to increase the ER’s processing capacity by providing larger lumenal spaces to house a higher 
secretory protein content (Cox, Chapman and Walter, 1997; Schuck et al, 2009).  This would have the 
benefit of reducing molecular crowding within the ER, theoretically decreasing the probability of 
misfolding proteins coming into contact to form insoluble aggregates, as well as providing larger areas 
of ER membrane to accommodate more ER membrane resident proteins that assist in folding.  Also 
worth noting is that ER expansion is often observed as an adaptation within specialised cells that 
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secrete large quantities of proteins in nature.  Examples include human B lymphocytes, which exhibit 
an increase in ER volume by approximately 3.7 fold during their differentiation into plasma cells 
secreting antibodies (Wiest et al, 1990), and pancreatic exocrine cells, known to secrete large 
quantities of enzymatic proteins and also contain large, stacked rough ERs (Lodish et al, 2000). 
 
5.1.4 Opi1p is a negative regulator of lipid biogenesis and ER membrane size in S. 
cerevisae 
 
Opi1p is classed as a leucine zipper transcriptional repressor of lipid biogenesis genes in  yeast (White 
and Henry 1991), although the majority of characterisation studies have only been conducted on the 
S. cerevisae homologue.  In S. cerevisae Opi1p was found to repress inositol and phopholipid 
biogenesis pathways by sequestering Ino2p/Ino4p from the upstream activating sequences on 
promoters of Ino2/Ino4 – regulated genes (UASINO) when free inositol levels are abundant in the cell.  
Ino2p/Ino4p complexes bound with Opi1p fail to activate the transcription of inositol -responsive 
phospholipid biogenesis genes such as INO1 (Wagner and Dietz, 2001).  The repressive effects of 
Opi1p are reversed under conditions where exogenous levels of inositol are low, and Opi1p is 
sequestered to the ER through associating with the ER bound protein Scs2p, where it  can no longer 
inhibit transcription (loewen, 2004).  The recruitment of Opi1p by Scs2p also requires functional 
Hac1p, suggesting that the regulation of Opi1p forms part of the molecular switch for activating 
phospholipid biogenesis and ER expansion during UPR (Brickner and Walter, 2004).  This was 
supported further through deletion studies for OPI, which found that Δopi1 mutants contain a 
constitutively expanded ER during growth on standard YPD medium (Schuck et al, 2009).   
Furthermore the role of ER expansion in alleviating ER associated stress was confirmed through the 
complementation of UPR – deficient mutants with the deletion of OPI1 (Schuck et al, 2009).  Mutants 
lacking the HAC1 gene, as used in the study, are unable to initiate UPR and do not grow in the 
presence of the artificial ER chemical stressor tunicamycin.  The deletion of OPI partially restored cell 
viability of Δhac1 strains exposed to 0.05μg/ml tunicamycin, suggesting that Δopi1 mutants exhibit an 
independent form of ER stress alleviation to the UPR through separating ER expansion from UPR 
regulation (Schuck et al, 2009).  The disruption of OPI1 could therefore have positive implications for 
the improvement of expression strains as it uncouples a process that increases the processing 
capabilities of the ER, in this case ER expansion, from UPR regulation.  This has been recently verified 
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in expression trials of S. cerevisae secreting recombinant Immunoglobulin-G (IgG), the results of 
which demonstrated that expression with Δopi1 mutants increased productivity up to 4 fold (de 




5.2 Identification and deletion of the P. pastoris OPI1 homologue 
 
A local protein sequence alignment with BLASTp (http://blast.ncbi.nlm.nih.gov) revealed an 
uncharacterised 388aa protein in P. pastoris with sequence similarity to Opi1p in S. cerevisae S288C.  
Although the putative protein only shares 27% identity, spanning 87% of S. cerevisae S288C Opi1p, 
further alignments against the sequence returned a 25-45% identity to a number of proteins classed 
as Opi1p homologues in other yeast species including Kluyveromyces marxianus, Candida utilis and 
Candida glabrata.  The conserved functional domain containing a leucine zipper motif and belonging 
to the Opi1p superfamily was also identified between amino acid residues 249 and 359, supporting 
the likelihood of the protein being a putative Opi1p homologue in P. pastoris (and is henceforth 
referred to as Opi1p). 
The adjacent sequence located immediately 5’ and 3’ to the corresponding gene within the NRRL 
11430 genome was obtained from the NCBI database (http://www.ncbi.nlm.nih.gov/) and used to 
design a knockout construct for P. pastoris OPI1.  Since the removal of only a single gene was 
required, the targeted gene replacement of OPI1 with an antibiotic resistance cassette was selected 




The knockout construct contains the tn903kanr gene expressed under the constitutive GAP promoter, 
conferring resistance to G418 in yeast.  The inclusion of a G418R cassette as a selectable marker 
allows the resulting Δopi1 mutants to remain compatible with the integration of pPICZα and pAVE522 
– based expression vectors utilising the zeocin resistance marker - sh ble for selection.  The cassette is 
Figure 26: Map of the 3681bp linear knockout construct for the targeted replacement of OPI1 in P. pastoris 
NRRL-11430 with a G418 resistance cassette.  The SmaI restriction site is present in tn903kanr but absent in 
OPI1, enabling initial confirmation of OPI1 removal by restriction digest. 
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flanked by sequences identical to the 1kb regions located immediately 5’ and 3’ to OPI1 within the 
NRRL 11430 genome to stimulate the replacement of OPI1 through a double crossover event, 
mediated by homologous recombination. 
The 5’ flanking region of OPI1 was PCR amplified from NRRL 11430 genomic DNA with the primers 18-
Opi1kan5’-F and 19-Opi1kan5’-R, whereas the 3’ region was amplified with 22-Opi1kan 3’-F and 23-
Opi1kan 3’-R (9.1).  The primers 19-Opi1kan5’-R and 22-Opi1kan 3’-F contained complementary ends 
to the 5’ and 3’ ends of the G418R cassette respectively.  The G418R cassette, supplied as a custom 
DNA fragment by Fujifilm Diosynth Biotechnologies (Billingham, UK), was PCR amplified to contain 
complementary ends to the 5’ and 3’ OPI1 flanking regions with the primers 20-Opi1kan-F and 21-
Opi1kan-R (9.1).  The 3 PCR amplicons were gel purified and joined by Gibson assembly.  To 
circumvent the requirement for cloning into E. coli, the reaction mix containing the fully assembled 
knockout construct was used as a template for PCR with the primers 18-Opi1kan5’-F and 23-Opi1kan 
3’-R to generate sufficient quantities of the construct for direct transformation into P. pastoris.  DNA 
fragments of the size corresponding to the full knockout construct were gel purified and cloned into 
P. pastoris NRRL 11430 and the recombinant strain - CLD804 by electroporation, with selection on 
0.5mg/ml G418 sulphate. 
A subsequent PCR analysis of genomic DNA isolated from NRRL 11430 and CLD804 colonies 
transformed with the OPI1 knockout construct was conducted with the primers 26-Opi1-F and 27-
Opi1-R, which specifically anneal to OPI.  The PCR revealed a high number of false positives that were 






Figure 27: PCR screen of genomic DNA from clones following transformation with the OPI1 knockout construct, 
using primers specific to OPI1.  A – clones from P. pastoris NRRL-11430 and B – clones from P. pastoris CLD804.  
The PCR of genomic DNA from the native strain is included in each case as a negative control. 
122 
 
This could have been caused by transient expression of tn903kanr from unintegrated expression 
cassettes within cells, or the insertion of the knockout construct into the OPI1 locus as a single 
crossover event without removing OPI1.  Even so the PCR screen identified a number of clones that 
had potentially lost OPI1.  Further testing to confirm the removal of OPI1 was conducted by PCR 
amplifying a section of the OPI1 locus, spanning the location of OPI1 and flanking sequence, from the 
genomic DNA of potential positive clones using the primers 28-Opi15’flankseq and 29-Opi13’flankseq 
(9.2).  A single SmaI restriction site is located centrally within the OPI1 knockout construct but is not 
found in the OPI1 gene.  Sequencing of the PCR amplified OPI1 loci with Opi15’flankseq and 29-
Opi13’flankseq, complemented by a restriction digest of the loci with SmaI confirmed the 






Figure 28: Digest of PCR amplified OPI1 locus DNA from NRRL 11430 Δopi1 with SmaI.  The presence of the 
smaller ~1.8kb bands confirms the replacement of OPI1 with the knockout cassette.  Lane 1 - 1kb DNA size 
marker, 2 - OPI1 locus from NRRL 11430 cut with Sma1, 3 - OPI1 locus from NRRL 11430 Δopi1 cut with SmaI. 
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5.3 Growth curve analysis and UPR regulation of Δopi1 mutants 
 
Since the deletion of OPI1 would potentially derepress a number of biosynthetic pathways, it is 
possible that the growth of Δopi1 mutants would be affected under certain conditions as the carbon 
flux into cells is unevenly distributed away from essential metabolic pathways and towards formerly 
Opi1p regulated processes.  To assess whether the loss of OPI1 is detrimental to cell viability when 
cells are cultured in standard growth and expression media, growth curves were compared between 
NRRL 11430 and NRRL 11430 Δopi1 in BMG and BMM media, containing 1% (v/v) glycerol and 0.5% 
(v/v) methanol respectively.  3 biological replicates for each strain were initially grown for ~16 hours 
in 5ml BMG at 30°C, 250rpm before subculturing into 25ml of the appropriate medium in 250ml 
baffled flasks at a normalised, starting OD600 of 0.1.  During exponential phase the cell densities were 
recorded at 1 hour intervals until the stationary phase of growth had been reached in each culture 







Figure 29: Growth curve of NRRL-11430 and NRRL-11430 Δopi1 on BMG media containing 1% (v/v) glycerol.  
Error bars represent the standard deviation of 3 biological replicates. 
Figure 30: Growth curve of NRRL-11430 and NRRL-11430 Δopi1 on BMM media containing 0.5% (v/v) methanol.  




The growth characteristics of NRRL 11430 Δopi were observed to be similar to native NRRL 11430 
when cultured in 1% (v/v) glycerol.  No notable changes in the growth rate during exponential phase 
or total growth occurred, suggesting that Δopi mutants do not experience reduced growth on typical 
concentrations of glycerol used in yeast media.  A slight shift in growth was observed for Δopi cells 
cultured in methanol, although no differences in final cell density were found.  The results from the 
growth curve may indicate that the duration of lag phase growth was increased in NRRL 11430 Δopi 
compared to NRRL 11430 but, once cells entered the exponential phase, that growth rate and total 
growth were indistinguishable from the wild type.  Most of the growth plotted for methanol appears 
to be linear rather than logarithmic, suggesting the incidence of oxygen limitation in the flask cultures  
(Elsworth, Williams and Harris-Smith, 1957) (Fredlund et al, 2004).  This could then potentially mask 
other differences in the growth phenotype of the two strains. 
To monitor the basal levels of UPR activation in NRRL 11430 Δopi under conditions that do not induce 
ER stress and under growth conditions experienced during methanol induction, the expression of 
HAC1 and the UPR factors PDI and KAR2 were measured by RT-qPCR for cells cultured in YPD and 
BMMY media.  Single colonies of NRRL 11430 and NRRL 11430 Δopi were grown for ~16 hours in 5ml 
of either YPD or BMMY media until exponential growth was reached, after which RNA was isolated 
from 1ml of culture (Figure 31, 32).  The relative expression levels of HAC1, PDI and KAR2 were then 








Figure 31: Expression of HAC1, PDI and KAR2 by NRRL 11430 and NRRL 11430 Δopi1 during exponential  growth 
in YPD media.  Values are given as a fold change in expression relative to ACT1.  Error bars represent the 
standard error of 3 biological replicates.  The significance levels of unpaired t - tests between strains for the 
expression of each gene are displayed – ns: p>0.05, *: p<0.05, **: p<0.01, ***: p<0.001 
Figure 32: Expression of HAC1, PDI and KAR2 by NRRL 11430 and NRRL 11430 Δopi1 during exponential growth 
in BMMY media (0.5% (v/v) methanol).  Values are given as a fold change in expression relative to ACT1.  Error 
bars represent the standard error of 3 biological replicates.  The significance levels of unpaired t - tests between 
strains for the expression of each gene are displayed – ns: p>0.05, *: p<0.05, **: p<0.01, ***: p<0.001 
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As expected during growth on a complete medium such as YPD, with no exposure to artificial ER 
stressors, the expression levels of the UPR regulated genes HAC1, PDI and KAR2 remained low in 
NRRL 11430 in comparison to values observed within this project and previous studies.  However PDI 
was comparatively upregulated in NRRL 11430 Δopi to ~2.1 fold of expression in NRRL 11430.  A 
similar pattern was observed when cells were grown in BMMY media, although the mean increase in 
PDI expression in NRRL 11430 Δopi was found to be statistically insignificant for the data set provided 
by the experiment.  The increased expression of PDI would normally signify a cellular response to 
increased levels of proteins requiring disulphide bond formation in the ER.  The results suggest either 
that protein traffic through the ER could be increased in Δopi mutants, or that the transcriptional 
regulation of PDI specifically could have been altered by the loss of OPI1, since the lack of a significant 
increase in HAC1 or KAR2 expression implies that conventional UPR has not been activated in NRRL 
11430 Δopi. 
 
5.4 Specific productivity and induction of the UPR during recombinant 
protein secretion in Δopi1 mutants 
 
5.4.1 Aprotinin production in CLD804 Δopi1 
 
As a preliminary analysis of the effect of the loss of OPI1 on the production of secreted, recombinant 
proteins using the AOX1 system, the specific productivity of CLD804 Δopi1 expressing aprotinin was 
compared to that of native CLD804.  Flask expressions for each strain were conducted by normalising 
the OD600 of cultures to 1.0 in 25ml BMMY, and expressing over 5 days with the continued addition 
of 0.5% (v/v) methanol.  The quantity of secreted aprotinin was assayed by the densitometric analysis 
of SDS – PAGE for each culture supernatant and used to calculate the mean specific productivity of 






Surprisingly the specific productivity of secreted aprotinin was significantly reduced in CLD804 Δopi1 
to approximately 55% of the aprotinin titre produced by CLD804.  The CLD804 strain was originally 
generated by screening large samples of transformants for high productivity following multiple 
rounds of selection with PTVA, and therefore represents a near – optimal productivity phenotype for 
aprotinin.  It could therefore be possible that, during the growth and transformation of CLD804 with 
the OPI1 knockout cassette that a reduction in optimal productivity unrelated to the deletion of OPI1 
could have occurred through mechanisms such as copy number loss by loop out recombination (Aw 
and Polizzi, 2013) or a drift in the production phenotype through sequential generations of daughter 
cells (Love et al, 2010).  Nevertheless the initial results raise concerns over the productivity of Δopi1 
mutants and will require further, detailed comparisons between more equivalent recombinant 
strains. 
  
Figure 33: Mean specific productivity of aprotinin for P. pastoris CLD804 and P. pastoris CLD804 Δopi1 following 
expression in BMMY over 5 days at 28°C.  Error bars represent the standard error of 5 biological replicates.  
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5.4.2 Specific productivity and UPR induction of Δopi1 mutants secreting glucose oxidase 
 
To account for secondary factors that could affect productivity such as copy number variation of the 
target gene and the background of clonal variation between initial transformants, both native NRRL 
11430 and NRRL 11430 Δopi1 were transformed with pGOxZα, assembled previously and containing 
the P. funiculosum glucose oxidase gene under control of PAOX1.  The resulting transformants were 
immediately screened for the copy number of GOX by qPCR of genomic DNA samples with the 
primers 40-qGOX2-F and 41-qGOX2-R in order to isolate 5 single copy integrants of pGOxZα for both 
NRRL 11430 and NRRL 11430 Δopi1.  The strains, renamed NpαGOxZ and NpαGOxZ Δopi1 were 
induced to express GOX in shake flask cultures of 25ml BMMY from a starting OD600 of 1.0 over a 48 
hour period.  The final GOx titre in the supernatant of each culture was then assayed to calculate the 
mean specific productivity for each strain.  Finally, the expression of HAC1, PDI and KAR2 relative to 
their expression in NRRL 11430 under identical conditions was measured by RT-qPCR of RNA samples 
isolated post –harvest to quantify the state of UPR activation in NpαGOxZ and NpαGOxZ Δopi1 







Figure 34: Mean GOx titres (A) and fold change in expression of the UPR genes HAC1, PDI and KAR2 relative to 
wild type NRRL 11430 levels (B) of NpαGOxZ and NpαGOxZ Δopi1 following a 48 hour expression trial.  Error 
bars represent the standard error of 5 biological replicates and the significance levels of unpaired t-tests 





A decrease in the mean specific productivity was again observed in the Δopi1 mutant, although the 
difference was less dramatic than for the production of aprotinin, as NpαGOxZ Δopi1 produced 
approximately 20% less GOx than NpαGOxZ.  The most notable difference was observed in the 
regulation of UPR genes in NpαGOxZ Δopi1 following methanol induction over 48 hours, specifically 
for KAR2 – which was upregulated to ~6 – fold of its expression in NpαGOxZ under identical 
conditions.  The mean expression of HAC1 was also increased in NpαGOxZ Δopi1 over NpαGOxZ 
although the difference was not found to be significant; most likely due to the higher degree of 
variation in HAC1 expression between the biological replicates of NpαGOxZ.  Although HAC1 
expression was upregulated by nearly 3 fold, native NpαGOxZ exhibited a negligible difference in the 
expression of KAR2 and PDI from wild type P. pastoris, suggesting that the expression of a single copy 
of GOX over 48 hours should not elicit excessive levels of ER stress.  Therefore considering the large 
increase in KAR2 expression together with the overall decrease in secreted productivity per cell; the 
results indicate that Δopi1 cells expressing GOX at a similar transcriptional rate to the native strain 
experience greater ER stress and a higher UPR activation state for a theoretically identical influx of 
unfolded proteins into the secretory system. 
 
5.4.3 Specific productivity and UPR induction of Δopi1 mutants secreting synthetic 
human lysozyme T70A 
 
Since the deletion of OPI1 in S. cerevisae uncoupled the expansion of the ER from the UPR, it was 
hypothesised that Δopi1 mutants would produce ERs with higher protein folding and processing 
capacities during unstressed conditions.  Therefore the Δopi1 phenotype would provide an advantage 
specifically in the secretion of recombinant proteins that would normally elicit high levels of UPR in 
cells.  To evaluate the performance of P. pastoris Δopi1 under conditions inducing a strong activation 
of UPR during recombinant protein production, control and Δopi1 – based strains expressing synthetic 
human lysozyme T70A (HuL T70A) were generated.  The T70A mutation of HuL reduces the native 
state stability of the protein’s tertiary structure, increasing its propensity to misfold and accumulate 
within the ER in an aggregated state (Kumita et al, 2006).  Consequently the secretion of over 
expressed HuL T70A by P. pastoris has been demonstrated to stimulate high levels of UPR, resulting in 
increases for the transcription of all 3 of the UPR genes tested in this study - HAC1, PDI and KAR2 
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(Whyteside et al, 2011).  The expression of HUL T70A under PAOX1 has hence been established as an 
effective molecular tool for inducing UPR through recombinant protein secretion. 
To generate strains expressing HUL T70A, NRRL 11430 and NRRL 11430 Δopi1 were transformed with 
the vector pPICzm-T70A, containing HUL T70A within an expression cassette comprising PAOX1 and the 
S. cerevisae α-mating factor secretion signal.  For ease of identification the new recombinant strains 
were designated NAαT70A and NAαT70A Δopi1.  Again, to account for differences in productivity 
occurring due to copy number variation, transformants were screened for the number of integrated 
copies of HUL T70A by qPCR of genomic DNA with the primers 83-qsynHuL3-F and 84-qsynHuL3-R.  
Once 5 single copy integrants had been identified, the strains were induced to express HUL T70A in 
shake flask cultures of 25ml BMMY from a starting OD600 of 1.0 over a 48 hour period.  The final HuL 
T70A titre in the supernatant of each culture was then quantified by a modified HuL activity assay 
(Section 2.5.3) and used to calculate the mean specific productivity for each strain (Figure 35A).  The 
method of quantification of the expression of HAC1, PDI and KAR2 in NpαGOxZ and NpαGOxZ Δopi1 
secreting GOX was repeated for cultures of NAαT70A and NAαT70A Δopi1 post-expression as a 








Figure 35: Mean HuL T70A titres (A) and fold change in expression of the UPR genes HAC1, PDI and KAR2 
relative to wild type NRRL 11430 levels, using ACT1 expression as a reference (B) of NAαT70A and NAαT70A 
Δopi1 following a 48 hour expression trial.  Error bars represent the standard error of 5 biological replicates and 
the significance levels of unpaired t-tests between strains for the expression of each gene are displayed – ns: 





Despite being characterised as encoding a protein inducing high levels of UPR in P. pastoris when 
targeted for cell secretion, NAαT70A expressing a single copy of HUL T70A did not exhibit a significant 
increase in the expression of HAC1, PDI or KAR2 in comparison to the levels observed for NpαGOxZ 
secreting GOx.  This finding was unexpected as the conditions and duration of the expression of 
NAαT70A was similar to those used by original study by Whyteside et al (2011).  However the method 
of selecting each strain employed within their study involved screening a number of transformants 
for productivity and choosing the highest producers to continue with expression studies, without 
confirming the copy numbers of each transformant.  Since the transformants for this experiment 
were selected based on the condition of containing a single copy of HUL T70A, it is highly likely that 
the clones of NAαT70A used in this experiment expressed lower levels of HUL T70A than in the 
original study, and so would not achieve the saturation of secretion that would be a likely 
requirement for UPR activation.  The difference in specific productivity of HuL T70A and the UPR 
profile for NAαT70A Δopi1 was found to mirror the results observed for the expression of aprotinin 
and GOx by P. pastoris Δopi1 strains.  NAαT70A Δopi1 transformants produced approximately 50% 
less HuL T70A per unit of cell mass, and increased the expression of KAR2 up to ~4.5 fold more than in 
native NAαT70A.  HAC1 was also significantly upregulated in NAαT70A Δopi1 but to a lesser degree, 
confirming that Δopi1 mutants experience higher degrees of UPR activation for the same level of 
expression of identical recombinant genes to native P. pastoris.  The similarity in the results obtained 
for the production of each of the proteins tested within the study, varying in size, function and 
stability provide strong evidence that the deletion of OPI1 in P. pastoris provides a universally adverse 
effect on the production of recombinant proteins and the protein processing capacity of the ER for 
the tested conditions. 
 
5.5 Δopi1 mutants exhibit altered growth characteristics on sorbitol  
 
The lipid biosynthesis pathway in yeast, which feeds into the phospholipid biosynthesis pathway, 
begins with the input of acetyl-CoA derived from glycolysis or the β-oxidation of fatty acids.  Acetyl – 
CoA is an important precursor for a range of vital cellular processes; feeding into the tricarboxylic 
cycle which, as well as forming part of cellular respiration, in turn provides the necessary 
intermediates for the biosynthesis of amino acids (Berg, Tymoczko and Stryer, 2002).  Should the loss 
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of OPI1 result in the constitutive derepression of phospholipid biosynthesis there could be potential 
ramifications for all pathways stemming from glycolysis, as an increased proportion of free acetyl-CoA 
is channeled towards lipid production.  This provides a hypothetical explanation for the decreased 
productivity and heightened ER stress in Δopi1 mutants as cells overexpressing recombinant proteins 
would also place a greater demand on the amino acid biosynthesis pathway, in conjunction with the 
hypothetically unregulated lipid biosynthesis, further limiting the availability of essential products 
from glycolysis in the cell.  If this were the case a possible solution to alleviate the negative effects 
observed in Δopi1 mutants would be to increase the availability of metabolised carbon sources during 
recombinant protein production.  Sorbitol is a non-repressing carbon source for methanol inducible 
genes in P. pastoris, including AOX1, and is converted to fructose 1, 6-diphosphate which enters 
glycolysis.  Therefore to test whether delimiting the available carbon source for glycolysis improves 
productivity in P. pastoris Δopi1, the 48 hour expression trial for NpαGOxZ and NpαGOxZ Δopi1 
described in section 5.4.2 was repeated with the inclusion of 4% (w/v) sorbitol in the methanol 
expression medium.  The final GOx titres and cell density for each culture were recorded and 








Figure 36: Final average cell  density (A) and volumetric productivity (B) for cultures of P. pastoris NpαGOxZ and 
P. pastoris NpαGOxZ Δopi1 following expression in BMMY (0.5% [v/v] methanol) or BMMY supplemented with 
4% (w/v) sorbitol over 48 hours at 28°C.  Error ba rs represent the standard error of 5 biological replicates and 
and the significance levels of unpaired t - tests between strains for the expression of each gene are displayed – 






Supplementing BMMY with 4% (w/v) sorbitol resulted in a large increase in the production of GOx by 
both NpαGOxZ and NpαGOxZ Δopi1 due, in part, to the enhanced growth of both strains during the 
expression trial, although the overall magnitude of the increase was diminished in NpαGOxZ Δopi1.  
Once again NpαGOxZ Δopi1 failed to produce comparable titres of GOx to the native strain with the 
addition of sorbitol, in fact producing proportionally less GOx to NpαGOxZ than when cells were 
grown on methanol as the sole carbon source for growth.  However NpαGOxZ Δopi1 also attained a 
significantly higher final cell density, producing ~1.37 fold more biomass than NpαGOxZ.  Whilst the 
results refute the hypothesis that the poor performance of Δopi1 mutants is attributable to an 
increased demand for carbon sources feeding into glycolysis, the difference observed between the 
final cell densities of each strain post-expression suggests a unique phenotype for sorbitol-based 
growth in P. pastoris Δopi1. 
To explore the changes in the sorbitol growth characteristics of the OPI1 deletion strain further a 
growth curve anlaysis was conducted between NRRL 11430 and NRRL 11430 Δopi1 on minimal media 
containing 4% (w/v) sorbitol.  3 biological replicates for each strain were normalised to a starting 
OD600 of 0.1 in 25ml culture in 250ml baffled flasks.  The cultures were grown at 30°C/ 250rpm, during 
which the cell densities for each strain were recorded at regular intervals and plotted upon the 






The growth rate of NRRL-11430 Δopi1 exceeded NRRL 11430 between hours 0-80, having, achieving a 
mean cell density of approximately double that of NRRL 11430 after 50h..  However, once they had 
entered mid-exponential growth, the mean cell densities appeared to increase at equivalent rates 
and had equalised upon the initiation of the stationary phase in both strains.  To check for any 
differences in the growth rate during exponential phase between NRRL-11430 Δopi1 and NRRL 11430, 
the natural logarithm of the recorded absorbance values were plotted against time and the period 
during which the rate of growth increased linearly, represented as a straight line on the semi -log 
graph (9.3) (Figure A2) was identified in both strains.  The starting and final absorbance values for 
each period were taken and used to calculate the doubling time of both NRRL-11430 Δopi1 and NRRL 
11430 with the following formula – previously described in section 4.3 and are displayed in Table 9: 
 
              
         
                                                  
 
 
Figure 37: Growth curve of NRRL-11430 and NRRL-11430 Δopi1 on minimal media containing 4% (w/v) sorbitol.  
Error bars represent the standard deviation of 3 biological replicates. 
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Strain  Doubling time/ h 
NRRL 11430 20.42 
NRRL-11430 Δopi1 20.66 
 
A ~1% difference in doubling time was found between NRRL-11430 Δopi1 and NRRL 11430, 
confirming that there is only a marginal difference in the growth rates of both strains on 4% (w/v) 
sorbitol.  One aspect that is particularly noticeable of P. pastoris’ growth on sorbitol is that, whilst 
final biomass concentrations remain high, the maximum growth rate is very slow in comparison to 
substrates such as glucose, glycerol or methanol.  This is evident from the ~20 hour doubling time of 
NRRL 11430 during exponential growth in addition to the duration of time that NRRL 11430 spends in 
lag phase growth; the semi-log graph revealing that early exponential phase is entered after 52 hours 
of growth.  The lag phase is significantly reduced in NRRL-11430 Δopi1, with cells appearing to begin 
exponential phase growth after approximately 20 hours.  Despite overall growth and growth rate 
remaining unchanged in P. pastoris Δopi1, the reduction in the lag phase before growth explains how 
higher cell densities were reached by NpαGOxZ Δopi1 during a relatively short, 48 hour expression 
trial.  However the increase in biomass during early growth in sorbitol/ methanol mixed feeds for 
NpαGOxZ Δopi1 does not correlate with an increase in the productivity over the native strain 
indicating that Δopi1 mutants continue to experience bottlenecks in recombinant protein secretion 
and increased ER stress irrespective of their improved growth characteristics on sorbitol. 
 
5.6 Attempting to stain and visualise the ER in P. pastoris Δopi1  
 
Considering the unexpected detrimental effects that the loss of OPI1 has on the productivity and the 
processing capacity of the ER in cells overexpressing recombinant proteins it would be pertinent to 
determine whether the function of Opi1p in S. cerevisae is conserved and, more specifically, if its 
Table 9: Cell  doubling times of NRRL 11430 and NRRL-11430 Δopi1 during growth in minimal media containing 
4% (w/v) sorbitol as a carbon source. 
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removal causes the same change in ER physiology in P. pastoris.  To do so, a method for visualising 
and quantifying the surface area or volume of ER in cells would be required.  
The cell permeable, lipophilic, fluorescent dye - 3,3′-dihexyloxacarbocyanine iodide (DiOC6(3)) binds 
to lipid bilayers of mitochondria at low concentrations and, at concentrationsof 1μg/ml, has been 
demonstrated to stain the ER in yeast cells (Koning et al, 1993).  As such, DiOC6(3) was been widely 
established as a standard fluorescent marker for the visualisation and study of ER morphology (Sabnis 
et al, 1997) and would be more suitable for the requirements of this study over more conventional 
methods for visualising the ER; often involving the generation of fluorescent reporters fused with ER-
membrane-associated proteins.  In contrast to fluorescent fusion proteins, the production of which is 
linked to the expression levels of their corresponding gene constructs, DiOC6(3) non-specifically binds 
to the ER surface, meaning that its accumulation in the cell should be directly proportional to the 
surface area of the ER.  This relationship has been previously exploited to provide a relative 
quantification of changes in ER size in S. cerevisae, through measuring the fluorescence generated by 
cells stained with DiOC6(3) by flow cytometry (Block-Alper et al, 2002).  The application of DiOC6(3) for 
the visualisation and quantification of the ER was therefore tested in P. pastoris. 
To ascertain whether DiOC6(3) staining would provide an accurate representation of ER size in P. 
pastoris, its specificity for binding the ER was tested by visualising P. pastoris NRRL 11430 cells, 
stained with DiOC6(3), by fluorescence confocal microscopy.  Cell suspensions were stained with a 






Imaging of stained NRRL 11430 cells revealed that DiOC6(3) was successfully taken up and retained 
intracellularly.  However, rather than incorporating specifically into the ER membrane, DiOC6(3) was 
instead found to be evenly distributed throughout the cell interior and no intracellular structures 
could be resolved.  The dye was found to be evenly distributed through all of the focal plains 
examined, confirming that DiOC6(3) was intracellular as opposed to specifically staining the cell 
exterior, which would have been th only alternative explanation for the pattern observed in Figure 
38.  No differences in the pattern of staining could be observed when the final concentration of 
DiOC6(3) was reduced to half of the standard concentration required for ER staining in S. cerevisae.  
Whilst incubation with an excess of DiOC6(3) results in staining of the ER membrane in S. cerevisae, its 
incorporation into P. pastoris appears to be significantly less targeted.  The fluorescence microscopy 
images of stained cells point towards DiOC6(3) either accumulating within the cytoplasm or non-
specifically incorporating into other membrane structures including the cell membrane; the latter 
being more likely due to its lipophilic properties.  This may provide a reason as to why DiOC6(3) 
Figure 38: Fluorescence images of NRRL 11430 cells stained with a final concentration 0.5, 0.75 or 1.0μg/ml  
DiOC6(3) and viewed by confocal microscopy.  Bright field images of the cell  periphery are displayed underneath 
the respective fluorescence image.  
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staining of the ER in P. pastoris has not been previously reported or why no DiOC6(3) staining 
protocols optimised for P. pastoris are currently available.  The lack of specificity of DiOC6(3) for the 
ER membrane and its high background of intracellular staining prevent its application as a marker for 
the estimation of ER surface area in P. pastoris and therefore cannot be used to quantitatively 




This study successfully identified and deleted a homologue belonging to the OPI1 family of yeast 
transcriptional repressors in the P. pastoris NRRL 11430 genome.  Even though cell viability was 
unaffected, analysis of the expression of certain UPR-associated elements showed that the PDI gene 
was significantly upregulated during regular growth in YPD media for the Δopi1 strain.  A 
comprehensive analysis of recombinant protein secretion involving 3 separate proteins under AOX1-
based expression, varying in structure and function, revealed not only that the specific productivity of 
secreted proteins was reduced, often severely, in Δopi1 mutants, but that the UPR genes - HAC1 and 
KAR2 were even further upregulated over native strains in the process.  The regulation of KAR2 in 
particular was significantly altered during recombinant protein production, as its expression was 
increased by a maximum of 6 fold over the native strain for the tested proteins.  Considering the role 
of Kar2p as an ER-resident chaperone assisting in protein folding, its strong upregulation during the 
overproduction of secreted proteins indicates that higher quantities of misfolded proteins 
accumulate within the ER of Δopi1 mutants.  This is further supported by the decrease in the mean 
titres of extracellular proteins in Δopi1 mutants normalised for gene copy number, suggesting that 
proteins that would normally traffic effectively through the secretory pathway and exit the cell in the 
native strain are instead obstructed within the ER to a greater degree in the Δopi1 variant.  Rather 
than reducing bottlenecks in the secretory pathway that occur during the overexpression of 
recombinant genes in P. pastoris, the loss of OPI1 only seems to compound them and result in the 
increased activation of the UPR.  Since its loss has the opposite effect to increasing the productivity of 
S. cerevisae (de Ruijter, Koskela and Frey, 2016), it is highly likely that P. pastoris Opi1p has evolved a 
different function and is directly or indirectly involved in maintaining the native processing capacity of 
the ER for secreted proteins.  Evidence of a functional diversity of Opi1 family proteins in more 
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distantly related yeast species has, in fact, previously been reported.  In the oleaginous yeast 
Yarrowia lipolytica the Yas3p transcription factor, identified as an Opi1p homologue, negatively 
regulates the transcription of genes involved in the metabolism of n-alkanes (Hirakawa et al, 2009) 
whereas in Candida albicans Opi1p controls the expression of both the SAP2 protease, involved in its 
virulence, and genes triggering the initiation of filamentous growth (Chen et al, 2015).  Additional 
experiments would be required to establish whether the role of P. pastoris Opi1p has differentiated 
from the S. cerevisae Opi1p since the method attempted to visualise the ER of P. pastoris in this study 
was unsuccessful.  The fusion of fluorescent reporters to ER-resident proteins and electron 
microscopy remain as the 2 most viable methods for visualising the ER in P. pastoris (Rossanese et al, 
1999; Guerfal et al, 2010).  Given that P. pastoris Opi1p belongs to the Opi1 family and contains a 
leucine zipper, often involved in DNA binding, its probable role as a transcriptional regulator could 
also be investigated through a transcriptomics-based approach to identify any differences in global 
gene expression as a result of its deletion.  The loss of OPI1 has also been found to cause a dramatic 
change in the lipidome of S. cerevisae, with cells amassing higher quantities of free fatty acids and 
phosphatidylinositol upon the deregulation of their respective biosynthesis genes ( Chumnanpuen, 
Nookaew and Nielsen, 2013).  A similar lipidomics approach employing techniques such as gas 
chromatography-mass spectrometry (GC-MS) and high performance liquid chromatography (HPLC) to 
quantify intracellular non-polar lipids and phospholipids, could be employed in future studies to 
determine whether Opi1p continues to regulate lipid biosynthesis in P. pastoris. 
Since the precise role of Opi1p in P. pastoris is ambiguous, though likely to not regulate ER 
homeostasis in the same way as S. cerevisae Opi1p, expanding the ER membrane through increasing 
the production of its constituent phospholipids remains an explorable avenue for improving the ER’s 
processing capacity.  P. pastoris is an inositol prototroph and contains a functional INO1 homologue 
encoding the enzyme catalyzing its biosynthesis (Chi, He and Yao, 2005).  Altering the expression of 
INO1, which is repressed by Opi1p in S. cerevisae, could therefore provide an alternative strategy for 
increasing the production of inositol-based phospholipids.  However unlike membrane structures in S. 
cerevisae, which contain a significant inositol-derived phospholipid component (Zinser et al, 1991), 
the major constituents of P. pastoris membranes are phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE); both making up ~27.48%/ ~36.15% of the cell membrane  and 
~54.4%/ 27.6% of peroxisomal membranes respectively (Wriessnegger et al, 2007; Grillitsch et al, 
2014).  The identification of genes involved in the synthesis of PC and PE in P. pastoris, or engineering 
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an orthologous, characterised, PC and PE biosynthetic pathway from a model organism such as S. 
cerevisae could also be considered in future approaches to achieve constitutive ER expansion. 
At present, the study concludes that the deletion of OPI1 has an adverse effect on recombinant 
protein secretion, reduces the processing capacity of the ER and increases ER-associated stress during 
recombinant gene overexpression.  The function of P. pastoris Opi1p therefore appears to be 
necessary in maintaining the native protein processing and folding capabilities of the ER and so is, in 









6.1.1 Aims and objectives 
 
Due to the favourable growth characteristics of P. pastoris in glucose, and the number of candidate 
factors and pathways found to contribute towards glucose repression of PAOX1, glucose repression was 
chosen as the primary focus of the research.  The aim of this study was to ultimately generate novel 
strains that exhibit partial derepression of PAOX1 in the presence of repressive levels of glucose, and 
are capable of fully induced PAOX1-driven expression in mixed feed media containing methanol and 
quantities of glucose that are detrimental to AOX1 expression in the native host. 
Firstly a simple screen differentiating between glucose repressed and methanol induced states of 
PAOX1 was designed to determine the relative production of recombinant protein from strains utilising 
the AOX1 system while growing on both methanol and glucose.  The screen was then implemented to 
test for the alleviation of glucose repression in new strains affected in 1 or more of the previously 
discussed factors involved in the regulation of PAOX1 during glucose repression and methanol 
induction.  The strategies for alleviating glucose repression in P. pastoris include knockouts for genes 
involved in glucose repression, a number of which produce mutants already known to exhibit partial 
glucose derepression, or attempts to uncouple positive regulators of PAOX1 from their inactivation 
during glucose repression. 
Any strains found to successfully induce AOX1 expression in the presence of methanol and increased 
levels of glucose could be taken forward to expression trials for secreted recombinant proteins in a 
range of expression media varying in glucose: methanol ratios.  The results of the study would 
determine whether productivity is improved over native P. pastoris both during standard methanol 




6.1.2 The disadvantages of methanol as both an inducing agent and growth substrate 
 
The ability to metabolise methanol in minimal media as well as the ubiquitous use of the methanol 
inducible AOX1 system has resulted in the wide acceptance of standard protocols for P. pastoris that 
utilise methanol as both a carbon source for respiration and an inducer for recombinant gene 
expression.  This aspect of P. pastoris expression is often viewed as advantageous as it simplifies and 
reduces the associated costs for producing expression media; the most common of which, such as 
BMMY, BMM and BMMH, include methanol as the sole carbon source.  Whilst the expression of 
numerous proteins at commercially viable titres has been achieved in the past using this method, 
there is evidence to suggest that growth on methanol alone is in fact detrimental to recombinant 
protein production. 
Firstly, the overall growth and relative growth rate of cells in methanol is poor in comparison to other 
substrates such as glucose and glycerol.  Whilst a low growth rate presents a greater obstacle to small 
scale expression, in the case of P. pastoris it is also relevant to large scale fermentation, as studies 
have found a positive correlation between productivity and the specific growth rate (μ) of cells at 
steady state within a chemostat culture (Rebnegger et al, 2014; Stadlmayr et al, 2010).  Moreover 
Rebnegger et al (2014) found that various genes directly involved in protein synthesis, translocation 
and glycosylation were upregulated with increasing μ, whereas a subset of genes comprising the 
proteolytic ERAD pathway were downregulated.  The results implicate increasing the specific growth 
rate in culture as beneficial for the promotion of cellular processes related to protein production and 
minimising stress responses incurred by the increased rate of protein synthesis by re combinant 
strains.  Thus the inherent concern arises that, in cultivating cells in a low growth carbon source such 
as methanol, a lower ceiling for the maximum specific growth rate is imposed, preventing the level of 
growth that would provide the optimal cell viability for protein production.  Whilst direct evidence for 
the negative effects of growth rates in methanol would be difficult to obtain, the implementation of 
fermentation strategies in which methanol is co-fed with alternative carbon sources such as sorbitol 
and glycerol have achieved higher total growth in culture and improved productivity for recombinant 
β-galactosidase and heavy-chain fragment C of botulinum neurotoxin serotype C respectively (Zhang 
et al, 2003; Niu et al, 2013).  The successes of both strategies at least demonstrate the merits of 
introducing alternative substrates promoting further growth in conjunction with methanol. 
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Poor growth rates are however not the only negative characteristic of growth on methanol.  The 
requirement for oxygen as a substrate for the oxidation of methanol by AOX during the first step of 
the Mut pathway places a particularly high demand for dissolved oxygen during fermentation of 
methanol-grown P. pastoris at high cell densities (Chen et al, 1997; Cregg et al, 2000).  During the 
methanol induced expression of cellulose binding module-lipase B fusion protein Jahic et al (2013) 
also attributed a significant loss of product with the presence of intracellular proteases in the culture 
supernatant, indicative of cell lysis.  Similar observations were made by Sinha et al (2005) for the 
expression of recombinant ovine interferon-τ, in which the proteases discovered in cytoplasmic 
fractions and the culture supernatants were found to be vacuolar in origin, and were present at far 
lower concentrations in all fractions when cells were cultivated with glycerol as the sole carbon 
source.  The results implicate an increased rate of protease production and cell lysis as a symptom of 
growth and expression on methanol.  The introduction of oxidative species in the form of 
formaldehyde and hydrogen peroxide, produced from the oxidation of methanol in the Mut pathway, 
require immediate conversion or detoxification to preserve peroxisome integrity and prevent cell 
damage.  Consequently the oxidative stress response in P. pastoris is strongly upregulated during 
growth on methanol, including genes encoding catalase and glutathione peroxidase (Vanz et al, 
2012). 
In addition to oxidative stress incurred through methanol metabolism, ER stress in response to 
increased protein traffic should also be taken into consideration.  The transfer of cell culture to media 
containing methanol accompanies a substantial shift in the P. pastoris proteome and physiology as 
genes encoding proteins in the Mut pathway are activated and peroxisomes housing its primary steps 
are formed.  Native AOX1 alone accounts for up to 30% of the total soluble protein within the cell 
(Couderc and Baratti, 1980) while formate dehydrogenase, S-(hydroxymethyl)-glutathione 
dehydrogenase (FLD1) and S-formylglutathione hydrolase (FGH1), all involved in the dissimilation of 
methanol into carbon dioxide, are also produced in high quantities (Vanz et al, 2012).  Should total 
cellular protein production during methanol metabolism exceed that of growth on more preferable 
carbon sources, the resulting burden on the protein translation and folding machinery would be 
hypothetically increased even prior to the introduction of recombinant proteins.  Furthermore the ER 
plays a primary role in the biogenesis of peroxisomes for methanol metabolism, not only in the 
delivery of lipid material in the formation of the organelle, but also in the targeting of certain 
peroxisomal proteins to localize within the peroxisome (Yan et al, 2008).  Vanz et al (2012) found that 
production of the UPR inducible ER resident disulphide isomerase – Pdi was increased during 
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methanol growth, albeit for a recombinant strain overexpressing Hepatitis B surface antigen, raising 
ambiguity as to whether PDI is upregulated in response to increased ER stress due to activation of the 
Mut pathway or recombinant protein synthesis.  However, data gathered from Edwards-Jones et al 
(2015) and also this project (5.3) supports the increase in transcription of PDI in WT P. pastoris during 




Figure 39: Expression of the UPR-regulated genes HAC1, PDI and KAR2 by P. pastoris NRRL 11430 following 16 
hours of growth in YPD media (2% (w/v) glucose) and BMMY media (0.5% (v/v) methanol – interpreted from 
5.3.  Values are given as a fold change in expression relative to ACT1.  Error bars represent the standard error of 
3 biological  replicates and statistical significance values derived from unpaired Student’s t-tests between each 
condition are reported – ns: p>0.05, *: p<0.05, **: p<0.01, ***: p<0.001.  
 
Interestingly the expression of HAC1 appears to be reduced in cells grown on methanol, but the 
overall fold change in expression is low under both conditions, although the results shown here 
represent total quantities of HAC1 transcript and cannot indicate changes in the proportion of the 
spiced variant encoding active Hac1p.  However PDI expression is approximately twice that of cells 
grown in YPD when P. pastoris is switched to growth on methanol.  Since the role of Pdi in the ER is to 
catalyse the formation of disulphide bonds while reverting erroneous disulphide bonds in native 
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protein structures (Wilkinson and Gilbert, 2004), its increase in expression provides evidence to 
suggest that the protein processing capacity of the ER may be raised in response to conditions 
imposed by cell growth on methanol, possibly through a burden incurred by higher quantities of 
unfolded protein within the ER lumen.  This constitutive increase in expression may be symptomatic 
of unfavourable conditions for recombinant protein secretion; a process which acts to only further 
increase the flux of proteins requiring modifications and folding into the ER, resulting in the activation 
of the UPR and ERAD pathways.  In summary, whilst utilising methanol as the sole carbon source for 
cell growth and as an inducer for expression from methanol regulated promoters has been a staple 
within the P. pastoris system since its inception (Tschopp et al, 1987), research conducted in the past 
decade points towards a physiological background occurring exclusively during growth in methanol 
which is not conducive for recombinant protein production. 
 
6.1.3 Regulation and catabolite repression of PAOX1 
 
Based on the evidence provided an ideal solution to reduce the deleterious effects of methanol-based 
growth would be to employ mixed feed strategies during expression, in which a different carbon 
source is implemented as the primary growth substrate.  A more ambitious approach would involve 
the development of knockout strains incapable of initiating the Mut pathway, leaving methanol as an 
unmetabolised inducer for AOX1 in culture in a similar vein to inducible systems in other expression 
systems, such as IPTG induction in E. coli (Kercher, Lu and Lewis, 1997).  In point of fact mutants with 
defective methanol utilisation phenotypes – MutS and Mut-, achieved through the disruption of 1 or 
both AOX genes, have previously been described (Cregg and Madden, 1987) and shown to increase 
productivity for the methanol induced expression of certain proteins (Krainer et al, 2012).  However a 
major obstacle towards eliminating the reliance on methanol as a growth substrate, and a potential 
reason for the preference of Mut+ strains over MutS and Mut-, is that methanol inducible promoters, 
particularly PAOX1, are partially or fully repressed in the presence of more favourable growth 
substrates (Hartner and Glieder, 2006).  Carbon catabolite repression (CCR) is a sophisticated, 
regulatory mechanism documented in both bacteria and eukaryotes and has been hypothesise d to 
have developed as an adaptation for organisms to preferentially select more rapidly metabolisable 
substrates from the surrounding environment (Deutscher, 2008).  In order to ensure that more 
readily assimilated substrates are utilised first, and to conserve the cell’s metabolic machinery, genes 
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encoding metabolic pathways for less preferred carbon sources are often silenced during CCR.  In the 
case of P. pastoris the expression of Mut pathway genes, including AOX1, is repressed when cells are 
cultured in glucose, glycerol or ethanol at concentrations that are not limiting to growth (Inan and 
Meagher, 2001).  Non-repressing carbon sources which are metabolised by P. pastoris and allow for 
full PAOX1 driven expression have been identified and include sorbitol, mannitol, alanine and trehalose 
(Inan and Meagher, 2001).  However the growth rate of P. pastoris in each of these substrates is 
considerably lower than in repressing carbon sources, limiting the number of practical growth 
substrates that are compatible with AOX1 expression.  In spite of their contribution towards CCR 
activation glucose and glycerol have previously been added in conjunction to methanol in chemostat 
cultures at concentrations that do not fully repress PAOX1, and have succeeded in improving 
productivity (Paulova et al, 2012; Zhang et al, 2013).  The threshold of glucose in culture required to 
repress PAOX1 has led to the development of commercially available defined growth media that 
maintain minimal concentrations of glucose in culture during methanol-induced expression, such as 
the EnPresso Y Defined growth system from BioSilta.  The media includes a proprietary 
polysaccharide that controls the slow release of glucose in culture, promoting higher overall protein 
production through increased cell growth.  The research findings and the presence of marketable 
products suggests a trend towards conducting methanol-induced expression on multiple growth 
substrates.  However glucose and glycerol repression of PAOX1 continues to limit the maximum 
concentration of each catabolite permissible in culture to maintain AOX1 expression, preventing the 
use of more optimal quantities of repressive substrate for growth in culture, as well as necessitating 
the requirement for accurate feed control during expression to prevent excess addition (Xie et al, 
2005; Paulová et al, 2012).  Engineering the partial or full alleviation of CCR of PAOX1 would therefore 
provide strains better suited to the expression of recombinant proteins on mixed feeds as they would 
be able to grow in media containing greater ratios of repressive substrates to methanol, promoting 
improved growth and viability, while retaining full PAOX1 activation. 
The molecular interactions governing the tight regulation of the AOX1 promoter in response to the 
presence of different carbon sources have yet to be understood in their entirety, although a number 
of studies have begun to characterise key enhancers and repressors that could provide promising 
candidates for the development of CCR resistant strains.  Rather than being controlled by a single 
regulatory pathway, CCR of PAOX1 instead appears to comprise a complex network of distinct pathways 
specific to individual carbon sources, with separate modes of repression occurring during cell growth 
in glucose, glycerol or ethanol, as illustrated in Figure 40.  Further explanation of the roles of each 
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factor, as well as other proteins found to be directly or indirectly involved in CCR of P AOX1 are 
summarised in Table 10. 
 
 
Figure 40: Schematic of the interactions between known regulatory factors for the methanol induction and CCR 
of PAOX1.  DNA binding sites for the positive transcription factors of PAOX1 are displayed in the correct position on 
the promoter and labelled in the corresponding colour of the binding factor.  Coloured lines indicate 
interactions that occur only in response to the presence of specific carbon sources, labelled on the bottom right, 
while black lines indicate processes that occur irrespective of carbon sour ce.  Crosses indicate pathways that are 
inhibited during repression with the relevant carbon source.  Question marks (?) next to interactions represent 




Table 10: Factors contributing to AOX1 regulation or CCR of AOX1, including a description of the phenotype of null mutants for the respective gene - if known. 
 Name 
 
Description Mechanism of action Mutant phenotype Reference 
Methanol 
induction 
Mxr1p Regulator of 
methanol 
expression 
Zinc finger transcription factor essential for the 
activation of a number of genes involved in the 
Mut pathway and peroxisome formation, 
including AOX1.  Binds directly to the AOX1 
promoter. 
Inability to grow on methanol or induce 
expression of AOX1, other Mut pathway 
genes and PEX genes required for 
peroxisome formation.  Peroxisome 
proliferation in response to methanol 










Transcription factor involved in the expression 
of certain genes comprising the Mut pathway 
under methanol induction, and binds to 
alternative sites on the AOX1 promoter to Mxr1 
or Mit1.  Its binding to AOX1 is abolished in the 
presence of glucose.  Binds to the Mit1 promoter 
to upregulate Mit1 expression during methanol 
induction.  Directly binds its own promoter and 
also upregulates its own expression as part of a 
positive feedback loop. 
Impaired growth in media containing 
only methanol as a carbon source.  
Reduced expression of AOX1 as well as 
other factors involved in the Mut 
pathway and peroxisome biogenesis 


















Transcription factor involved in the 
upregulation of Mut factors during methanol 
induction, including AOX1.  Contains 2 regions 
characterized as redundant, named RR1 and 
RR3, which are required for glycerol repression 
of AOX1.  Like Mxr1p and Trm1p, Mit1 binds to 
the AOX1 promoter but at independent sites to 
the other 2 transcription factors. 
 
No growth on media containing methanol 
as the sole carbon source.  10 fold 
reduction in AOX1 expression compared 
to wild type when grown in 0.5% (v/v) 
methanol.  Truncation mutants missing 
the RR1 and RR3 domains exhibit an 
increase from 1.2% to 19% expression of 
AOX1 compared to induced expression 
levels when grown in 1% (w/v) glycerol. 


















Unknown.  Hypothesised that PpHxt1 is directly 
involved in transcriptional repression of AOX1 
during growth on glucose in conjunction to its 
role as a sugar carrier. 
Comparable growth to wild type in 
glucose and methanol.  Partial but 
significant derepression and activation 
of the AOX1 promoter in media 
containing 1% (w/v) glucose and 0.5% 
(v/v) methanol during early growth 
stages. 







homolog in P. 
pastoris 
Suggested to be a low affinity glucose sensor in 
P. pastoris.  Studies with 2-deoxy-d-glucose 
provide evidence to suggest that PpGss1 is 
required for glucose uptake and, consequently, 
glucose repression of the Mut pathway. 
Severely impaired growth on 2% (w/v) 
glucose.  Minor decrease in growth in 
0.5% (v/v) methanol.  Mutants capable 
of growing in the presence of the toxic 
glucose homolog - 2-deoxy-d-glucose 
and exhibits partial expression of AOX1 
in media containing 2% glucose.  












Transcriptional repressor of AOX1 in the 
presence of glucose and glycerol.  Directly binds 
to regions containing the 2 furthest upstream 
Mxr1p binding sites and 1 Trm1p binding site 
on the AOX1 promoter, suggesting it functions 
as a competitive inhibitor of the 2 transcription 
factors. 
 
Reduced growth in 1% (w/v) glucose, 
1% (w/v) glycerol and 0.5% (v/v) 
methanol.  Slight de-repression of AOX1 
(<25% of fully induced wild type) in 
media containing 0.02% (w/v) glucose 
and 1% (v/v) glycerol. 



















homolog in P. 
pastoris 
Binds to a putative 14-3-3 binding site on 
Mxr1p located at position 212-225 through 
phosphorylation of Ser215 during ethanol 
repression. 
The point mutation S225A on Mxr1p 
results in the transcription factor no 
longer binding 14-3-3.  Mutants harboring 
this mutation exhibit significant 
derepression of AOX1 in the presence of 
0.5% (v/v) ethanol and comparable 
expression of AOX1 to the methanol 
induced wild type when grown in 0.5% 
(v/v) methanol, 0.5% (v/v) ethanol. 
 
Parua et al 
(2012) 




Zinc finger transcription factor originally 
found to be induced during methanol and 
biotin starvation.  Localises to the nucleus and 
competitively binds Mxr1p recognition sites on 
PAOX1 to partially repress its expression, along 
with other Mut genes, when P. pastoris is 
grown in rich media containing yeast extract 
and peptone. 
Improved growth over P. pastoris GS115 
and increased expression of AOX1, DHAS 
and FDH when cultured in media 
containing 2% (v/v) methanol when 
supplemented with yeast extract and 
peptone.  No difference in growth or 





Unknown PpZta1 Zeta 
crystalline 
homolog in P. 
pastoris 
Single stranded DNA binding protein found to 
be bound at region -288 to -115 on the AOX1 
promoter, which is inhibited in the presence of 
NADPH.  No other information on its 
expression profile in different carbon sources 
or its mechanism of action in relation to 
catabolite repression is available, although its 
ability to bind PAOX1 alone suggests it is 











Of each of the 3 known modes of CCR of PAOX1 – glucose, glycerol and ethanol repression, the largest 
number of contributing factors and pathways have been elucidated for glucose repression at present.  
The expression profile of AOX1 consists of a catabolite repressed state, an induced state caused by 
the presence of methanol and absence of repressive carbon sources, and a derepressed state under 
the absence of both methanol and repressive carbon sources, through which expression occurs at 
approximately 1-2% of the induced state (Tschopp et al, 1987).  Methanol induction is facilitated by 
the collective interaction of 3 zinc finger transcription factors Mxr1p, Trm1p and Mit1 with P AOX1, each 
of which are regulated differently to achieve the characteristic tight control of AOX1 expression in 




Mxr1p was the first global transcriptional regulator for Mut pathway genes discovered for P. pastoris, 
and is essential for their activation during growth on methanol (Lin-Cereghino, 2006).  Its association 
with AOX1 regulation was initially perceived during screening experiments for peroxisome biogenesis 
mutants incapable of growth in methanol, during which mxr1 mutants defective in both growth in 
methanol and AOX1 expression were also identified (Lin-Cereghino, 2006).  Not only is AOX1 
production severely reduced to less than 5% of native levels in methanol induced Δmxr1 strains, but 
the production of the Mut pathway enzymes Fdh and Fld, as well as the production of catalase for 
hydrogen peroxide detoxification, are also negatively affected (Lin-Cereghino, 2006). 
Mxr1p is a large, 1155 amino acid protein with homology to the S. cerevisiae alcohol dehydrogenase 
regulator - Adr1p and, like Adr1p, contains a conserved, zinc finger DNA binding domain located 
within its N-terminal region, specifically at positions 38-95 (Lin-Cereghino, 2006).  Through sequential 
yeast one-hybrid assays a major activation domain essential for transcription was mapped to 
positions 246-280 in Mxr1p (Parua et al, 2012).  The same study also found that a truncated form of 
Mxr1p consisting of the N-terminal 400 amino acids, spanning both the zinc-finger DNA binding 
domain and the major activation domain was sufficient to generate native Mxr1p activity in mxr1 
mutants, despite the positioning of a conserved fungal transcription factor regulatory region, 
predicted by NCBI’s conserved domain database (Marchler-Bauer et al, 2015), beyond of the specified 





This finding is of particular importance for informing genetic engineering approaches entailing the 
recombinant expression or alteration of MXR1 to modify AOX1 expression, as it describes a more 
minimal, simplistic form of Mxr1p with potentially fewer regulatory domains that can be expressed to 
achieve AOX1 activation as well as reducing the size of the associated biological parts and expression 
vectors that would be required. 
Electrophoretic mobility shift assays (EMSA) between the N-terminal 150 amino acids of Mxr1p, 
expressed recombinantly in E. coli, and DNA fragments spanning the PAOX1 region identified 6 specific 
Mxr1p binding sites on PAOX1 (Kranthi et al, 2009).  A core binding motif for Mxr1p of 3’-CYCC-5’ was 
determined through sequence analysis of the binding domains, and confirmed when mutations within 
the motifs abolished Mxr1p binding.  The study notes that the presence of multiple Mxr1p binding 
sites on PAOX1 is likely to be a key factor involved in the exceptionally high strength of PAOX1, 
particularly as deletions of regions containing a fraction of the total number of Mxr1p binding sites on 
the promoter significantly reduces AOX1 expression in vivo (Hartner et al, 2008). 
The regulation of Mxr1p to reduce its binding and prevent its activation of PAOX1 in glucose – grown 
cells appears to occur through the alteration of its subcellular localisation.  During growth of P. 
pastoris on glucose Mxr1p is found diffused throughout the cell interior whereas, during growth on 
other tested carbon sources including methanol, glycerol and ethanol, it appears exclusively within 
Figure 41: Linear map of Mxr1p, containing the positions of defined, essential regions for function (blue), 




the nucleus where it can activate transcription (Lin-Cereghino, 2006).  The established importance of 
its DNA binding for AOX1 expression, and the fact that it remains localised to the nucleus in the 
presence of the other repressive carbon sources – ethanol and glycerol, suggests that the change in 
Mxr1p’s subcellular localisation in glucose-grown cells, and its subsequent reduction in nuclear 




The methylotrophic yeast Candida boidiinii contains an analogous Mut pathway to P. pastoris that is 
also regulated by methanol induction and CCR (Hartner and Glieder, 2006).  A putative gene found in 
P. pastoris encoding a protein with 58% homology to Trm1p, a transcriptional activator of at least 5 
Mut pathway genes in C. boidiinii (Sasano et al, 2008), was studied and also named Trm1p – although 
it is sometimes referred to Prm1p in reference to the organism (Sahu, Krishna and Rangarajan, 2014).  
Δtrm1 mutants exhibited retarded growth in methanol, albeit not as severe as Δmxr1 mutants, 
reduced expression of the Mut pathway genes AOX1, FLD, DHAS, FDH and reduced expression of 3 
peroxisome biogenesis genes, implicating Trm1p as a second master regulator of methanol induced 
expression in P. pastoris (Sahu, Krishna and Rangarajan, 2014).  An EMSA of Trm1p did not identify 
any Trm1p binding sites on PAOX1, although EMSAs performed in a separate study found that Trm1p 
bound PAOX1 at 2 independent sites from Mxr1p (Wang et al, 2016).  The EMSAs were complemented 
with in vivo chromatin immunoprecipitation (ChIP) analysis of Trm1p binding to PAOX1 in response to 
different carbon sources, in which it was found that Trm1p binding was abolished in glucose – grown 
cells, suggesting a potential regulatory mechanism governing Trm1p activity during glucose 
repression.  The deletion of TRM1 resulted in an 80% drop in transcription of the gene encoding the 
3rd positive regulator of PAOX1 – MIT1 implying that Trm1p can indirectly influence AOX1 activation 
through upregulating expression of MIT1 (Wang et al, 2016).  This was supported by the identification 
of a Trm1p binding site on the MIT1 promoter (Wang et al, 2016).  Expression of recombinant GFP 
from the TRM1 promoter was also reduced in Δtrm1 mutants grown in glucose, glycerol and 
methanol, and Trm1p was also found to bind a site on its own promoter (Wang et al, 2016).  The 
results of the study indicate that Trm1p enhances AOX1 expression during methanol induction via 3 
interactions: binding PAOX1 to increase AOX1 transcription, upregulating MIT1 expression and 
upregulating its own expression.  The latter pathways imply that, through the activity of Trm1p, the 
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Mit1 is the most recently characterised of the 3 known zinc finger transcriptional activators of AOX1, 
having been identified as a potential candidate for Mut pathway regulation in P. pastoris through the 
sequence homology of its DNA binding domain to the Mut pathway transcriptional regulator Mpp1 in 
Hanselula polymorpha (Prielhofer et al, 2015; Wang et al, 2016).  Its null mutant also exhibits the 
same characteristic poor growth on methanol and highly downregulated AOX1 expression as Δmxr1 
and Δtrm1 mutants (Wang et al, 2016).  3 specific Mit1 binding sites were located on PAOX1 at 
independent locations from those of both Mxr1p and Trm1p, suggesting that all 3 transcription 
factors independently activate AOX1 transcription to varying degrees (Wang et al, 2016).  
Interestingly a number of domains on Mit1, named RR1, RR3 and UR3 were found to be involved in 
glycerol repression of PAOX1, as their deletion resulted in significant derepression of AOX1 expression 
in glycerol-grown cells, expressing AOX1 at up to 19% of methanol induced levels (Wang et al, 2016).  
The study concluded that the presence of these sites confirm that Mit1 is involved in the direct 
repression of PAOX1 during growth on glycerol but it is also possible that the domains house 
recognition sites for trans – acting factors that repress AOX1 expression by binding and inactivating 
Mit1, similar to ethanol repression of Mxr1p. 
While the expression of both MXR1 and TRM1 genes are maintained at consistent, low levels 
regardless of carbon source availability (Lin-Cereghino, 2006; Sahu, Krishna and Rangarajan, 2014), 
meaning that they are regulated post – translationally during CCR, the regulation of Mit1 occurs at 
the transcriptional level.  Mit1 remains permanently localised to the nucleus and is capable of binding 
PAOX1 in both glucose and glycerol-grown cells, but transcription of the MIT1 gene is heavily repressed 
in both growth substrates (Wang et al, 2016).  Upon shifting cells to growth on methanol, transcript 
levels of MIT1 increase sharply, most likely due in part to the positive feedback loop in expression 





6.1.3.4 Negative regulators 
 
In contrast to the number and level of characterisation of positive enhancers of PAOX1 discovered less 
is known about trans – acting factors that directly repress PAOX1 during CCR.  A homologue for ScNrg1, 
a transcription factor mediating glucose repression in S. cerevisiae, was found in P. pastoris, and 
encodes a zinc finger transcription factor (Wang et al, 2015).  The protein, named PpNrg1, was found 
through EMSA to bind PAOX1 at sites between the Mxr1p binding sites furthest upstream of AOX1 and 
a site directly spanning 1 of the 2 Trm1p binding sites (Wang et al, 2015).  Δppnrg mutants also 
displayed increased AOX1 expression on 1% (v/v) glycerol and 0.02% (w/v) glucose to up to 
approximately 17% of methanol induced levels.  An increase in expression was also observed for a 
number of other Mut pathway genes including AOX2, DAS, peroxisome biogenesis genes and 2 genes 
encoding peroxisomal membrane proteins, supporting the role of PpNrg1 as a global transcriptional 
repressor of the Mut pathway during glycerol and glucose repression (Wang, 2015).  However it 
should be noted that the repressive effects of PpNrg1 were not observed in cells grown in 1% (v/v) 
glucose, indicating that its function is more likely to be specific to glycerol repression and under 
growth limiting conditions.  The location of the PpNrg1 binding sites on PAOX1 indicate that PpNrg1 
must compete for binding with the positive transcription factors Mxr1p and Trm1p as its mechanism 
of repression during CCR. 
During ethanol repression Mxr1p was found to be inactivated post – translationally by a 14-3-3 
homologue in P. pastoris (Parua et al, 2012).  The interaction was initially investigated based on 
evidence that the homologue of Mxr1p – Adr1p is regulated by the 14-3-3 protein Bmh in S. 
cerevisiae, which was shown to also be capable of binding Mxr1p (Parua et al, 2012).  Sequence 
alignments of both Adr1p and Mxr1p revealed the homologous positioning of a serine residue (S225) 
on Mxr1p that is phosphorylated on Adr1p during 14-3-3 interaction.  The point mutation S225A 
resulted in an Mxr1p variant that no longer bound a 14-3-3 homologue in P. pastoris, and strains 
bearing the mutation exhibited significant levels of AOX1 transcription in media containing ethanol as 
a sole carbon source and an almost complete alleviation of repression in media containing both 
ethanol and methanol.  Interestingly a ChIP-seq analysis revealed that Mxr1p is still able to bind PAOX1 
during ethanol repression, suggesting that the P. pastoris 14-3-3 is capable of non – competitively 
inhibiting Mxr1p activity after it has bound to recognition sequences (Parua et al, 2012).  The study 
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was able to confirm a second inhibitory mechanism for Mxr1p which provides an explanation, in part, 
as to how CCR continues to occur in spite of conditions where Mxr1p is fully localised in the nucleus. 
Other proteins found to affect glucose repression of PAOX1 include the low affinity hexose transporter 
PpHxt1 and the low affinity glucose sensor PpGss1 as deletion mutants for either gene were capable 
of expressing AOX1 at minimal levels when cells were grown in media containing glucose, although 
growth in glucose was also impaired (Zhang et al, 2010; Polupanov, Nazarko and Sibirny, 2012).  The 
phenotype of their respective knockout mutants, and their function in P. pastoris suggests that both 
PpHxt1 and PpGss1 indirectly facilitate glucose repression by their involvement in maintaining 
intracellular levels of glucose; a factor which most likely signals the activation of glucose repression 
pathways. 
 
6.2 Design of a screen to determine PAOX1 activation states 
 
In order to confirm the alleviation of glucose repression in the novel strains generated within the 
experiment a suitable screen allowing for the partial quantification of the expression of recombinant 
genes by PAOX1 in response to glucose and methanol is required.  The expression of the zeocin 
resistance marker sh ble provided a suitable candidate to screen for PAOX1 activity since the 
inactivation of zeocin within cells is titratable to the quantity of Sh ble produced.  The resistance of P. 
pastoris cells expressing sh ble under PAOX1 to increasing concentrations of zeocin would therefore 
correlate with the level of transcriptional repression experienced by PAOX1.  For the generation of test 
strains expressing sh ble under PAOX1 the vector pAVECRS, based on the P. pastoris expression vector 








pAVE522 was selected to form the vector backbone for pAVECRS as it contains the AOX1 promoter 
followed immediately by a multiple cloning site to allow the simple construction of AOX1 expression 
cassettes.  However pAVE522 also contains sh ble under the constitutive TEF1 yeast promoter as a 
selectable marker, requiring replacement with an alternative marker for the vector to function 
correctly as part of the screen. sh ble, including some flanking sequence belonging to PTEF1 and the 
CYC1 terminator region was excised from pAVE522 by a double restriction digest with NcoI and StuI.  
The G418R marker tn903kanr was PCR amplified from the G418R  cassette supplied by Fujifilm 
Diosynth Biotechnologies (Billingham, UK), with ends containing the regions of PTEF1 and the CYC1 TT 
removed by the NcoI and StuI digest, as well as a further 40bp of complementary Gibson ends, using 
10-Gibkan-F and 11-Gibkan-R (Figure 43). 






tn903kanr was inserted into the site formerly containing sh ble and the new vector, named pAVE522-
k, was electroporated into E. coli with selection on 30μg/ml kanamycin.  The correct insertion of 
tn903kanr downstream of PTEF1, and the restoration of the 3’ region of PTEF1 were confirmed by 
sequencing with the primers 16-Selseqb-F and 17-Selseqb-R. 
Following its assembly, pAVE522-k was restricted with BstBI and SacII to remove the S. cerevisiae α-
mating secretion signal and to linearise the vector between the AOX1 promoter and the AOX1 TT.  sh 
ble was then PCR amplified using the Gibson primers 24-GibAOXzeo-F and 25-GibAOXzeo-R from 
pAVE522, gel purified and inserted downstream of PAOX1 in the linearised pAVE522-k by Gibson 
assembly.  Colony PCRs of E. coli cloned with the assembled vector and sequencing within the AOX1 
locus with 12-5’AOX1 and 13-3’AOX1 confirmed the correct insertion of sh ble with high efficiency to 
complete pAVECRS (Figure 44). 
 
Figure 43:  Generation of parts to assemble the vector backbone for pAVECRS.  Lane 1 – 1 .0kb DNA marker, 2 – 
PCR of tn903kanr with replacement sequence and complementary ends to PTEF1 and CYC1 TT, 3 – removal of a 





6.2.2 Resistance of P. pastoris cloned with pAVECRS to zeocin is dependent on PAOX1 
derepression and induction 
 
To generate a screenable strain for PAOX1 activity, pAVECRS was linearised by SacI and integrated into 
the AOX1 locus of P. pastoris NRRL 11430 by electroporation with selection on G418 sulphate.  To test 
whether the expression of sh ble could be influenced by glucose repression of PAOX1 a positive P. 
pastoris NRRL 11430 + PAVECRS transformant was grown in 5ml minimal media containing either 1% 
(w/v) glucose or 1% (w/v) glucose and 0.5% (v/v) methanol and grown for a maximum period of 16 
hours to prevent the concentration of glucose in culture falling to growth – limiting levels.  The 
transformants were also grown separately in 1% (w/v) sorbitol to examine the derepressed state of 
PAOX1 and 0.5% (v/v) methanol to fully induce sh ble expression.  The cultures were normalised to a 
low OD600 of 0.1 to prevent tolerance arising from the sequestering of free zeocin in the media by an 
excess of cells, and were subsequently plated onto 0-500μg/ml zeocin gradient agar plates matching 
the growth substrate used in each culture.  The growth on each carbon substrate was imaged after 48 
hours and is displayed in Figure 45. 
 
Figure 44: Colony PCRs confirming the insertion of sh ble downstream of P AOX1 in pAVECRS for each tested E. coli 






The addition of an excess of glucose in the media, even in the presence of methanol, was sufficient to 
prevent resistance to zeocin developing in P. pastoris expressing sh ble under PAOX1, as P. pastoris + 
pAVECRS grew at only a slightly higher concentration of zeocin than the wild type in the presence of 
glucose . The finding suggests that a low, basal level of expression occurs even under glucose 
repression.  Despite the lack of growth substrates inducing CCR for P. pastoris + pAVECRS cultured in 
1% (w/v) sorbitol no resistance to even low concentrations of zeocin could be observed, suggesting 
that expression levels from derepressed PAOX1 do not generate adequate quantities of active Sh ble 
to confer resistance to zeocin.  A decrease in the susceptibility to zeocin compared to P. pastoris NRRL 
11430 could only be observed in P. pastoris + pAVECRS under methanol induction, which resulted in 
zeocin resistant colonies developing at concentrations ranging up to 500μg/ml.  However colony 
Figure 45: Susceptibility of P. pastoris + pAVECRS to zeocin grown on different carbon sources.  Media 
containing 1% glucose (red) represses the AOX1 promoter even in mixed feeds containing methanol.  
Insufficient Sh ble is expressed under de-repressing conditions during growth on sorbitol (black) and inducing 
conditions in which methanol is the only carbon source present is sufficient to generate partial resistance to up 
to 500μg/ml zeocin (green). 
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growth and morphology was relatively impaired in comparison to cells grown in the control region of 
plates containing no zeocin.  While resistance was evidently increased, the comparison indicates that 
only a fraction of the cells plated grew to form colonies.  A contributing factor to the non-uniformity 
of resistance between cells was attributed to the low growth rates of P. pastoris in minimal methanol 
media containing which, when coupled with exposure to high concentrations of zeocin, results in a 
substantial decrease in viability and weakened growth even in resistant cells.  The addition of 3% 
(w/v) sorbitol to the minimal methanol media significantly improved the confluency of methanol 
induced, resistant P. pastoris + pAVECRS cells on zeocin gradient plates, and was therefore used for 
the remainder of the zeocin gradient plate experiments in this study. 
The ability to distinguish methanol induction from repression of PAOX1 by examining the growth of P. 
pastoris + pAVECRS on zeocin gradient agar plates has established a suitable, simple screen for the 
alleviation of glucose repression from AOX1 – based expression.  The presence of 1% (w/v) glucose in 
the growth media is able to silence the expression of sh ble in wild type P. pastoris transformed with 
pAVECRS and therefore novel strains exhibiting significant alleviation in glucose repression of P AOX1 
should be identifiable through their increased resistance to zeocin when grown in mixed feeds of 
glucose and methanol. 
 
6.3 Attempting to implement a CRISPR system for the disruption of 
multiple genes in P. pastoris  
 
To date the majority of research into CCR of P. pastoris has entailed the deletion or mutation of single 
genes with hypothetical roles in CCR and examining its effect on the regulation of methanol inducible 
genes.  The discovery of glucose transporters, sensors, transcriptional repressors of P AOX1 and 
regulatory regions on Mxr1p that can be deleted or altered to partially alleviate CCR of P AOX1 suggests 
that a combination of a number of the modifications previously studied would yield further alleviation 
of glucose repression over the respective single mutant strains.  However, in an attempt to find the 
optimal set of mutations to uncouple a regulatory network as complex as glucose repression from 
AOX1 expression, a combinatorial approach testing multiple gene deletions within single strains 
would be required, necessitating the use of a more sophisticated system for gene disruption or 
editing than has previously been used within this project.  Such a system would have to employ 
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scarless gene modification to preserve the limited number of antibiotic selectable markers available 
to clone expression vectors into the novel P. pastoris strains generated.  A method requiring fewer 
integration/ self-removal events of gene specific knockout cassettes, typical of FLP-recombinase gene 
deletion systems, would also facilitate more rapid generation of multiple deletion strains, providing 
an improvement to current systems validated for P. pastoris.  Therefore, to design a system for the 
generation of multiple candidate strains for the alleviation of glucose repression, and to contribute to 
the molecular toolbox of P. pastoris, the development of a rudimentary CRISPR-Cas9 system for the 
disruption of multiple genes was explored. 
 
6.3.1 CRISPR – Cas9 in yeast 
 
Clustered, regularly interspaced short palindromic repeats (CRISPR) coupled with CRISPR – associated 
factors (Cas) were originally discovered as an adaptive immune response in different species of 
bacteria and archaea for excising invasive viral DNA from the host genome (Barrangou et al, 2007), 
but have since been developed into a powerful in vivo gene editing tool.  The modularity of the 
CRISPR-Cas system, its high targeting efficiency for specific DNA sequences within host genomes and 
recent modifications expanding its repertoire to include systems for inserting foreign DNA into loci, as 
well as the transcriptional activation or silencing of target genes, has generated considerable interest 
within the biotechnology community (Larson et al, 2013; Zhang et al, 2015).  Currently CRISPR-Cas 
systems have been developed for a host of model organisms including the yeasts S. cerevisiae and 
Candida albicans (DiCarlo et al, 2013; Sander and Joung, 2014; Vyas, Barrasa and Fink, 2015). 
The most common use for CRISPR-Cas is the disruption of genes within the host genome to prevent 
their expression, with the CRISPR-Cas9 system, adapted from the native type II CRISPR system in 
Streptomyces pyogenes, having emerged as a standard for this application (Jinek et al, 2012; Cong et 
al, 2013; Mali et al, 2013).  CRISPR-Cas9 is made up of 2 elements – the first being the Streptococcus 
pyogenes CAS9, which encodes a large DNA endonuclease.  The endonuclease activity of Cas9 is 
significantly reduced unless paired with a guide RNA (gRNA), which consists of a “scaffold” sequence 
necessary for Cas9 binding and a targeting region, designed by the user, to direct the Cas9-gRNA 
complex to the target DNA sequence and initiate double stranded breaks (Cong et al, 2013; Mali et al, 





The gRNA is modified to target the site specific activity of Cas9 by altering the targeting region to 
complement a 20bp sequence located within the gene to be disrupted (Jinek et al, 2012).  The one 
limitation that exists for the targeting of Cas9-gRNA complexes within the genome is that the 20bp 
recognition sequences occur directly 5’ to an NGG triplet, known as the protospacer adjacent motif 
(PAM) (Mojica et al, 2009; Jinek et al, 2012).  Once Cas9 has been successfully targeted to the desired 
region, mutations within the region causing a frameshift or a premature translation termination of 
the encoded gene, occurring as a result of the repairing of double stranded DNA breaks by the error 
prone non-homologous end joining pathway (NHEJ) can be screened for in the affected cells (Cong et 
al, 2013; Mali et al, 2013).  Alternatively precise editing of the region spanning the recognition and 
break site can be achieved by co-transforming the CRISPR-Cas9 machinery into cells with homologous 
donor DNA (Ran et al, 2013).  The donor DNA encodes the precise sequence modification required by 
the user, such as a premature stop codon, flanked by homologous sequence to the target gene 
adjacent to the CRISPR-Cas9 recognition site.  The donor DNA then forms a template to stimulate the 
repairing of the Cas9-mediated DNA damage by the cell’s homology direct repair (HDR) pathway, 
which results in the insertion of the modification contained in the donor DNA, into the genome with 
high fidelity (Ran et al, 2013). 
Figure 46: Schematic of gRNA interacting with Cas9 to direct site – specific double stranded DNA breaks in the 
target sequenc e, taken from DiCarlo et al (2013). 
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The relatively small size of the gRNA and the target region means that different gRNA expression 
cassettes targeting Cas9 to multiple regions on the genome are simple and cost effective to construct.  
The stable expression of gRNA in cells is not necessarily a requirement either, as genome editing by 
transforming cells with the genes encoding Cas9 and gRNA on transient expression cassettes that are 
not replicated within the host has been validated in a number of model organisms (Jiang et al, 2014) 
(Rahdar et al, 2015; Zhang et al, 2016).  This strategy has also been partially implemented in S. 
cerevisiae, where the targeted mutation of 2 individual genes at high efficiency was achieved in cells 
stably expressing CAS9 under the constitutive TEF1 promoter, following transformation with transient 
gRNA expression cassettes and donor templates (DiCarlo et al, 2013). 
The prospect of inducing the disruption of specific genes through the transient expression of gRNAs in 
P. pastoris would be ideal for the rapid generation of large numbers of multiple knockout strains.  The 
transient CRISPR-Cas9 system, if successfully implemented in P. pastoris with high targeting 
efficiencies, would enable the sequential or even multiplex targeting of several genes by transforming 
CAS9-expressing cells with different combinations of gRNAs.  As such this study will attempt to 
construct a semi-transient CRISPR-Cas9 system, comparable to the system previously established in S. 
cerevisiae, for multiple gene disruption in P. pastoris. 
 
6.3.2 Constitutive expression of CAS9 compatible with pPICZ/ pAVE522 vectors 
 
To begin developing a CRISPR – Cas9 system in P. pastoris, a strain stably expressing CAS9 under a 
strong, constitutive promoter was required.  Since any mutants generated through CRISPR-Cas9 
editing would be subsequently transformed with pPICZ or pAVE522 – based vectors, including the 
glucose repression screening vector pAVECRS, the use of a CAS9 expression vector integrating into 
the AOX1 locus, utilising zeocin or G418 resistance as selectable markers would impede the further 
testing of the resultant strains for the alleviation of glucose repression.  Considering these 







pGrzαHSA integrates within the ribosomal DNA (rDNA) locus and contains a the gene encoding 
human serum albumin with the S. cerevisiae α – mating secretion signal, expressed under the 
constitutive GAP promoter.  The replacement of αmf – HSA with the CAS9 gene tagged with a C-
terminal SV40 nuclear localisation signal (NLS), confirmed to effectively target recombinant proteins 
to the nucleus in P. pastoris (Weninger, Glieder and Vogl, 2015), and the replacement of sh ble with 
hph, encoding the hygromycin resistance gene from Klebsiella pneumonia would create a CAS9 
expression vector compatible with pPICZ and pAVE522 – based vectors. 
  
Figure 47: Vector map for pPCas9, containing the human optimised CAS9 with C-terminal SV40 nuclear 





A double restriction digest of pGrzαHSA with LguI and NotI removed αmf – HSA downstream of PGAP, 
in addition to ~200bp of the 3’ region of PGAP.  This region was included as a Gibson part in order to 
restore PGAP upon reassembly of the vector with CAS9, through PCR amplification of the PGAP 3’ region 
with the primers 50-GibGapfrag-F and 51-GibGapfrag-R (9.1).  Finally human optimised CAS9-SV40 
was PCR amplified from p414-TEF1p-Cas9-CYC1t, with flanking MssI restriction sites to enable the use 
of the vector backbone for future studies and complementary ends to its locus of insertion within the 




The 3 parts were joined by Gibson assembly and transformed into E. coli BioBlue with selection on 
25μg/ml zeocin.  The insertion of CAS9-SV40 and the restoration of PGAP was confirmed by sequencing 
the plasmids isolated from a subset of positive transformants with the primers 111-5’GAP and 13-
3'AOX1. 
Figure 48: Generation of parts for the assembly of CAS9 into pGrzαHSA.  Lane 1 - 1.0kb DNA marker, 2 – PCR 
amplicons of ~200bp of 3’ PGAP with Gibson ends, 3 -  PCR amplicons of human optimised CAS9-SV40 with MSSI 
restriction sites and Gibson ends, 4 – Restriction digest of pGrzαHSA with LguI and NotI with the ~6.0kb band 
corresponding to the linearised vector backbone. 
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To replace sh ble with hph, pGrzαHSA containing CAS9-SV40 was restricted with the enzymes NcoI 
and StuI, and hph was PCR amplified with complementary ends to the former sh ble site on pGrzαHSA 
with 48-Gibhph-F and 49-Gibhph-R.  Gibson assembly was used again to insert hph into the vector, 
which was then cloned into E. coli BioBlue with selection on 100μg/ml hygromycin – b.  Sequencing 
the plasmids isolated from the resulting positive transformants with 16-Selseqpb-F and 17-Selseqb-R 
confirmed the correct insertion of hph to complete the CAS9 expression vector, which was named 
pPCas9. 
pPCas9 was linearised within the rDNA sequence with SpeI, transformed into P. pastoris NRRL 11430 
by electroporation, and transformants were selected on 200μg/ml hygromycin b.  To confirm the 
constitutive expression of CAS9-SV40 from the rDNA locus, which had not previously been tested 
within this study, total cellular RNA was purified from P. pastoris +pPCas9 grown for ~16 hours in 5ml 
YPD.  An RT-PCR of the isolated RNA with the primers 55-Cas95’1kb-F and 56-Cas95’1kb-R, annealing 
specifically to the 5’ ~1kb region of CAS9, confirmed the presence of the CAS9-SV40 mRNA transcript, 
indicating its expression from PGAP (Figure 49). 
 
 
Figure 49: RT-PCR of P. pastoris NRRL-11430 cloned with pPCas9 to confirm transcription of CAS9.  Lane 1 – 1kb 
DNA size marker, 2 – control of P. pastoris NRRL-11430 cDNA with primers amplifying ~200bp of ACT1, 3 – P. 
pastoris NRRL-11430 + pPCas9 cDNA with primers for ACT1, 4 – negative control of P. pastoris NRRL-11430 
cDNA with primers amplifying 1kb of the 5’ region of CAS9, 5 - P. pastoris NRRL-11430 + pPCas9 cDNA with 
primers amplifying 1kb of the 5’ region of CAS9. 
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6.3.3 Design and transformation of gRNA expression cassettes targeting ADE2 
 
With the establishment of a strain constitutively expressing Cas9, assumed to be nuclear localised by 
the SV40 signal sequence confirmed to function in P. pastoris by Weninger, Glieder and Vogl (2015), 
expression cassettes for the transcription of mature, functional gRNA were designed for the targeting 
of Cas9 to the P. pastoris ADE2 homologue.  ADE2 encodes a phosphoribosylaminoimidazole 
carboxylase in S. cerevisiae and P. pastoris that catalyzes an essential step during purine biosynthesis 
(Stotz and Linder, 1990) (Lin Cereghino et al, 2001).  In media containing low levels of adenine, ade2 
mutants produce a visible phenotypic change, as the build-up of coloured, purine precursors within 
the vacuoles of cells results in the growth of red/pink colonies on solid media (Lin Cereghino et al, 
2001).  ADE2 therefore provides an ideal candidate gene to test the functionality and targeting 
efficiency of the CRISPR – Cas9 system as a proof of concept. 
The web tool E-Crisp (http://www.e-crisp.org/E-CRISP/) was used to locate all possible 20bp Cas9 – 
gRNA recognition sequences with either a 3’ NGG motif  or 3’NAG, which has also been demonstrated 
to function as a PAM, in P. pastoris ADE2.  The recognition sequences were aligned against the P. 
pastoris genome to control for potential off target Cas9 activity, leading to the identification of 2 
unique recognition sites on ADE2 occurring closest to the translation start site: a 5’-N20NAG-3’ at 
position 340 and a 5’-N20NGG-3’at position 689 (9.4.1). 
The production of functional gRNAs in eukaryotes requires the use of promoters that do not recruit 
RNA polymerase II (RNA Pol II) to drive expression.  The promoters for protein encoding genes all 
direct RNA Pol II – mediated transcription of their respective genes, which processes the resulting 
RNA post-transcriptionally to form mature mRNA for translation (Kornberg, 1999).  These post – 
transcriptional modifications, including the attachment of the 5’ cap and 3’ poly-adenylation, 
interfere with gRNA function and so CRISPR – Cas systems in eukaryotes often employ promoters 
recruiting RNA Pol III, which transcribes non – coding RNAs such as tRNAs and components of the 
spliceosome natively (Ma et al, 2014).  This presents an obstacle to the expression of gRNAs in P. 
pastoris, as there are no well characterised or tested RNA Pol III promoters for recombinant 
expression in the P. pastoris molecular toolkit.  To circumvent this issue 2 separate strategies were 




6.3.3.1  S. cerevisiae PSNR52 and SUP4 TT 
 
SNR52 encodes a small, nucleolar non – coding RNA in S. cerevisiae and its native promoter has been 
previously utilised to drive RNA Pol III mediated transcription (Guffanti et al, 2006).  P SNR52 was also 
used for the expression of functional gRNAs in the S. cerevisiae CRISPR – Cas9 system, which the 
current system tested within this study is modelled on (DiCarlo et al, 2013).  Based on the 
compatibility observed for a number of native S. cerevisiae promoters with gene expression in P. 
pastoris as a rationale, the S. cerevisiae gRNA expression cassette, comprising PSNR52 and the SUP4 
RNA Pol III specific transcription terminator was tested for gRNA expression within the P. pastoris 
CRISPR – Cas9 system.  Whilst PSNR52 has yet to be tested, the SUP4 TT has been shown to retain its 
function when implemented in P. pastoris (Young et al, 2009).  
 
6.3.3.2  Ribozyme – mediated processing for mature gRNA production 
 
A second strategy, designed initially by Gao and Zhao (2014), facilitates the expression of gRNAs from 
RNA Pol II promoters.  DNA encoding the gRNA is flanked by sequences encoding a Hammerhead (HH) 
type ribozyme at the 5’ end, and the hepatitis delta virus (HDV) ribozyme at the 3’ end.  Following 
transcription, the HH and HDV ribozymal units within the mature mRNA molecule form secondary 
structures that catalyze their self – cleavage, removing the 5’ and 3’ ends from the mRNA molecule 
and releasing the full gRNA free of any post – transcriptional modifications.  As such a gRNA cassette 
was designed with HH and HDV ribozymes, using the G1 promoter, a variant of PGAP (Qin et al, 2011) 
to drive high level constitutive expression, and the S. cerevisiae ADH1 transcription terminator (9.4.3) 
(Figure A4). 
 
Expression cassettes employing each strategy, for separate gRNAs targeting either of the 2 previously 
identified recognition sites on ADE2 were designed and synthesised in E. coli holding vectors.  The 
total 4 expression cassettes were designated as shown in Table 11. Further information about the 




ADE2 target S. cerevisiae CRISPR – gRNA 
cassette 
HH and HDV ribozyme cassette 
340 - NAG PSNR52-340-SUP4t PG1-340-ADHt 
689 - NGG PSNR52-689-SUP4t PG1-689-ADHt 
 
6.3.3.3  Transformation of gRNA cassettes 
 
The transient gRNA cassettes were transformed into P. pastoris + pPCas9 either within circular E. coli 
holding vectors, or as linear PCR products amplified with 57-sc-gRNA-F/ 58-sc-gRNA-R for the S. 
cerevisiae-based gRNA cassettes or 59-ribo-gRNA-F and 60-ribo-gRNA-R for cassettes utilising the HH 
and HDV ribozymes.  After transformation cells were incubated at 28°C in 5ml YPD for 12 hours to 
allow the expression of both CAS9 and gRNAs.  The incubation period was not extended further, and 
the cell samples were minimally agitated at 100rpm to prevent excessive growth as ade2 variants are 
slower growing, and risk being outcompeted by unmutated cells.  10-fold serial dilutions of cell 
suspensions post-incubation up to a dilution factor of 106 were set up in PBS, and plated in 
quadruplicate on YPD + 200μg/ml hygromycin-b to yield ~500 discrete colonies per transformation.  
The various conditions tested for each gRNA cassette are summarised in Table 12. 
  
Table 11: List of the 4 different gRNA expression cassettes for ADE2 disruption utilising either the 340 -5'N20-
NAG-3‘ or 689-5'N20-NGG-3‘ recognition sequences, and either the S. cerevisiae or ribozyme flanking strategies 
for gRNA expression. 
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Cloning method Expression cassette 
format 





linear PCR product  







linear PCR product  






Linear PCR product  Yes  PSNR52-689-SUP4t 
PG1-689-ADHt 
Electroporation 
(Lithium acetate + 
DTT pretreatment) 





(Lithium acetate + 
DTT pretreatment) 
Linear PCR product Yes PSNR52-689-SUP4t 
PG1-689-ADHt 
 
To test whether precise gene editing through the HDR pathway would be possible as well as simple 
gene disruption through the error-prone NHEJ pathway, a ~120bp donor template was designed to 
contain a premature stop codon in-frame, within the NGG PAM located at position 689 on ADE2, and 
synthesised for use in conjunction with the PSNR52-689-SUP4t and PG1-689-ADHt gRNA cassettes.  
Under conditions requiring its inclusion, 1nmol of the double stranded donor template was co-
transformed into P. pastoris + pPCas9 with 5-10μg of the appropriate gRNA. 
Table 12: List of the conditions, including the subset of gRNAs tested for each condition, for the transformation 
and expression of transient gRNA cassettes in P. pastoris + pPCas9. 
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None of the transformation conditions yielded any colonies displaying the ade2 phenotype with any 
of the 4 gRNA cassettes tested, or with the inclusion of a donor template.  To determine whether the 
transformation efficiency for the insertion of the gRNA cassettes was limiting their expression within 
cells, a variety of electroporation methods were also applied.  Both the standard protocol specified by 
Thermo Fisher Scientific for the transformation of P. pastoris and a modified electroporation protocol 
from Fujifilm Diosynth Biotechnologies (Billingham, UK) were tested.  The electrocompetency of P. 
pastoris + pPCas9 was also improved by incubating competent cell suspensions in 0.1M lithium 
acetate and 10mM DTT prior to electroporation, which was observed to increase the transformation 
efficiency of P. pastoris by up to 150 – fold over conventional protocols (Wu and Letchworth, 2004).  
However none of the electroporation protocols used resulted in the generation of any colonies with 
the ade2 phenotype, suggesting that transformation efficiency alone was not an impediment to the 
expression of CRISPR-Cas9.  To check for the presence of any synonymous mutations or mutations not 
abolishing Ade1p function, the ADE1 locus was PCR amplified from the genomic DNA of 10 colonies 
cloned through the lithium acetate + DTT pretreatment method with ei ther PSNR52-689-SUP4t or PG1-
689-ADHt, with or without the donor template.  Sequencing of ADE2 with 63-ade2seq-F and 64-
ade2seq-R revealed that the ADE2 gene from colonies for each of the specified conditions remained 
unchanged from the wild type, indicating the failure of the formation of the Cas9-gRNA complex in 
vivo, or its targeting of ADE2. 
The remaining possibilities explaining the lack of CRISPR-Cas9 activity against ADE2 could include that 
transient expression is not viable for the production of adequate quantities of gRNAs for effective 
Cas9 targeting, in which case the use of a CRISPR-Cas9 system would be limited for the requirements 
of future experiments within this study.  Another possibility could be that the Cas9 protein is 
incorrectly folding within the P. pastoris environment, or that translation rates are lowered due to the 
human optimised version of CAS9 introducing combinations of rare codons for P. pastoris.  Whilst low 
levels of activity of the CRISPR-Cas9 system in some cells could potentially be occurring, the results of 
the experiment are conclusive in that the actual gene disruption efficiency of the proof of concept 
CRISPR-Cas9 system is far too low (<0.02%) to use in practice for the knockout of genes involved in 
glucose repression, all of which would produce no visible phenotype and thus would require more 
intensive screening.  As such, an alternative method for the generation of glucose repression mutants 




6.4 Partial alleviation of glucose repression by the constitutive expression 
of MIT1 
 
6.4.1 Strategies for uncoupling positive transcription factors of AOX1 from glucose 
regulation 
 
In the absence of an effective gene knockout system for the removal of known factors contributing 
towards the transcriptional repression of PAOX1, the focus of the study was shifted to the 
transcriptional enhancers of AOX1 expression during methanol induction.  Previous strategies looking 
to mitigate the inhibition of the positive AOX1 transcription factors during glucose repression have 
achieved success through constitutively expressing MXR1 and TRM1 under the GAP promoter (Takagi 
et al, 2012).  Strains overexpressing both MXR1 and TRM1 can partially induce AOX1 in the presence 
of non-limiting quantities of glucose.  Since Mxr1p is distributed evenly throughout the cell interior 
during glucose repression, increasing its production most likely provides more similar levels of nuclear 
Mxr1p present during methanol induction to competitively bind PAOX1.  Increasing the expression of 
TRM1 constitutively also partially uncouples its carbon source-dependant regulation as Trm1p 
upregulates its own transcription, most likely as a mechanism to activate AOX1 expression – but only 
during methanol induction (Wang et al, 2016).  Currently the strategy of constitutively expressing 
AOX1 positive transcription factors to reduce glucose repression has not been tested on MIT1, though 
it arguably bears more significance to MIT1 than it does for either MXR1 or TRM1.  The regulation of 
Mit1 differs from Mxr1p as it is localised to the nucleus during all modes of CCR and, unlike Trm1p, is 
also capable of binding PAOX1 in glucose-grown cells (Wang et al, 2016).  Since only its expression is 
affected during glucose repression, it could be concluded that Mit1 regulation occurs purely at the 
transcriptional level.  Therefore constitutively expressing MIT1 should result in fully uncoupling its 
activity from glucose repression, rather than simply compensating for its inhibition.  In methanol-
grown cells Trm1p also actively upregulates MIT1 transcription (Wang et al, 2016), so constitutively 
expressing MIT1 would also have the benefit of emulating a Trm1p function during methanol 
induction.  To investigate the effect of constitutively expressing MIT1 on glucose repression of P AOX1, 




6.4.1.1  Constitutive MIT1 expression – pPhGmit1 
 
To generate a strain constitutively expressing MIT1 with compatibility to pAVECRS to test for glucose 
repression alleviation, and pPICZ/pAVE522 expression vectors, a MIT1 expression vector integrating 
outside of the AOX1 locus and utilising selectable markers other than zeor and G418r was required.  
As such the vector backbone created for pPCas9, integrating into the rDNA locus and using 
hygromycin resistance as a selectable marker, was used to design the MIT1 expression vector – 
named pPhGmit1 (Figure 50). 
 
  




6.4.1.2  Constitutive MIT1 and MXR1 expression – pPhGmm1 
 
The deletion of the gene encoding Mxr1p impairs AOX1 expression and cannot be rescued through 
overexpressing MIT1, suggesting that both transcription factors induce PAOX1 independently, and that 
the uncoupling of both Mit1 and Mxr1p from glucose inhibition will be necessary to alleviate the 
repression of PAOX1 (Wang et al, 2016).  Since the mechanism by which Mxr1p changes its subcellular 
localisation in response to glucose is unknown, the overexpression of MXR1 under PGAP was opted for 
as a strategy to overcome low nuclear concentrations of Mxr1p during glucose repression.  However 
the limited number of remaining available expression vectors and selectable markers necessitates 
expressing both MXR1 and MIT1 in a single, polycistronic vector as opposed to two separate vectors.  
The inclusion of both of the commonly used strong, constitutive promoters for P. pastoris – PGAP and 
PTEF currently in pPhGmit1 presents a second design constraint as repeating either promoter in the 
vector to express MXR1 would introduce closely located homologous sequences, which could 
compromise the vector through loop-out recombination once integrated into the host genome.  As a 
solution the viral T2A sequence was implemented in the design of a polycistronic vector for the co-
expression of both MIT1 and the sequence encoding the functional region of Mxr1p (Figure 51).  Viral 
2A sequences were discovered originally in picornavirus polyproteins (Ryan, King and Thomas, 1991) 
as short, ~20aa peptides that cause the host ribosome to skip the synthesis of a bond at their C-
termini during translation and resume for any sequence immediately downstream, resulting in the 
production of multiple, discrete peptides from a single mRNA transcript (Radcliffe and Mitrophanous, 
2004).  2A sequences have been established as tools for polycistronic vectors for over a decade 
(Szymczak et al, 2004) and those specifically tested in P. pastoris include the T2A peptide from the 
Thosea asigna virus, which was used to engineer a biosynthetic pathway comprising of  9 genes within 
a single expression cassette (Geier et al, 2015).  The T2A sequence was therefore selected to be 
cloned immediately downstream of MIT1, followed by the 5’ 1200bp of MXR1, encoding a minimal 





6.4.1.3  Disruption of Mxr1p regulation through tagging with a C-terminal NLS 
 
An alternative strategy to achieve true uncoupling of the function of Mxr1p from glucose repression, 
through attempting to disrupt the relocalisation of Mxr1p with a C-terminal nuclear localisation signal 
(NLS) was devised.  NLS’s, specifically those classified as “classic” nuclear import pathway, typically 
consist of one (monopartite) or two (bipartite) short sequences of positively charged amino acids on 
the protein surface (Dingwall and Laskey, 1991).  Classic NLS’s (cNLS) direct the transport of tagged 
proteins through the nuclear membrane by binding to karyopherin proteins that facilitate their 
import through nuclear pore complexes (Mafori et al, 2011).  Analysis of the amino acid sequence of 
Mxr1p with the cNLS prediction software – cNLS Mapper (Kosugi et al, 2009) was unable to identify 
Figure 51: Vector map of pPhGmm1 for the simultaneous, strong constitutive expression of both MIT1 and a 
truncated, functional form of MXR1. 
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any putative partite or bipartite NLS’s, suggesting that its nuclear import in the absence of glucose is 
potentially mediated by an unrelated pathway.  The addition of a cNLS could provide Mxr1p with an 
alternative, unregulated route into the nucleus, thus increasing nuclear levels of Mxr1p during 
glucose repression.  The SV40 NLS from the Simian vacuolating virus (Kalderon et al, 1984) was 
selected to tag Mxr1p as it has previously been demonstrated to effectively direct the nuclear 
localisastion of proteins tagged at the C-terminus in P. pastoris (Weninger, Glieder and Vogl, 2015).  
The truncated form consisting of the N-terminal 400aa of Mxr1p (Mxr1t) was preferentially chosen to 
be expressed with a C-terminal SV40 NLS, with the aim of creating a minimal transcription factor for 
PAOX1, with fewer potential regulatory regions that could be bound by antagonistic factors to inhibit its 
transport or function.  To complement strains constitutively expressing MIT1, and to immediately test 
for glucose repression, pAVECRS was redesigned to also contain an expression cassette for Mxr1t-







6.4.1.4  Cloning 
 
pPCas9, assembled as described in section 6.3.2.1, was restricted with MssI to excise CAS9-SV40 to 
produce the vector backbone for pPhGmit1 and pPhGmm1.  In the case of pPhGmit1, MIT1 was 
amplified from NRRL 11430 genomic DNA with the primers 99-GibGapmit1-F and 100-Gibmit1AOX-R, 
and inserted into Mss1-restricted pPCas9 by Gibson assembly.  For pPhGmm1 MIT1 was instead 
amplified with 99-GibGapmit1-F and 107-Gibmit1T2A to add a 3’ Gibson end complementary to the 
downstream T2A, and MXR1T was amplified from NRRL 11430 cDNA with 109-GibT2Amxr1t-F and 
110-Gibmxr1tAOX1-R (Figure 53). 
Figure 52: Vector map for pAVECRS-mxr1t-sv40, controlling the expression of both sh ble under PAOX1, and a 





Gibson assembly of MIT1, MXR1T and 108-GibT2A, a synthesised 100bp oligonucleotide encoding the 
T2A sequence with Gibson ends for both MIT1 and MXR1T, was conducted to insert the full MIT1-
T2A-MXR1T sequence into MssI-restricted pPCas9.  pPhGmit1 and pPhGmm1 were individually 
transformed into E.coli BioBlue and selected on 100μg/ml hygromycin b.  The correct assembly of 
both vectors was confirmed by sequencing plasmids isolated from selected positive transformants 
with 111-5’GAP and 13-3'AOX1. 
To insert an MXR1T-SV40 expression cassette into pAVECRS, the vector was linearised with PciI to 
expose an independent site between the CYC1 transcription terminator and the bacterial origin of 
replication.  A fragment consisting of the region -755 - +1200 to the MXR1 gene to contain MXR1T, its 
native promoter and compatible Gibson ends for insertion into pAVECRS was PCR amplified with 71-
Gibmxr1p-F and 72-Gibmxr1sv40-R.  72-Gibmxr1sv40-R also adds the SV40 sequence and a stop 
codon immediately 3’ of MXR1T in frame.  As a transcription terminator for the new cassette the 
ADH1 TT was PCR amplified from pG1-689-adht with the primers 73-Gibadh1tt-F and 74-Gibadh1tt-R.  
Both fragments were inserted simultaneously into the linearised pAVECRS backbone, transformed 
into E. coli BioBlue and selected on 30μg/ml kanamycin.  The insertion of MXR1T was verified by a 
single restriction digest of plasmids isolated from selected positive transformants with LguI, which 
Figure 53: Generation of parts for the assembly of pPhGmm1.  Lane 1 - 1.0kb DNA marker, 2 – PCR amplicon of 
the ~2.7kb MIT1 gene with Gibson ends 3 -  PCR amplicon the ~1.2kb MXR1T with Gibson ends, 4 – Restriction 
digest of pPCas9 with MSSI removing CAS9-SV40. 
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cuts specifically within MXR1T (Figure 54).  The correct configuration of the entire MXR1T-SV40 
expression cassette was also confirmed by sequencing plasmids tested as positive for containing 




6.4.2 Constitutive expression of MIT1 abolishes its transcriptional repression in glucose-
grown cells 
 
pPhGmit1 and pPhGmm1 were linearised within the rDNA locus with SpeI and cloned into P. pastoris 
NRRL 11430 by electroporation to generate the strains: NGmit1 and NGmm1, respectively.  To 
prevent the introduction of differences in gene dosage of transcription factors between strains as 
another variable, both NGmit1 and NGmm1 were verified to contain a single copy of the transformed 
vectors by qPCR of the genomic DNA of a selection of positive transformants with the primers 114-
qhygb2-F and 115-qhygb2-R, which anneal to the hph selectable marker. 
Firstly the GAP-driven expression of MIT1 was tested to find if it provides similar quantities of MIT1 
mRNA transcript to the methanol-induced state even in glucose-grown cells.  5ml of liquid minimal 
Figure 54: Diagnostic restriction digest of pAVECRS-mxr1t-sv40 with LguI.  Lane 1 - 1.0kb DNA marker, 2-6 – 
Single restriction digest of plasmids from positive transformants with LguI.  A single band ~6.0kb in size indicates 
the assembly of full  pAVECRS-mxr1t-sv40. 
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media containing 1% (w/v) glucose and 0.5% (v/v) methanol, having previously been demonstrated to 
cause repression of AOX1-based expression, was inoculated with colonies of either NRRL 11430 or 
NGmit1 to a starting OD600 of 0.1.  Growth was maintained for ~16 hours to allow cells to reach 
exponential phase growth and MIT1 expression was analysed by RT-qPCR of RNA isolated from each 
culture with the primers 116-qmit1-F and 117-qmit1-R.  The expression of MIT1 in both strains was 
compared against native MIT1 levels during methanol induction by culturing NRRL 11430 under 
identical conditions in a minimal medium containing 0.5% (v/v) methanol, with subsequent RT-qPCR 




As expected the expression of MIT1 in NRRL 11430 grown in media containing 1% (w/v) glucose was 
low, with a fold change of 0.02 relative to the expression of beta-actin, implying that its transcription 
was repressed in conditions eliciting glucose repression as has been previously reported (Prielhofer et 
al, 2015; Wang et al, 2016).  Also consistent with previous reports on its expression profile was that 
Figure 55: Fold change in expression of MIT1 relative to ACT1 of NGmit1 and NRRL 11430 following ~16 hours of 
growth in 1% (w/v) glucose and 0.5% (v/v) methanol, as well as methanol induced NRRL 11430 grown in 0.5% 
(v/v) methanol as a sole carbon source.  Error bars represent the standard error of 3 biological replicates . 
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upregulation in MIT1 transcription was also observed during methanol induction, with NRRL 11430 
grown in 0.5% (v/v) methanol expressing MIT1 at a ~45 fold higher level than cells grown in 1% (w/v) 
glucose and 0.5% (v/v) methanol.  The substantial increase in MIT1 transcription found in published 
results initially raised concerns that GAP-based expression would be insufficient to emulate methanol 
induced levels of MIT1 in glucose-grown cells.  However, following 16 hours of growth in 1% (w/v) 
glucose and 0.5% (v/v) methanol, MIT1 was expressed over 7.5 fold higher on average in NGmit1 
compared to native, methanol induced MIT1 levels following a similar growth period.  The results 
indicate that expression of a single copy of MIT1 by PGAP is not only sufficient to completely abolish its 
transcriptional repression during growth on mixed feeds of glucose and methanol, but also results in 
its overexpression.  Nevertheless glucose repression experiments were continued with NGmit1 and 
NGmm1 with the caveat that tuning the strength of MIT1 recombinant expression using a weaker 
promoter, to more closely resemble methanol induced levels, may have to be taken into future 
consideration if overexpression is found to be detrimental towards cell viability or productivity. 
 
6.4.3 Glucose repression screening of NGmit1, NGmm1 and NGmit1 + Mxr1t-sv40 
 
To test for the alleviation of glucose repression in strains constitutively expressing MIT1 and MXR1T, 
NGmit1 and NGmm1 were cloned with pAVECRS, screened for copy number by qPCR with 93-
qshble2-F and 94-qshble2-R and isolated as single copy integrants for the sh ble gene.  To also test the 
alternate strategy of complementing the MIT1 over-expressing strain with an NLS-tagged variant of 
Mxr1p, NGmit1 was also cloned with the modified pAVECRS-mxr1t-sv40 and screened to find a single 
copy integrant.  The 3 experimental strains, each now containing a single copy of sh ble regulated by 
PAOX1, were screened for their sensitivity to zeocin on minimal gradient agar plates containing either 
2% (w/v) glucose (Figure 56), 0.5% (v/v) methanol/ 3% (w/v) sorbitol (Figure 57) or 1% (w/v) glucose/ 







Figure 56: Sensitivity of the 3 experimental strains: NGmit1 (MIT1), NGmm1 (MIT1, MXR1T) and NGmit1 + 
mxr1t-sv40 (MIT1, MXR1T-SV40) – containing the pAVECRS screening vector to zeocin at concentrations up to 
1000μg/ml on 2% (w/v) glucose.  NRRL 11430 (WT) and NRRL 11430 +pAVECRS were simultaneously tested as 
negative control/ reference strains. 
Figure 57: Sensitivity of the 3 experimental strains: NGmit1 (MIT1), NGmm1 (MIT1, MXR1T) and NGmit1 + 
mxr1t-sv40 (MIT1, MXR1T-SV40) – containing the pAVECRS screening vector to zeocin at concentrations up to 
1000μg/ml on 0.5% (V/v) methanol and 3% (w/v) sorbitol.  NRRL 11430 (WT) and NRRL 11430 +pAVECRS were 





Surprisingly NGmit1 showed little to no growth in each of the tested media types, even within the 
control region on plates containing no zeocin.  Some growth was observed across the zeocin gradient 
in inducing conditions, suggesting that AOX1 expression was still occurring.  However NGmit1 was 
capable of forming regular colonies on standard YPD agar and grow in liquid media so the 
overexpression of MIT1 itself was not assumed to be lethal.  It was noted that NGmit1 grew to a 
lower OD600 in all of the starter cultures for the glucose repression screens, suggesting that, though 
viable, NGmit1 appeared to suffer impaired growth in minimal media.  Since the glucose repression 
screen associates PAOX1-driven expression not solely by overall protein production but also cell growth 
in response to excessive quantities of antibiotic it could be possible that, despite expressing sh ble, 
the low growth rate of NGmit1 coupled with the cellular stress incurred by high zeocin levels still 
resulted in a loss of viability.  The antibiotic within gradient plates also begins to diffuse laterally over 
extended periods of time, which could present a further disadvantage to slow growing strains.  If the 
time required for NGmit1 to establish colonies on minimal agar exceeds the period in which the 
zeocin gradient begins to normalise it could provide an explanation as to why the strain was unable to 
grow even at lower concentrations.  It was therefore concluded that the glucose repression screen in 
Figure 58: Sensitivity of the 3 experimental strains: NGmit1 (MIT1), NGmm1 (MIT1, MXR1T) and NGmit1 + 
mxr1t-sv40 (MIT1, MXR1T-SV40) – containing the pAVECRS screening vector to zeocin at concentrations up to 
1000μg/ml on 0.5% (V/v) methanol and 1% (w/v) glucose.  NRRL 11430 (WT) and NRRL 11430 +pAVECRS were 
simultaneously tested as negative control/ reference strains. 
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its current form is not able to accurately determine the transcriptional activation of P AOX1 in NGmit1, 
or for any slow growing recombinant strains for that matter. 
Despite also overexpressing MIT1, NGmm1 exhibited normal growth and colony formation in regions 
containing no zeocin.  Very minimal derepression of PAOX1 could also be observed in NGmm1 growing 
on 0.5% (v/v) methanol/ 1% (w/v) glucose; forming 2 colonies on the lowest zeocin concentration 
region tested.  sh ble expression in NGmm1 was significantly higher when grown in 2% (w/v) glucose, 
indicating that “leaky” expression, in which PAOX1 is partially induced even in the absence of methanol, 
occurs when MIT1 or MXR1T are overexpressed.  The strength of PGAP is increased when cells are 
grown on glucose (Waterham et al, 1997), and could be the reason why sh ble expression was much 
higher for NGmm1 when grown in the standard concentration for yeast culture of 2% (w/v) glucose as 
opposed to the glucose/ methanol mixed feed, which only contained 1% (w/v) glucose.  However this 
would be based on the assumption that intracellular levels of glucose vary as the concentration of 
extracellular glucose is increased past 1% (w/v). 
Of each of the three novel strains tested NGmit1 containing MXR1T-SV40 performed the best, 
exhibiting the highest resistance to zeocin when grown in 0.5% (v/v) methanol/ 1% (w/v) glucose and 
similar, if not less, leaky expression to NGmm1 when grown on glucose without methanol.  The 
increase in colony frequency when grown in methanol/ glucose over solely glucose indicates that 
both derepression and partial methanol induction of PAOX1 can be effected by NGmit1 + MXR1T-SV40 
in the presence of 1% (w/v) glucose.  The results suggest that, rather than being able to freely bind 
and activate AOX1 transcription simply when present in the nucleus, either one or both transcription 
factors have individual activation states determined by the presence of methanol in the cell. 
To further quantify, and establish in the case of NGmit1, the degree of glucose repression alleviation 
in each strain, samples of each culture in 0.5% (v/v) methanol/ 1% (w/v) glucose were harvested 
immediately prior to plating onto zeocin gradients for RNA purification.  RT-qPCR for sh ble of RNA 
from each sample, in addition to RNA from NRRL 11430 + pAVECRS grown in 0.5% (v/v) methanol/ 3% 
(w/v) sorbitol as a reference for full PAOX1 activation, was conducted with the primers: 93-qshble2-F 






The data from the RT-qPCR confirms a number of observations made during the initial glucose 
repression screen, namely that each of the novel strains were repressed to a lesser extent than the 
native strain but that full derepression of PAOX1 did not occur when cells were grown in minimal 
methanol medium supplemented with 1% (w/v) glucose.  Despite growing poorly on zeocin gradient 
plates during the initial screen NGmit1 achieved the highest mean transcription of sh ble under 
glucose repressing conditions, followed by NGmit1 expressing MXR1T-SV40, although a Games-
Howell post hoc test comparing the two found no statistically significant difference between the 
overall expression levels.  NGmm1 was also confirmed to exhibit the weakest derepression of PAOX1 in 
the glucose/ methanol mixed medium.  Considering that it should be expressing equal quantities of 
MIT1 to both NGmit1 and NGmit1 + mxr1t-sv40, and that increased derepression occurs at higher 
glucose concentrations, it was concluded that NGmm1 is inefficiently synthesising Mit1 and Mxr1t, 
Figure 59: Fold change in expression of sh ble expression between NRRL 11430 (WT), NGmit1 (MIT1), NGmm1 
(MIT1, MXR1T) and NGmit1 + mxr1t-sv40 (MIT1, MXR1T-SV40) – containing pAVECRS following ~16 hours of 
growth in 0.5% (v/v) methanol, 1% (w/v) glucose, prior to screening for  catabolite repression.  sh ble expression 
from NRRL 11430 + pAVECRS grown in 0.5% (v/v) methanol, 3% (w/v) sorbitol was also tested as a positive 
control for full  PAOX1 activation within the set conditions.  Expression values are calculated as a fold change in 
relation to the expression of ACT1.  Error bars represent the standard error of 3 biological replicates.  The 
results of an ANOVA test for the homogeneity of mean expression between the sample sets specified are 
displayed - ns: p>0.05, *: p<0.05, **: p<0.01, ***: p<0.001 
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thus requiring stronger promoter activities to match the derepression observed in the other strains.  
This could have been brought about by inefficient ribosome skipping at the T2A sequence during 
translation, resulting in a portion of translated Mit1 and Mxr1t forming a non-functional hybrid rather 
than two discrete proteins.  Inefficient ribosome skipping has previously been reported for the use of 
T2A sequences in P. pastoris, though the severity of the effect and the ensuing ratio of protein fusions 
to mature protein depend on the sequences of the respective genes as well as their order within the 
polycistronic cassette (Weninger, Glieder and Vogl, 2015). 
 
6.4.4 Production of synthetic human lysozyme T70A by NGmit1 and NGmm1 in mixed 
glucose and methanol media 
 
To determine how the results observed in the glucose repression screen translate to the secreted 
production of recombinant proteins in glucose-supplemented expression media, microexpression 
trials were designed for NGmit1 and NGmm1.  HuL T70A was selected as a marker to test for 
productivity due to the rapid screening methods available to assay its activity and of the 2 main 
proteins tested within this project, the other being glucose oxidase, the secretion of HuL T70A would 
not compromise a glucose-based medium.  Previous expression studies (5.4.3) also showed that the 
expression of a single copy of HUL T70A does not induce the excessive levels of ER stress found in 
previous studies.  As both strains are immediately compatible with pPICZ vectors pPICZm-T70A was 
linearised within the AOX1 locus to clone into NGmit1 and NGmm1 by electroporation.  Positive 
transformants were selected with 100μg/ml zeocin and screened for single copy integrants by qPCR 
of genomic DNA with 83-qsynHuL3-F/ 84-qsynHuL3-R as previously described.  The resulting strains 
were designated as NGmit1-AαT70A and NGmm1-AαT70A 
As the previous screen showed - concentrations from 1% (w/v) glucose in the growth medium 
continue to significantly repress AOX1-based expression in all strains so newly defined methanol 
expression media, supplemented with glucose to a final concentration of either 0.25% (w/v) or 0.5% 
(w/v), was composed to test the performance of NGmit1-AαT70A and NGmm1-AαT70A.  Expression 
trials for both strains, in addition to native NAαT70A were conducted in 24 well microtiter plates from 
a starting OD600 of 1.0 in BMMY, BMMY + 0.25% (w/v) glucose or BMMY + 0.5% (w/v) glucose over a 
48 hour period.  To maintain glucose levels within each of the mixed media types, 20% (w/v) glucose 
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was added in combination with methanol up to the specified final concentration of the original 
medium at 24 hour intervals.  HuL activity was assayed in culture supernatants to quantify the 
volumetric and specific productivities of HuL T70A for each strain within the range of glucose 






Figure 60: Comparison of the volumetric productivity (A) and the specific productivity (B)  of secreted HuL T70A 
by NAαT70A (native), NGmit1-AαT70A (MIT1) and NGmm1-AαT70A (MIT1, MXR1T) in BMMY (0.5% (v/v) 
methanol supplemented with increasing concentrations of glucose (w/v).  Error bars represent the standard 
error of 4 biological replicates.  The results of ANOVA tests (black line) between the mean values of each strain 





The impaired growth of NGmit1 observed in minimal media was not evident in any of the BMMY-
based media tested within the experiment, as it achieved similar final cell densities to the native 
strain under each condition; suggesting that no loss in viability occurs during growth in rich media.  In 
standard BMMY containing no glucose NGmit1-AαT70A slightly outperformed NAαT70A and 
produced ~20% more active HuL T70A on average.  However an ANOVA between NAαT70A, NGmit1-
AαT70A and NGmm1-AαT70A could not determine a statistically significant difference between the 
mean volumetric or specific productivities of each, most likely due to the wider distribution of HuL 
activities recorded between the biological replicates specifically for expression on 0.5% (v/v) 
methanol.  The addition of glucose at a final concentration of 0.25% (w/v) caused a concurrent 
increase in the overall productivity for all three strains, signifying that the utilisation of glucose was 
sufficient to stimulate higher protein production through increasing cellular growth.  No difference in 
productivity could be observed between any of the tested strains, suggesting that 0.25% (w/v) 
glucose is not fully repressive or doesn’t prolong repression of AOX1 expression, as has been 
previously demonstrated (Paulová et al, 2012).  An alternative possibility, and an initial concern, was 
that the growth of cells in glucose-fed cultures cannot be regulated effectively in micro expression 
trials.  More rapidly growing cultures in methanol/glucose mixed media would be able to deplete the 
available glucose to limiting concentrations earlier, reducing the period in which CCR is maintained 
during the expression.  However glucose repression became evident when the final glucose 
concentration was increased to 0.5% (w/v), causing a decrease in the volumetric productivity for 
NAαT70A and NGmm1-AαT70A from expression in 0.5% (v/v) methanol/ 0.25% (w/v) glucose.  It was 
reasoned that the addition of 0.5% (w/v) glucose at 24 hour intervals was able to create a large 
enough window of AOX1 repression before being consumed to produce a noticeable effect on total 
production of HuL T70A after 48 hours.  However NGmit1-AαT70A remained unaffected and even 
showed a slight increase in its volumetric productivity.  Again, NGmit1-AαT70A produced ~20% more 
HuL-T70A than the native strain per ml of culture supernatant, which was found through a post hoc 
analysis from a one way ANOVA to be statistically significant within the 95% confidence level.  The 
difference was found to be more pronounced when examining specific productivity as NGmit1-
AαT70A exhibited over a 25% increase in the titre of HuL T70A, suggesting that an increase in ce llular 
production, rather than improved growth in 0.5% (v/v) methanol/0.5% (w/v) glucose, was the 
underlying cause.  The results indicate that the GAP-based expression of MIT1 alleviates glucose 
repression of PAOX1 at lower concentrations, thereby increasing the threshold for the total glucose 
useable in culture beyond which protein production is negatively affected. 
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In contrast NGmm1-AαT70A displayed negligible differences in productivity from NAαT70A in all the 
media types tested, suggesting that it was experiencing native AOX1 regulation in response to 
methanol and glucose.  This reaffirmed previous assumptions that the translation and synthesis of 




The study began with the design and successful implementation of a screen to measure AOX1 
promoter activity in cells grown on glucose or methanol, based on the PAOX1-driven expression of the 
zeocin resistance marker.  A screen for the activation of methanol utilisation in the presence of 
glucose has been previously developed for methylotrophic yeasts and involves growing cells on a 
medium containing methanol and 2-deoxy-D-glucose; a glucose analogue capable of inducing CCR of 
Mut pathway genes (Stasyk et al, 2004).  2-deoxy-D-glucose cannot be metabolised and so cell 
survival can only be ensured through co-utilisation of the available methanol.  However the screen 
developed within this study directly assays the situational  promoter strength of PAOX1, rather than 
testing for the full activation of the Mut pathway, and is therefore more suited to identifying strains 
carrying out high levels of AOX1-based transgene expression.  The low setup time and the ability to 
test multiple strains simultaneously give the screen a high degree of versatility and in future could be 
applied to larger experiments examining libraries of variants, with examples including directed 
evolution or combinatorial approaches looking to improve the function and optimise the expression 
of the transcriptional activators tested here.  Furthermore, full repression of PAOX1 in strains 
containing pAVECRS was found to result in cell death even at lower concentrations of zeocin.  The 
screen could therefore be adapted into a selection method for the derepression of AOX1 with a low 
occurrence of false positives, and combined with random mutagenesis experiments to identify novel 
mutants with impaired glucose repression of PAOX1. 
In order to undertake a multiplex gene disruption strategy to develop strains with increased 
alleviation of glucose repression over the single knockout mutants previously described in literature 
CRISPR-Cas9 gene editing in P. pastoris was attempted but was ultimately unsuccessful.  However, 
since the conclusion of this study, a CRISPR-Cas9 system with high targeting efficiency has been 
validated in P. pastoris (Weninger et al, 2015B).  The authors tested a combinatorial library consisting 
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of 95 constructs varying in constitutive and inducible promoters, gRNA expression cassette types, 
gRNA scaffold sequences and codon usage biases for the CAS9 sequence (Weninger et al, 2015B).  Of 
the constructs screened only ~6% yielded efficiently targeted CRISPR-Cas9 activity, concluding that P. 
pastoris is not as amenable to CRISPR-Cas9 gene editing as other established species, and that more 
precise optimisation is required to engineer an effective system within the organism.  Interestingly 
the constructs that functioned correctly bear similarities to the strategies used within this study, 
including the expression of human optimised, SV40 tagged CAS9 by PGAP, and the use of the HH and 
HDV ribozymes in conjunction with RNA pol II P. pastoris constitutive promoters for the expression of 
gRNAs.  Where the constructs differ are in the use of the HTB or HTX promoter to drive gRNA 
expression, the use of an alternative scaffold sequence for the gRNA (Jinek et al, 2012) and the 
transient expression of both CAS9 and gRNAs on an episomal, autonomously replicating plasmid.  The 
failure of the CRISPR-Cas9 system in this study can therefore be pinpointed to the poor expression of 
functional gRNAs, either through suboptimal transcription rates through the use of the G1 promoter 
or the transient expression method, or the scaffold sequence for the gRNA failing to form the correct 
secondary structure to dock with Cas9.  The development of proficient CRISPR-Cas9 editing is an 
invaluable addition to the P. pastoris molecular tool kit and its associated publication can inform the 
modification of the parts made within this study to replicate the working system for future 
experiments targeting glucose repression. 
In the absence of a system for enabling simple and rapid multiple gene deletions the study moved 
towards uncoupling transcription enhancers of AOX1 from their inhibition in glucose-grown cells, with 
focus on the methanol induced transcription factor – Mit1.  Expressing MIT1 constitutively under the 
GAP promoter was capable of not only abolishing its transcriptional repression during growth on a 
mixed feed of glucose and methanol but also increasing expression beyond its native level in 
methanol-grown cells.  This sole modification significantly alleviated glucose repression of AOX1-
based expression and enables the use of higher concentrations of glucose with methanol in 
expression media that otherwise begin to be detrimental to methanol-induced protein production in 
the native strain.  The expression of both MIT1 and MXR1T in a polycistronic cassette was intended to 
improve the efficiency of transformation and expression of both genes but instead resulted in less 
derepression in comparison to the sole expression of MIT1, despite the overexpression of MXR1 
having been previously shown to reduce glucose repression (Takagi et al, 2012).  This has made the 
assessment of the effect of co-overexpressing both Mit1 and Mxr1p somewhat difficult.  The 
expected alleviation of glucose repression was restored when expressing MIT1 and MXR1T 
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separately, as observed in the strain NGmit1 + mxr1t-sv40.  Employing polycistronic cassettes using 
2A peptides would still be very beneficial for this type of expression in P. pastoris through scaling 
down the number of expression cassettes or vectors required and so optimisation of the translation 
efficiency of Mit1 and Mxr1t with T2A should be considered.  Potential strategies include switching 
the order of each gene within the expression cassette or the addition of codons encoding a glycine-
serine-glycine spacer at the N-terminus of the T2A peptide, which has been shown to improve 
cleavage efficiency (Szymczak et al, 2004) (Holst et al, 2006). 
Another promising result that warrants further investigation was the co-expression of a gene 
encoding a truncated form of Mxr1p with a C-terminal SV40 NLS, with MIT1.  Whilst exhibiting similar 
levels of PAOX1-driven expression to strains overexpressing only MIT1 when grown in 0.5% (v/v) 
methanol/ 1% (w/v) glucose, NGmit1 + mxr1t-sv40 exhibited standard growth on minimal media 
during glucose repression screening whereas MIT1 overexpressing strains grew poorly.  The results 
highlight a phenotypic difference between the two strains that implies that the expression of MXR1T-
SV40 is providing some effect.  However the basis for the difference in growth on minimal media 
between each strain can only be speculated at.  As each of them have been shown to regulate 
methanol inducible promoters differently, it could be possible that increasing the  expression of only 
one of the master regulators of methanol metabolism results in an unbalanced activation of a subset 
of the Mut pathway that may potentially interfere with other metabolic or biosynthetic pathways 
within the cell.  Whilst this has not been confirmed previously, the overexpression of MXR1 under 
PAOX1 was found to be lethal in methanol-grown cells (Lin-Cereghino et al, 2006). 
Also worthy of note is that, while partial PAOX1 activation in the presence of repressive quantities of 
glucose was exhibited, complete abolishment of glucose repression was not observed for any of the 
newly engineered strains.  This could implicate the involvement of other interacting factors that 
govern the activity of the master regulators of the Mut pathway and suggests that the full picture for 
CCR of PAOX1 is yet to be fully understood, but may be revealed by looking at highly resistant variants.  
In order to shift methanol inducible expression systems in P. pastoris away from the reliance on 
methanol as a growth substrate, while still maintaining the characteristically high strength of PAOX1, 
resistance to repression at final glucose concentrations up to 2% (w/v), the standard used for yeast 
growth, would be needed.  Nevertheless the partial derepression presented in this study provides a 
starting point for optimisation strategies and strain improvement.  Since the major form of regulation 
of Mit1 appears to be transcriptional, tuning its expression by testing a range of different strength 
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constitutive promoters could possibly alleviate glucose repression further.  Evaluating the 
effectiveness of the SV40 NLS in targeting Mxr1t to the nucleus through the generation of fluorescent 
reporter fusion constructs would also be pertinent, especially since the mechanism by which Mxr1p is 
localised in the cytoplasm, and whether nuclear retention is the only condition required to eliminate 
the inhibition of Mxr1p during glucose-growth remains unknown.  The constitutive expression of 
MIT1 and MXR1T confers some resistance in cells cloned with pAVECRS to zeocin under glucose 
repression; a phenotype that can be targeted and sequentially improved through multiple rounds of 
mutation with antibiotic selection.  Strains selected in this fashion would hypothetically accumulate 
mutations disrupting genes involved in glucose repression of PAOX1, increasing the compatibility of 
AOX1-based transgene expression with glucose growth while also providing more insight into the 
factors mediating glucose repression.  Finally the results of the microexpression trials presented in 
this study have aided in defining the range of glucose content that is optimal for protein production in 
MIT1 which can begin to inform successive scale-up experiments.  Testing the performance of NGmit1 
and future strains in which Mxr1p function is uncoupled from glucose regulation in chemostat 
cultures is not only key in assessing their industrial relevance but also enables the precise control of 
growth substrate concentrations and biomass accumulation.  Cultures maintained at steady state 
growth will be unable to deplete available glucose or methanol, causing the inherent fluctuations in 
carbon source concentrations between feeding intervals during rapid growth in batch trials.  The 
initial results for the expression of HuL T70A in NGmit1 shows promise that sustaining constant rates 
of AOX1-based expression by preventing methanol and glucose concentrations dropping to limiting 
levels throughout expression, NGmit1 will further outperform both native P. pastoris at higher 





7. Final discussion and conclusions 
 
7.1 The investigation of clonal variation and current research landscape  
 
This project aimed to take a fundamental approach in identifying and evaluating the contribution of 
key factors that have been flagged as potential sources of variation in productivity within the Pichia 
system.  The artificial environments and processes that P. pastoris is subjected to during 
transformation and transgene expression were first examined, identifying the widespread use of 
zeocin as a selective antibiotic as an initial focus of study.  The increased mutagenic background 
caused by zeocin, even in resistant human cell lines, led to the hypothesis that exposure to zeocin 
during the formative stages of colony growth post-transformation would result in significant 
phenotypic divergence between positive transformants.  However a comprehensive study ex amining 
the secreted production of four different recombinant proteins across two different host strains 
found that the standard application of zeocin in recombinant clone selection and colony growth has 
no effect on clonal variation.  On the contrary the maintenance of a selective pressure, using either 
zeocin resistance or HIS4 complementation during colony growth, resulted in the formation of clonal 
groups with reduced variability in productivity.  The mechanism behind this phenomenon, and the 
variation in its effect depending on the recombinant protein being produced could not be elucidated.  
Analysis of transgene copy numbers in clonal samples selected with zeocin however revealed a 
tighter distribution of copy numbers occurred within clones grown in the presence of zeocin, 
suggesting that zeocin may selectively enrich for specific copy numbers at different concentrations.  
However this pattern was not repeated in clonal populations utilising the alternative selection 
method while still reducing clonal variation and so either contradicts this assumption or supports that 
the phenomenon is unique to zeocin selection.  As a result the conclusions made from the initial 
study were that, whilst shown to be mutagenic, the use of zeocin at the concentrations and exposure 
times used in the selection of P. pastoris transformants does not contribute to clonal variation, and 
that selection in itself actually confers an increased consistency in protein production within clonal 
populations. 
Variation between recombinant clones in factors that have been previously linked to productivity, 
including transgene transcription, HAC1 expression and growth were also explored.  Whilst 
considerable variation was found within the sample of clones tested for each of the aforementione d 
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factors, only changes in the rate and total growth of cells in culture correlated weakly with 
recombinant protein secretion.  The positive relationship between growth and productivity in P. 
pastoris has been covered extensively, having been found in a number of independent studies 
(Schenk et al, 2008; Love et al, 2010; Buchetics et al, 2011; Rebnegger et al. 2014).  More specifically 
productivity has been demonstrated to be cell cycle dependent as, during faster growth and high 
protein secretion, a shift in the distribution of cell cycle phases of cells in culture towards G2 and the 
mitotic stage occurs (Buchetics et al, 2011).  This research has recently been taken further to discover 
that a large proportion of recombinant protein secretion takes place at the bud tip of replicating cells 
during the G2 phase, confirming that productivity in P. pastoris is strictly coupled to active growth 
(Puxbaum, Gasser and Mattanovich, 2016).  Indeed the higher producing subset of clones that were 
tested also displayed a small but significant shift in the distribution of their growth rates, with an 
increase in the median growth rate by a modest 4% over the low secreting clonal group.  Whilst the 
previously mentioned studies varied culture growth through the control of specific growth rate in 
chemostat culture, the findings from this study also suggest that differences in the individual growth 
rates of clones in batch cultures provide a slight predisposition towards recombinant protein 
secretion.  However the weakness in the correlation suggests that growth variation forms only a 
minor facet of the collection of positive traits improving the ability of individual clones to secrete 
recombinant proteins, the rest of which may prove challenging not only to identify but also to enrich 
in clonal populations.  The reduction in the strength of the correlation found in previous studies 
(Rebnegger et al, 2014) suggests that the aspect of cell growth being studied within these 
experiments differs from other publications.  In contrast to chemostat cultures that tightly control 
growth rate by increasing the rate of nutrient supplementation, the variation in growth observed in 
the batch trials of this study reflect the individual propensities of clones for transporting and 
metabolising the limiting substrate in culture.  The results suggest the likelihood that variability in 
metabolism rates for growth substrates arises within generations grown from homogenous cell lines, 
and that this may contribute to individual performance of clones but that, ultimately, this variation 
can be controlled well in scale-up processes that maintain optimal specific growth rates for protein 
production.  Nevertheless the link between growth rate and productivity has introduced another 
target for bioprocess development in the Pichia system in previous studies (Buchetics et al, 2011) and 




At present the genetic instability in the integration and maintenance of multi-copy constructs within 
genomic loci remains the most influential, known factor affecting variation between P. pastoris 
clones.  In fact research aimed at reducing the occurrence of additional recombination events 
between heterologous DNA sequences after transformation has made great strides in improving the 
consistency of transformants as well as their performance in longer fermentations.  Notable examples 
include the discovery of the 5S rRNA gene locus, also used within this study (rDNA), as a better 
integration site for expression vectors to support their retention in the host genome (Steinborn et al, 
2006; Marx et al, 2009).  The rDNA locus is repeated 16 times across all chromosomes in the P. 
pastoris genome (De Schutter et al, 2009), presenting independent, spatially distant sites for vector 
integration such that the resulting multicopy strains are not necessarily generated by the head to tail 
multimerisation of vector sequence within a single locus; an orientation that is more prone to genetic 
instability.  More recently a large-scale analysis of AOX1 vector integration in P. pastoris screened 845 
transformants producing GFP for recombinant productivity, copy number and integrated DNA 
sequence revealed several subgroups of copy number variants, transformants integrating vector 
copies in a head to head or tail to tail orientation as opposed to the expected head to tail 
configuration, Mut phenotype variation and false positives that had undergone a second 
recombination event to lose the expression vector – all of which produce a marked effect on 
productivity (Schwarzhans et al, 2016).  By simply replacing the AOX1 transcription terminator within 
the GFP expression cassette with the S. cerevisiae CYC1 terminator, leaving the AOX1 promoter as the 
sole region with any homology to the P. pastoris genome, the instances of false positives were 
significantly reduced to 0 out of 120 tested transformants (Schwarzhans et al, 2016).  The results 
highlight the unsettling reality that mainstream transformation methods for P. pastoris produce a 
massive heterogeneity in the recombinant genotype between transformed cells, and the continued 
importance of rigorous screening of clones as part of the upstream process.  Obvious targets that 
arise for the reduction of clonal variation by improving genetic stability would be the non-
homologous end joining (NHEJ) and the homologous recombination (HR) pathways, both of which 
mediate the processes causing non-specific vector integration and copy number loss from loop-out 
recombination (Zhu et al, 2009B; Aw and Polizzi, 2013).  As such the inactivation of NHEJ in P. pastoris 
has already been addressed in a study which deleted the KU70 homologue, responsible in part for the 
initiation of the pathway, and found that the targeting of integrating vectors into the intended 
genomic locations occurred at a much higher efficiency whilst transgene copy numbers up to 7 could 
be maintained in strains over a 480 hour culture period.  The lack of published results and also 
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previous work on the subject (Aw, 2012) suggests that a similar approach is not possible for limiting 
homologous recombination frequencies in P. pastoris, and that the complete disruption of the HR 
machinery is lethal.  This is not entirely unexpected as homologous recombination is the dominant 
repair pathway for DNA damage in yeast (Sonoda et al, 2006) and its complete loss in and of itself is 
also undesirable as it forms the key mechanism for the integration and amplification of expression 
vectors in the genome (Higgins and Cregg, 1998; Sunga, Tolstorukov, and Cregg, 2008).  However the 
recent development of next generation synthetic biology tools for P. pastoris, including inducible 
promoter libraries (Hartner et al, 2008) and a CRISPR-Cas9 system (Weninger et al, 2016), could be 
set to modernise pathway regulation in this system which, up until recently, has been limited to the 
binary decision of either knocking out or overexpressing target genes.  We envisage that synthetic 
regulatory circuits, enabled by technologies such as CRISPR or TALENs already being used in yeast 
(Blount, Weenink and Ellis, 2012; Jusiak et al, 2016), will eventually be applied to fine tune gene 
expression in P. pastoris and overlay on/off switches to cellular processes affecting clonal variation or 
even productivity in future strain improvement.  Since homologous recombination and end joining 
can be both beneficial or disruptive depending on the stage of the Pichia system process, these would 
make prime targets, and could be used to engineer platform strains that maintain or upregulate HR 
during transformation and vector amplification while transcriptionally limiting HR machinery 
expression during recombinant protein production to improve genetic stability. 
 
7.2 Strain development for the increased production of secreted 
recombinant proteins 
 
Whilst the secretion of recombinant proteins into extracellular media is an attractive option in the 
Pichia system to simplify downstream processing, redirecting large fluxes of proteins through the 
secretory pathway of P. pastoris introduces a number of process bottlenecks and product loss points 
that negatively affect final titres.  The engineering of various aspects of the secretory pathway to 
adapt its capacity for larger volumes of protein has therefore formed a major focal point of P. pastoris 
research over the past decade and is ongoing with a number of currently active research projects 
within the field (Gasser, 2016; Puxbaum et al, 2016; Zahrl et al, 2016).  Addressing the problems 
surrounding the trafficking of recombinant proteins through the ER formed one of the initial 
objectives within this project, since it is one of the most researched causes of secretion bottlenecks in 
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P. pastoris yet remains to be fully resolved.  That being said, a strategy that has achieved past success 
in increasing recombinant protein secretion has entailed constitutively expressing ER resident UPR 
effectors, helping in protein folding and processing, that are normally only upregulated during ER 
stress (Gasser et al, 2005; Inan et al, 2006; Gasser et al, 2007B).  In this vein a homologue belonging 
to the Opi1 transcription factor family was tested as a potential candidate to enhance the ER’s 
capacity, as its deletion in S. cerevisiae uncoupled UPR-mediated ER expansion from the ER stress 
response and was shown to increase productivity.  However the Δopi1 phenotype was strongly 
concluded to be detrimental to recombinant protein secretion, instead causing increased 
bottlenecking in the secretory pathway and higher levels of UPR activity.  The results indicate that the 
Opi1p in P. pastoris may regulate a different subset of genes governing cellular processes interacting 
with the secretory pathway to help maintain its native function.  Alternatively it could be possible 
that the deletion of OPI1 causes a remodeling of the ER but that, unlike S. cerevisiae, its new 
physiology grants it a reduced capacity for protein folding and processing, thereby worse adapting it 
to the high volumes of recombinant protein entering the secretory system during AOX1-driven 
expression.  ).  One issue to note however is that all specific productivities and cellular growth values 
calculated in each study within this project used the optical density of cultures at 600nm (OD600) as a 
measure for cell number.  Whilst it provides a valid measure of cell density, changes in cell size that 
often occur under different growth conditions or as a direct result of the removal of certain genes will 
affect the OD600 of a cell culture irrespective of the actual cell count.  Whilst this risk was minimised 
throughout the studies investigating clonal variation by maintaining consistent growth conditions 
between control and test samples, changes in the cell size of Δopi1 mutants were not tested for and 
could therefore potentially have influenced the results if found to differ from the native strain.  
However the relationships between the specific productivities for the strains reported closely 
resembled the differences between their respective volumetric productivities, which provide a 
measure of total protein titre and do not account for cell density, supporting the validity of the 
observations presented in this study. 
Throughout the course of this project it became increasingly clear that a major process flaw in the 
Pichia system was the use of expression media containing methanol as a sole carbon source for 
growth and the induction of transgene expression.  While P. pastoris is classed as methylotrophic, 
methanol is far from the organism’s most preferred carbon source and its metabolism via the Mut 
pathway creates a detrimental physiological background with knock-on effects on growth, viability, 
cellular stress and ultimately, productivity (Inan and Meagher, 2001; Vanz et al, 2012; Edwards-Jones 
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et al, 2015).  This discovery has spawned a range of improved fermentation strategies centred around 
growing cells in mixed feeds of methanol and other carbon sources during expression (Zhang et al, 
2003; Solà et al, 2007; Paulová et al, 2012; Niu et al, 2013).  Even within this study a significant 
enhancement in protein production during batch expressions could be observed when methanol 
expression media was supplemented with either glucose or sorbitol.  However considerable 
limitations are placed on the maximum efficacy of mixed feed strategies as growth on primary carbon 
sources results in the transcriptional repression of methanol-inducible promoters, including the 
popular AOX1 promoter (Inan and Meagher, 2001).  Based on a collection of recent studies mapping 
the regulatory network of PAOX1, this study switched focus to alleviating glucose-induced repression of 
AOX1 expression to generate new platform strains capable of growing on less limiting concentrations 
of glucose without compromising on protein production.  The constitutive expression of a 
transcriptionally regulated global activator of Mut pathway genes – Mit1, resulted in a >20% increase 
in the specific productivity of cells grown in a mix of 0.5% (v/v) methanol and 0.5% (w/v) glucose, 
while the modifications made to a second global regulator – Mxr1p, show potential in reducing 
glucose repression further.  A potential challenge arising from constitutively expressing its 
transcriptional enhancers is that the discrete repressed/induced states conferring the switch-like 
nature of PAOX1 could be compromised, as an increase in leaky expression on media lacking methanol 
was observed.  However, the independent pathways in which PAOX1 is regulated by different carbon 
sources works to the benefit of this study and it is hypothesised that tight repression of PAOX1 in 
glucose repression resistant strains could be restored through redesigning the pre -culture medium to 
contain other repressive carbon sources.  Examples include ethanol, which represses P AOX1 through 
inhibiting Mxr1p binding (Parua et al, 2012), and glycerol, which has been demonstrated to cause 
repression mediated by Mit1 (Wang et al, 2016). 
Concepts for reducing glucose repression, or repression from other carbon sources, are unfortunately 
limited to the current understanding of the full regulatory network of PAOX1, which is still incomplete.  
Transcriptomic profiles of P. pastoris grown in methanol have contributed to communal knowledge 
(Prielhofer et al, 2015) but many of the interactions that control the inhibition, activation and 
promoter binding of the global regulators of methanol inducible genes at the post-translational level 
remain unknown.  Whilst the intracellular detection and transport of glucose plays a part in triggering 
glucose repression (Zhang et al, 2010; Polupanov, Nazarko, and Sibirny, 2012), the signalling pathways 
connecting carbon source sensing to transcription factor activation/ inhibition is yet to be elucidated.  
Little to no information is available on the 3D structures, activation domains, phosphorylated sites or 
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the existence of binding partners for the three main activators of PAOX1: Mxr1p, Trm1p or Mit1.  
Research into each of these areas would not only give a better insight into how one of the most 
favoured promoters for recombinant expression in the Pichia system is modulated, but would also 




7.3 Final conclusions 
 
Investigation into clonal variation within this project has observed that through seemingly stochastic 
events, the cause of which is independent to significant copy number variation, clones with an 
extreme deviation in productivity from the majority of the population arise at relatively high 
frequencies.  These findings concur with previous research conducted by this group on the subject 
(Aw, 2012) and contribute by providing evidence to confirm that the use of zeocin as a selective agent 
is not a causative factor in clonal variation.  Considerable variability in other native factors was also 
observed within clonal populations in this study but only differences in growth rate displayed any 
correlation to productivity, suggesting that differences in substrate metabolism between individual 
clones provide a small contributing factor amongst other traits to the variation in protein production 
between clones.  The abnormally large differences between the highest and lowest producers found 
within the larger samples tested as part of this project show that caution must be taken when 
examining changes in the specific productivity of strains and that variability between biological 
replicates within samples needs to be critically assessed before making valid conclusions.  Whilst it is 
difficult to recommend a representative sample size for a clonal population, practices such as 
controlling for transgene copy number, using more replicates, random selection as opposed to 
screening for the highest producers, anomaly detection and appropriate statistical testing are all vital 
in minimising the bias from clonal variation when evaluating strain improvement strategies for P. 
pastoris. 
The transformation of any biological organism into a successful expression system requires the 
development of processes that grant high production consistencies, for which clonal variation 
presents an issue, but also the engineering of cells to prioritise the production of a foreign product 
over their own native functions.  Considerable progress has been made in the repurposing of the 
secretory system of P. pastoris to export far larger quantities of proteins exceeding its own native 
requirements.  Originally postulated as a method to further improve recombinant protein secretion, 
this project has now eliminated the deletion of the transcription factor OPI1 as a strategy for 
increasing specific productivity.  However the engineering of P. pastoris to reduced glucose 
repression of the AOX1 promoter, presented in this study, can help inform the development of new 
strains that are capable of higher levels of methanol induced expression in mixed carbon source 
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9.1 DNA vectors and oligomers used within this study 




03-AmpR-F CAAACAAACCACCGCTGG 65.7 forward primer - AmpR (including 
promoter and terminator region) 
from pUC18 
04-AmpR-R TTCAAATATGTATCCGCTCATG 61.7 reverse primer - AmpR (including 




















61.6 Gibson forward primer for the GOX 
gene from P. funiculosum to insert 




60.8 Gibson reverse primer for the GOX 
gene from P. funiculosum to insert 




64.5 Forward primer for kanr for Gibson 





60.4 Reverse primer for kanr for Gibson 
assembly into pAmpZ 
12-5'AOX1 GACTGGTTCCAATTGACAAGC 63.8 Forward primer for sequencing of 
vectors containing the AOX1 
promoter 
13-3'AOX1 GCAAATGGCATTCTGACATCC 66.8 Reverse primer for sequencing of 





60.9 Forward primer for HIS4 for Gibson 
assembly into pAmpZ 
 
Table A1: Oligonucleotides used within this study.  Lowercase sequence represents regions without homology 








60.8 Reverse primer for HIS4 for Gibson 
assembly into pAmpZ 
16-Selseqpb-F GGCGGTGTTGACAATTAATC 61 Forward sequencing primer for genes 
within the pPICZαb/pAVE522's 
selective marker cassette 
17-Selseqpb-R TTACATGATATCGACAAAGG 56 Reverse primer for genes within the 






65.6 Forward primer for 5' flanking region 
to OPI1 in P. pastoris to assemble the 





63.3 Gibson reverse primer for 5' flanking 
region to OPI1 in P. pastoris to 




64.2 Gibson forward primer for Tn903kanr 




65.2 Gibson reverse primer for Tn903kanr 







65.1 Gibson forward primer for the 3' 
region flanking OPI1 in P. pastoris to 
assemble OPI1 knockout construct 
23-Opi1kan 3'-
R 
AACGGATATTACTGCGGAGCC 66.3  Reverse primer for the 3' region 
flanking OPI1 in P. pastoris to 






67.7 Gibson forward primer for sh ble for  







67.4 Gibson reverse primer for sh ble for  




64.3 Forward primer annealing to OPI1 to 
test for its presence by PCR 
27-Opi1-R CTATTCTTGCTTTTCCCCCG 64.8 Reverse primer annealing to OPI1 to 





56 Forward primer annealing 50bp 5' to 





56 Reverse primer annealing 92bp 3' to 
OPI1 to amplify part of the OPI1 locus 
30-qACT1-F GCTTTGTTCCACCCATCTGT 56.9 qPCR forward primer for ACT1, 
producing a 163 bp amplicon. 
Efficiency = 91.05% 
230 
 
31-qACT1-R TGCATACGCTCAGCAATACC 56.8 qPCR reverse primer for ACT1, 
producing a 163 bp amplicon. 
Efficiency = 91.05% 
32-qHAC1-F CGACTACATTACTACAGCTCC
ATCA 
64 qPCR forward primer for HAC1, 
producing a 124bp amplicon.  
Efficiency = 89.24% 
33-qHAC1-R TGCTGTAATGTGTAAAGATGA
ATCC 
61 qPCR reverse primer for HAC1, 
producing a 124bp amplicon.  
Efficiency = 89.24% 
34-qKAR2-F TCAAAGACGCTGGTGTCAAG 58 qPCR forward primer for KAR2, 
producing a 151bp amplicon.  
Efficiency = 89.04% 
35-qKAR2-R TATGCGACAGCTTCATCTGG 58 qPCR reverse primer for KAR2, 
producing a 151bp amplicon.  
Efficiency = 89.04% 
36-qPDI-F GCCGTTAAATTCGGTAAGCA 56 qPCR forward primer for PDI, 
producing a 145bp amplicon.  
Efficiency = 89.84% 
37-qPDI-R TCAGCTCGGTCACATCTTTG 58 qPCR reverse primer for PDI, 
producing a 145bp amplicon.  
Efficiency = 89.84% 
40-qGOx2-F CCGCACGAACAATATCAAGG 61.4 qPCR forward primer for GOX, 
producing a 120bp amplicon. 
Efficiency = 91.35% 
41-qGOx2-R TCCATGCCAAAGACCTTCTC 60.2 qPCR reverse primer for GOX, 
producing a 120bp amplicon. 




64.4 Gibson forward primer for hph for 





65.3 Gibson reverse primer for hph for 
Gibson assembly into pPCas9 
50-GibGapfrag-
F 
GAGAGCTTCTTCTACGGCCC 64.6 Forward primer amplifying a 272bp 3' 
fragment of the GAP promoter for 





63.2 Reverse primer amplifying a 272bp 3' 
fragment of the GAP promoter for 




60 Gibson forward primer for CAS9-SV40 
with an MssI site for Gibson assembly 





61 Gibson reverse primer for CAS9-SV40 
with an MssI site for Gibson assembly 





63.3 RT-PCR forward primer to confirm the 
transcription of CAS9 
56-Cas95'1kb-R AAAGTCAAGTCTTGGTGGTGC 63.5 RT-PCR reverse primer to confirm the 
transcription of CAS9 
57-sc-gRNA-F TCTTTGAAAAGATAATGTATG
ATTA 
56 PCR forward primer to amplify gRNA 
with the S. cerevisiae SNR52 
promoter and SUP4 terminator 
58-sc-gRNA-R GGAAGTGAATGGAGACATAA 57.1 PCR reverse primer to amplify gRNA 
with the S. cerevisiae SNR52 
promoter and SUP4 terminator 
59-ribo-gRNA-F TTTTTGTAGAAATGTCTTGGTG
TC 
61.2 PCR forward primer to amplify gRNA 
with the G1 promoter, ribozyme sites 





60.4 PCR reverse primer to amplify gRNA 
with the G1 promoter, ribozyme sites 
and ADH terminator 
61-ade2-F ATGGATTCTCAGGTAATAGGT
ATTC 
58.1 PCR forward primer to amplify the P. 
pastoris ADE2 gene 
62-ade2-R TCAAAGACGATTCTTCAAATA
G 
59.7 PCR reverse primer to amplify the P. 
pastoris ADE2 gene 
63-ade2seq-F GTTGAAGTCCCGGACTATG 54.1 Forward sequencing primer for ADE2 




62.8 Gibson forward primer for the  
assembly of the region -700 - +1200 







62.1 Gibson reverse primer for the  
assembly of the region -700 - +1200 





57.9 Gibson forward primer for the  
assembly of the ADH1 transcription 
terminator downstream of  mxr1t-




57.8 Gibson reverse primer for the  
assembly of the ADH1 transcription 
terminator downstream of  mxr1t-
sv40 in pAVECRS 
75-
mxr1sv40seq-F 
CTGTACAGACGCGTGTACG 56.9 Sequencing forward primer for 
mxr1t-sv40 within pAVECRS 
76-
mxr1sv40seq-R 
AGCGACCTCATGCTATACC 55.5 Sequencing reverse primer for mxr1t-
sv40 within pAVECRS 
83-qsynHuL3-F CGGGTACCGTGGTATCTCTTT 60.2 qPCR forward primer for HUL T70A, 
producing a 97bp amplicon.  
Efficiency = 99.26% 
84-qsynHuL3-R CCTGTCACCAGCGTTGTAGTT 60.2 qPCR reverse primer for HUL T70A, 
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producing a 97bp amplicon.  
Efficiency = 99.26%  
93-qshble2-F AGTTGACCAGTGCCGTTCC  61.1 qPCR forward primer for sh ble, 
producing a 105bp amplicon. 
Efficiency = 93.02% 
94-qshble2-R AGTCGTCCTCCACGAAGTCC 61.6  qPCR reverse primer for sh ble, 
producing a 105bp amplicon. 






60.4 Gibson forward primer for the 
assembly of MIT1 downstream of  






60.5 Gibson reverse primer for the 
assembly of MIT1 upstream of the 






60.9 Gibson reverse primer for the 
assembly of MIT1 into the 







N/A Gibson part containing the T. asigna 







63.1 Gibson forward primer for the 
assembly of mxr1t-sv40 downstream 
of the T2A sequence within the 








62.1 Gibson forward primer for the 
assembly of mxr1t-sv40 upstream of 
the AOX1 transcription terminator 
sequence within the polycistronic 
expression cassette 
111-5'GAP GTCCCTATTTCAATCAATTGAA 59.8 Forward primer for sequencing of 
vectors containing the GAP promoter 
114-qhygb2-F GACAATGGCCGCATAACAG 60.1 qPCR forward primer for hph, 
producing a 114bp amplicon.  
Efficiency = 89.18% 
115-qhygb2-R CTGCTCCATACAAGCCAACC 60.7 qPCR reverse primer for hph, 
producing a 114bp amplicon.  
Efficiency = 89.18% 
116-qmit1-1-F CCAAGCAGATCTGTGGGATT 60.1 qPCR forward primer for MIT1, 
producing a 193bp amplicon.  
Efficiency = 97.22% 
117-qmit1-1-R AACTCCTTGCCCTTCCAGTT 60.1 qPCR reverse primer for MIT1, 193bp 







Description Source Reference 
pPICZαB P. pastoris secreted 
expression vector utilising 
the AOX1 promoter for 
targeted integration into the 
AOX1 locus  
sh ble; pUC ori; 5’AOX1-αmf-
MCS-AOX1 TT poly-histidine 




Thermo Fisher Scientific catalogue 
pAmpZα Modified from pPICZαB with 
an AmpR expression cassette 
cloned between the Sh ble 
expression cassette and pUC 
ori 
This study Unpublished 
pGOxZα Based on pAmpZα, with gox 
cloned into the MCS 
downstream of the AOX1 
promoter 
This study Unpublished 
pGOxHα Modified from pAmpZα, with 
sh ble replaced with HIS4 in 
the same expression cassette 
and gox cloned into the MCS 
downstream of the AOX1 
promoter 
This study Unpublished 
pAVE522 P. pastoris expression vector 
utilizing the AOX1 promoter 
for targeted integration into 
the AOX1 locus  
sh ble; bacterial ori; 5’AOX1-








pAVE522-k Modified from pAVE522, with 
sh ble replaced with 
Tn903kanr in the same 
expression cassette 
This study Unpublished 
pAVECRS Modified from pAVE522-k, 
with sh ble cloned into the 
MCS, downstream of the 
AOX1 promoter 
This study Unpublished 






Description Source Reference 
pAVECRS-
mxr1t-sv40 
Modified from pAVECRS to 
contain an expression 
cassette consisting of an 
expression cassette for the N 
terminal 400 amino acids of 




This study Unpublished 
pIB2 P. pastoris expression vector 
utilizing the GAP promoter 
and integrating into the HIS4 
locus 








Sears et al. (1998) 
pGrzαHSA P. pastoris expression vector 
integrating into the rDNA 
locus, based on pPICZα. 
5’AOX1 upstream region 
replaced with rDNA locus 
sequence and the GAP 
promoter from pIB2.  





pAG32 Vector containing an hph 
expression cassette for S. 
cerevisiae, based on pFA6. 







Goldstein and McCusker (1999) 
p414-TEF1p-
Cas9-CYC1t 
S. cerevisiae expression 
vector for human-optimised 
S. pyogenes Cas9. 
ampr; pBR322 ori, 5’ TEF1-















Description Source Reference 
pPCas9 P. pastoris expression vector for human-optimised 
S. pyogenes Cas9, modified from pGrzαHSA.  sh 
ble replaced with hph and αmf-HSA replaced with 
CAS9-sv40 NLS 
This study Unpublished 
pPhGmit1 Modified from pPCas9.  CAS9-SV40 NLS replaced 
with MIT1 
This study Unpublished 
pPhGmm1 Modified from pPCas9.  CAS9-SV40 NLS replaced 
with MIT1-T2A-MXR1 (5’ 1200bp) 
This study Unpublished 
pJET 
1.2/blunt 
E. coli blunt cloning vector with a lethal insert for 
positive selection of transformants cloned with 
blunt PCR products 










Expression cassette consisting of the S. cerevisiae 
snr52 promoter, gRNA targeting position 340 of P. 
pastoris ade2 and S. cerevisiae sup4 TT cloned 
into pJET 1.2/blunt 







Expression cassette consisting of the S. cerevisiae 
snr52 promoter, gRNA targeting position 340 of P. 
pastoris ade2 and S. cerevisiae sup4 TT cloned 
into pJET 1.2/blunt 






Expression cassette consisting of the P. pastoris 
G1 promoter - Hammerhead ribozyme - gRNA 
targeting position 340 of P. pastoris ade2 - HDV 
ribozyme - adh TT cloned into pMK-RQ. 
kanr; Col E1 ori;  







Expression cassette consisting of the P. pastoris 
G1 promoter - Hammerhead ribozyme - gRNA 
targeting position 689 of P. pastoris ade2 - HDV 
ribozyme - adh TT cloned into pMK-RQ. 
kanr; Col E1 ori;  







P. pastoris expression vector based on pPICZα.  
pPICZα expression cassette replaced with pPIC9k-
based expression cassette containing HULT70A 
downstream of the AOX1 promoter. 













Figure 61: Standard curve plotting the emission values at 590nm after excitement at 530nm against the activity 








Figure A62: Growth curve displaying the natural logarithm (ln) of cell  density for P. pastoris NRRL 11430 (WT) 
and NRRL 11430 Δopi1 against time during growth in minimal media containing 4% (w/v) sorbitol.  The dotted 
line for each plot represents the range of data points used to calculate the doubling times of each strain. 
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9.4 Biological parts designed and synthesised for CRISPR-Cas9 of P. 
pastoris 
 









Figure A63: Map of P. pastoris ADE2 showing the location of the 2 potential CRISPR recognition sequences used 
in this study.  A 5'(N20)-NAG-3‘ site occurs at position 340 on the sense strand while a 5'(N20)-NGG-3‘ site was 
identified at position 689 on the antisense strand. 
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Figure A64: Generalised maps for expression cassettes employing the 2 different strategies for gRNA expression 
in P. pastoris.  A – Expression cassette described by DiCarlo et al. (2013) for gRNA expression in S. cerevisiae, 
employing the yeast SNR52 promoter for RNA polymerase III mediated transcription, and the SUP4 transcription 
terminator.  B – Expression cassette based on the system described by Gao and Zhao (2014) for expression 
using RNA polymerase II promoters.  Mature gRNA sequences are flanked by self-processing ribozymes that 
catalyze their cleavage and removal from the resulting mRNA transcript.  
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Figure A65: Schematic from Gao and Zhao (2014) illustrating the mechanism of self-cleavage of pre-guide mRNA 








Figure A66: Prediction of importin α-dependent nuclear localisation signals in Mxr1p by cNLS Mapper (Kosugi et 
al, 2009).  No putative monopartite or bipartite cNLS’s could be located within the full  amino acid sequence for 
Mxr1p. 
